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This	  dissertation	  explores	  three	  distinct,	  but	  interrelated,	  areas	  of	  research	  that	  
provide	  important	  additions	  to	  the	  current	  colorectal	  cancer	  (CRC)	  screening	  literature.	  	  
The	  first	  study	  reveals	  the	  problematic	  nature	  of	  the	  common	  practice	  of	  ignoring	  the	  
impetus	  for	  CRC	  testing	  when	  specifying	  outcomes	  in	  survey	  design	  and	  analysis.	  	  The	  
results	  show	  significant	  overestimation	  of	  true	  screening	  rates,	  high	  rates	  of	  diagnostic	  
testing	  and	  disproportionate	  rates	  of	  screening	  among	  those	  with	  less	  socioeconomic	  
privilege	  when	  compared	  with	  those	  with	  more	  socioeconomic	  resources.	  	  The	  second	  
study	  finds	  that	  survey	  measurements	  often	  mistake	  diagnostic	  testing	  referrals	  for	  true	  
screening	  recommendations,	  resulting	  in	  significant	  misperception	  about	  who	  is	  likely	  to	  
receive	  a	  screening	  recommendation.	  	  Finally,	  the	  third	  study	  showed	  that	  although	  
individuals	  with	  multiple	  chronic	  conditions	  are	  more	  likely	  to	  engage	  in	  diagnostic	  
testing,	  their	  overall	  rates	  of	  true	  screening	  are	  higher	  than	  the	  general	  population.	  	  	  
Based	  on	  our	  findings,	  we	  recommend	  immediate	  changes	  to	  survey	  
methodology,	  specifically	  collecting	  data	  that	  allow	  researchers	  to	  clearly	  differentiate	  
diagnostic	  testing	  and	  true	  screening.	  Furthermore,	  behavioral	  researchers	  need	  to	  
reanalyze	  additional	  NHIS	  data	  to	  determine	  the	  extent	  to	  which	  diagnostic	  testing	  has	  
misestimated	  improvements	  in	  CRC	  screening	  rates	  across	  time.	  	  Researchers	  exploring	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psychosocial	  and	  instrumental	  barriers	  and	  facilitators	  of	  CRC	  screening	  need	  to	  actively	  
engage	  with	  individuals	  from	  many	  sociodemographic	  groups.	  	  Our	  results	  show	  
troubling	  variation	  in	  screening	  uptake	  and	  recommendations	  across	  groups.	  	  We	  need	  
to	  understand	  the	  source	  of	  this	  variation	  in	  order	  to	  design	  and	  target	  interventions	  
appropriately.	  	  We	  further	  recommend	  that	  policymakers	  reconsider	  their	  approach	  to	  
federal	  screening	  goals.	  	  Specifically,	  a	  one-­‐size-­‐fits-­‐all	  goal	  that	  averages	  very	  high	  and	  
very	  low	  rates	  across	  sociodemographic	  groups	  fails	  to	  acknowledge	  the	  challenges	  we	  
face	  in	  improving	  public	  health	  across	  levels	  of	  privilege.	  	  Significant	  gaps	  in	  screening	  
rates	  will	  continue	  to	  persist	  if	  resources	  are	  not	  allocated	  to	  addressing	  these	  
disparities.	  Finally,	  our	  results	  show	  we	  must	  continue	  to	  explore	  contextual	  factors	  
such	  as	  MCC	  as	  we	  seek	  to	  identify	  influential	  factors	  at	  multiple	  levels	  that	  influence	  

















Whether	  we	  are	  undergraduate	  students	  studying	  a	  public	  health	  challenge	  for	  
the	  first	  time,	  doctoral	  students	  crafting	  their	  dissertation	  research	  agenda,	  or	  well-­‐
established	  researchers,	  we	  all	  strive	  to	  do	  great	  research.	  	  	  Our	  shared	  goal	  is	  to	  reduce	  
suffering,	  to	  improve	  quality	  of	  life,	  and	  to	  broaden	  our	  level	  of	  understanding	  of	  the	  
complex	  challenges	  that	  we	  face	  in	  the	  field	  of	  public	  health.	  	  Sometimes	  our	  goals	  are	  
met	  by	  following	  established	  convention	  in	  the	  approach	  that	  we	  take,	  whether	  we	  are	  
doing	  research,	  practice	  or	  policy	  work.	  	  Other	  times,	  we	  have	  to	  think	  outside	  the	  
proverbial	  box	  to	  discover	  something	  that	  we	  might	  be	  missing.	  	  	  
Despite	  decades	  of	  research	  on	  strategies	  to	  reduce	  morbidity	  and	  mortality	  
from	  colorectal	  cancer	  (CRC),	  the	  disease	  remains	  the	  third	  most	  commonly	  diagnosed	  
cancer	  and	  third	  leading	  cause	  of	  cancer-­‐related	  death	  in	  the	  United	  States	  (American	  
Cancer	  Society,	  2011).	  	  Compared	  to	  other	  tumor-­‐related	  cancers,	  CRC	  is	  unique	  in	  that	  
it	  is	  nearly	  completely	  preventable	  with	  the	  detection	  and	  removal	  of	  pre-­‐cancerous	  
polyps	  through	  screening.	  	  	  Unlike	  other	  cancer	  screenings	  that	  can	  involve	  patient-­‐
directed	  behaviors	  at	  home	  such	  as	  self-­‐exams	  of	  the	  breast,	  testicles,	  and	  skin,	  all	  types	  
of	  CRC	  screening	  require	  active	  participation	  of	  both	  patient	  and	  their	  physician.	  	  
	  	   3	  
Physician	  referrals	  are	  necessary	  to	  initiate	  tests	  ranging	  from	  non-­‐invasive	  fecal	  occult	  
blood	  tests	  (FOBT)	  to	  invasive	  tests	  such	  as	  colonoscopies	  and	  sigmoidoscopies.	  	  Over	  
ten	  percent	  of	  cancer	  deaths	  in	  this	  country	  are	  attributable	  to	  CRC.	  	  This	  statistic	  
reflects	  the	  troubling	  patterns	  of	  low	  population	  screening	  rates	  and	  low	  rates	  of	  
physician	  recommendations	  to	  screen,	  resulting	  in	  later,	  less	  survivable	  stage	  at	  
diagnosis	  (American	  Cancer	  Society,	  2010;	  Coughlin	  &	  Thompson,	  2005).	  	  Considering	  
the	  tools	  at	  our	  disposal	  to	  prevent	  CRC	  morbidity	  and	  mortality,	  the	  degree	  to	  which	  
the	  disease	  impacts	  population	  health	  is	  simply	  unacceptable,	  and	  we	  need	  novel	  
approaches	  to	  understanding	  	  
a) patterns	  in	  screening	  and	  recommendation	  rates;	  	  
b) factors	  that	  contribute	  to	  patients’	  persistent	  underutilization	  of	  CRC	  
screening	  and	  	  
c) 	  factors	  that	  contribute	  to	  physicians’	  lack	  of	  communication	  of	  CRC	  
screening	  recommendations	  to	  their	  patients.	  	  	  
This	  introduction	  will	  provide	  an	  overview	  of	  features	  of	  CRC	  screening,	  my	  entry	  into	  
this	  line	  of	  research	  and	  the	  research	  questions	  explored	  throughout	  the	  dissertation.	  
Most	  clinical	  and	  advocacy	  organizations	  recommend	  initiation	  of	  CRC	  screening	  
in	  average	  risk	  adults	  at	  age	  50,	  with	  earlier	  screening	  recommended	  for	  individuals	  with	  
gastrointestinal	  comorbidities	  or	  a	  family	  history	  of	  CRC	  (American	  Cancer	  Society,	  2011;	  
US	  Preventive	  Services	  Task	  Force,	  2008).	  	  This	  age	  group	  is	  growing:	  	  by	  the	  end	  of	  the	  
year	  2015,	  an	  estimated	  one	  in	  five	  Americans	  will	  be	  ages	  50-­‐64	  (Holden,	  Jonas,	  
Porterfield,	  Reuland,	  &	  Harris,	  2010).	  Accurate	  assessment	  of	  behavioral	  trends	  and	  
predictors	  will	  be	  crucial	  to	  effective	  design	  of	  interventions	  to	  engage	  this	  population	  
and	  their	  physicians	  in	  CRC	  screening.	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Over	  the	  past	  decades,	  researchers	  have	  developed	  methods	  to	  understand	  CRC	  
screening	  in	  many	  ways	  including	  analysis	  of	  large-­‐scale	  surveys,	  electronic	  health	  
record	  reviews,	  state-­‐level	  surveys,	  and	  more	  (Breen,	  Wagener,	  Brown,	  Davis,	  &	  Ballard-­‐
Barbash,	  2001;	  Centers	  for	  Disease	  Control,	  2010;	  Doubeni	  et	  al.,	  2010;	  Guerra,	  Katrina	  
Armstrong	  MD,	  &	  Brown,	  2007).	  	  This	  research	  is	  mainly	  in	  two	  areas	  of	  focus:	  	  first,	  on	  
patients	  and	  their	  engagement	  with	  CRC	  screening.	  	  Researchers	  have	  assessed	  rates	  of	  
screening,	  sociodemographic	  and	  psychosocial	  predictors	  of	  screening,	  trends	  over	  time	  
and	  disparities	  across	  groups.	  	  Second	  is	  a	  focus	  on	  physicians	  and	  patterns	  and	  
predictors	  of	  their	  behaviors	  with	  their	  patients.	  	  Here,	  too,	  researcher	  have	  looked	  at	  
rates	  of	  recommendations,	  predictors	  of	  the	  physician’s	  recommendation	  patterns	  
(both	  in	  terms	  of	  demographic	  characteristics	  of	  the	  physician	  and	  his	  or	  her	  patient),	  
trends	  over	  time	  and	  disparities	  in	  who	  reports	  the	  receipt	  of	  a	  recommendation	  to	  
screen	  for	  CRC	  from	  their	  physician	  or	  other	  health	  care	  provider.	  	  	  
Overall,	  we	  have	  seen	  some	  improvements	  in	  CRC	  screening	  rates	  at	  both	  the	  
patient	  and	  physician	  level	  over	  time,	  but	  both	  rates	  remain	  far	  below	  federal	  goals	  set	  
by	  Healthy	  People	  2010	  and	  Healthy	  People	  2020	  (US	  Department	  of	  Health	  &	  Human	  
Services,	  2013).	  	  Furthermore,	  there	  is	  evidence	  of	  disparities	  existing	  between	  males	  
and	  females,	  across	  race/ethnicity,	  age,	  education,	  and	  income	  categories	  and	  between	  
states	  and	  wider	  geographic	  areas	  (Ahmed,	  Pelletier,	  Winter,	  &	  Albatineh,	  2013;	  
Ananthakrishnan,	  Schellhase,	  Sparapani,	  Laud,	  &	  Neuner,	  2007;	  Cole,	  Jackson,	  &	  
Doescher,	  2012;	  James,	  2006).	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My	  dissertation	  research	  seeks	  to	  answer	  three	  important	  sets	  of	  questions	  that	  
will	  be	  valuable	  additions	  to	  the	  current	  literature	  on	  CRC	  screening.	  	  The	  research	  aims	  
were	  driven	  in	  large	  part	  by	  my	  involvement	  with	  a	  qualitative	  study	  led	  by	  Dr.	  Arden	  
Morris	  examining	  treatment	  decisions	  of	  CRC	  patients.	  	  Although	  the	  primary	  aims	  of	  
the	  study	  were	  about	  decisions	  related	  to	  treatment	  of	  their	  disease	  and	  not	  directly	  
related	  to	  CRC	  screening,	  I	  noticed	  three	  themes	  while	  analyzing	  the	  interview	  and	  focus	  
group	  data:	  
• participants	  were	  diagnosed	  most	  often	  by	  diagnostic	  testing	  and	  not	  
pre-­‐symptomatic	  screening;	  
• participants’	  discussions	  with	  their	  physician	  were	  related	  to	  referrals	  for	  
diagnostic	  testing	  and	  not	  recommendations	  for	  pre-­‐symptomatic	  
screening;	  and	  
• acute	  and	  multiple	  chronic	  conditions	  appear	  to	  be	  associated	  with	  delay	  
or	  omission	  of	  CRC	  screening.	  	  	  	  
	  
Answering	  the	  specific	  questions	  that	  arise	  from	  each	  theme	  will	  complement	  the	  
existing	  body	  of	  literature	  on	  CRC	  screening,	  and	  will	  have	  unique	  implications	  for	  
researchers,	  practitioners,	  and	  policymakers.	  	  For	  researchers,	  it	  will	  be	  important	  to	  
answer	  these	  questions	  so	  that	  we	  know	  whether	  we	  are	  measuring	  what	  we	  have	  
intended	  to	  measure.	  	  This	  applies	  not	  only	  to	  rates	  of	  screening,	  but	  also	  to	  trends	  in	  
screening	  over	  time,	  disparities	  in	  screening,	  and	  predictors	  of	  screening.	  	  For	  
practitioners,	  answering	  these	  questions	  will	  clarify	  the	  impact	  of	  conflation	  of	  
screening	  versus	  diagnostic	  testing,	  which	  has	  the	  potential	  to	  interfere	  with	  accurate	  
measurement	  of	  intervention	  efficacy.	  	  Specifically,	  our	  study	  will	  reveal	  whether	  simply	  
counting	  procedures	  (colonoscopy)	  provides	  adequate	  assessment	  of	  the	  success	  or	  
failure	  of	  an	  intervention	  or	  whether	  we	  must	  also	  ask	  why	  the	  procedure	  was	  ordered.	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And	  finally,	  policymakers	  will	  gain	  evidence	  supporting	  or	  refuting	  longstanding	  
perceptions	  of	  the	  gap	  between	  rates	  of	  screening	  and	  established	  Healthy	  People	  
goals.	  	  Answering	  these	  questions	  will	  also	  enable	  policymakers	  to	  better	  understand	  
disparities	  in	  screening,	  which	  is	  essential	  to	  effective	  program	  planning	  at	  federal	  and	  
state	  levels.	  
Are	  We	  Really	  Measuring	  Screening?	  
The	  first	  theme	  from	  the	  preliminary	  qualitative	  data	  was	  that	  most	  patients	  
delayed	  screening	  and	  few	  were	  diagnosed	  through	  testing	  at	  an	  asymptomatic	  stage,	  
what	  I	  will	  call	  “true	  screening”.	  	  Instead,	  over	  70%	  of	  the	  patients	  were	  diagnosed	  as	  
the	  result	  of	  post-­‐symptomatic	  testing,	  what	  I	  will	  call	  “diagnostic	  testing”	  (Becker,	  E.,	  
Elliott,	  H.,	  Griffith,	  D.,	  Alexander,	  G.,	  &	  Morris,	  A.,	  2010).	  	  I	  began	  to	  wonder	  how	  cancer	  
researchers	  specified	  behavioral	  outcomes.	  	  If	  they	  did	  not	  distinguish	  the	  two	  
behaviors,	  respondents	  like	  these	  study	  participants	  engaging	  in	  post-­‐symptomatic	  
testing	  will	  be	  categorized	  as	  true	  screeners,	  which	  was	  certainly	  not	  reflective	  of	  their	  
behaviors,	  nor	  is	  it	  consistent	  with	  the	  behavioral	  outcome	  that	  will	  improve	  public	  
health.	  
As	  I	  began	  to	  explore	  the	  cancer	  screening	  literature	  and	  CRC	  screening	  data	  
sources	  in	  particular	  to	  see	  if	  these	  questions	  had	  been	  addressed,	  I	  found	  that	  there	  
was	  persistent	  conflation	  of	  diagnostic	  testing	  and	  true	  screening	  behaviors.	  	  In	  fact,	  I	  
found	  only	  three	  studies	  that	  did	  not	  conflate	  the	  two	  behaviors.	  	  As	  I	  reviewed	  the	  
survey	  protocol,	  I	  found	  that	  the	  National	  Health	  Interview	  Survey	  inquired	  about	  the	  
impetus	  for	  testing,	  leaving	  me	  wondering	  why	  so	  few	  survey	  analysts	  used	  the	  available	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data	  on	  impetus	  for	  testing	  in	  their	  research	  analyses.	  	  And	  perhaps	  the	  most	  often	  cited	  
resource	  for	  cancer	  screening	  data,	  the	  Behavioral	  Risk	  Factor	  Surveillance	  Survey	  
(BRFSS),	  did	  not	  even	  ask	  respondents	  why	  they	  engaged	  in	  CRC	  testing	  or	  why	  their	  
physician	  discussed	  it	  with	  them.	  	  In	  fact,	  the	  conflation	  of	  diagnostic	  testing	  and	  true	  
screening	  was	  a	  consistently	  cited	  limitation	  across	  studies	  using	  BRFSS	  data.	  	  
Furthermore,	  I	  found	  no	  examination	  of	  the	  potential	  impact	  of	  conflation	  of	  these	  two	  
behaviors	  when	  examining	  published	  screening	  rates.	  	  	  	  
Considering	  the	  paucity	  of	  available	  information	  on	  these	  issues,	  the	  first	  
research	  area	  that	  I	  explore	  in	  this	  dissertation	  is	  patient-­‐focused;	  namely,	  in	  Chapter	  2,	  
I	  explore	  whether	  or	  not	  researchers	  have	  been	  overestimating	  population	  rates	  of	  
screening	  by	  conflating	  diagnostic	  testing	  and	  true	  screening	  in	  cancer	  screening	  
research.	  
Are	  We	  Really	  Measuring	  Physician	  Recommendations	  to	  Screen?	  
This	  theme	  of	  diagnostic	  testing	  versus	  true	  screening	  is	  highly	  relevant	  for	  the	  
second	  theme	  that	  emerged	  from	  the	  qualitative	  study,	  the	  lack	  of	  clarity	  around	  	  the	  
physician	  recommendation	  for	  colonoscopy	  for	  colorectal	  cancer	  testing.	  	  The	  study	  
participants	  often	  spoke	  of	  the	  interactions	  with	  their	  physicians	  and	  how	  that	  impacted	  
their	  engagement	  (or	  lack	  thereof)	  with	  CRC	  testing.	  	  In	  addition,	  many	  study	  
participants	  reported	  scenarios	  in	  which	  diagnostic	  testing	  was	  the	  clear	  reason	  for	  the	  
referral,	  rather	  than	  a	  recommendation	  for	  true	  screening.	  	  Improving	  public	  health	  
mandates	  high	  rates	  of	  recommendations	  for	  true	  screening,	  whereas	  high	  rates	  of	  
diagnostic	  testing	  indicate	  that	  not	  enough	  patients	  are	  being	  screened.	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The	  second	  research	  area	  I	  explore	  this	  dissertation	  is	  physician-­‐focused;	  namely,	  
in	  Chapter	  Three,	  I	  seek	  to	  answer	  the	  question,	  have	  we	  been	  overestimating	  rates	  of	  
physician	  screening	  recommendations	  by	  conflating	  referrals	  for	  diagnostic	  testing	  with	  
recommendations	  for	  true	  screening	  in	  our	  surveys	  and	  analyses	  of	  electronic	  health	  
records?	  	  	  
As	  mentioned	  earlier,	  CRC	  screening	  is	  a	  behavior	  that	  requires	  action	  by	  both	  
patient	  and	  physician.	  	  Prior	  research	  has	  consistently	  demonstrated	  that	  a	  top	  
predictor	  of	  patients’	  engagement	  with	  screening	  is	  a	  recommendation	  from	  their	  
physician	  (Coughlin	  &	  Thompson,	  2005;	  Klabunde,	  Breen,	  &	  Meissner,	  2005).	  	  The	  
implications	  of	  these	  questions	  are	  important	  to	  researchers	  as	  they	  seek	  to	  accurately	  
assess	  rates,	  predictors	  and	  trends	  of	  physician	  CRC	  screening	  behaviors.	  	  Practitioners	  
can	  use	  this	  evidence	  to	  determine	  if	  healthcare	  quality	  benchmarks	  in	  cancer	  screening	  
recommendations	  are	  met.	  	  However,	  conflating	  referrals	  for	  diagnostic	  testing	  and	  
recommendations	  for	  true	  screening	  may	  give	  a	  false	  impression	  of	  recommendation	  
rates	  and	  may	  misrepresent	  success	  of	  reaching	  these	  benchmarks.	  Finally,	  
policymakers	  will	  find	  these	  analyses	  useful	  as	  they	  develop	  goals	  for	  physician	  
recommendation	  rates,	  such	  as	  the	  goals	  now	  in	  the	  developmental	  phase	  for	  Healthy	  
People	  2020	  (US	  Department	  of	  Health	  &	  Human	  Services,	  2013).	  
Exploring	  the	  Influence	  of	  MCC	  on	  CRC	  Screening	  and	  Recommendations	  to	  Screen	  
In	  the	  preliminary	  qualitative	  study	  ,	  another	  important	  discovery	  was	  the	  third	  
theme	  explored	  in	  this	  dissertation:	  the	  impact	  of	  acute	  and	  multiple	  chronic	  conditions	  
(MCC)	  on	  participants’	  delays	  in	  engaging	  in	  true	  screening	  and	  instead	  engaging	  in	  post-­‐
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symptomatic	  diagnostic	  testing.	  	  While	  study	  participants	  with	  acute	  health	  challenges	  
(e.g.	  knee	  replacement)	  described	  delays	  in	  screening,	  respondents	  with	  multiple	  
chronic	  conditions,	  defined	  as	  two	  or	  more	  co-­‐occurring	  chronic	  conditions	  (e.g.	  
diabetes	  and	  kidney	  disease),	  described	  other	  barriers	  such	  as	  physiological	  symptoms	  
(e.g.	  chronic	  pain)	  that	  caused	  them	  to	  be	  apprehensive	  about	  going	  through	  another	  
medical	  test	  unrelated	  to	  their	  conditions.	  	  Furthermore,	  patients	  with	  MCC	  described	  
feeling	  fearful	  of	  yet	  another	  diagnosis,	  and	  therefore	  avoiding	  cancer	  screening	  
altogether	  (Becker,	  Elliott,	  Griffith,	  Alexander,	  &	  Morris,	  2010).	  	  The	  third	  research	  area	  
explored	  in	  this	  dissertation	  is	  focused	  on	  the	  role	  of	  multiple	  chronic	  conditions	  in	  
screening	  and	  recommendations	  for	  CRC	  screening;	  namely,	  in	  Chapter	  4,	  I	  explore	  the	  
association	  between	  MCC	  and	  screening	  and	  recommendations	  to	  screen.	  
To	  date,	  much	  of	  the	  CRC	  screening	  literature	  has	  focused	  on	  sociodemographic	  
and	  psychosocial	  characteristics	  and	  their	  influence	  on	  screening	  behaviors	  of	  study	  
participants	  and	  their	  physicians.	  	  This	  is	  helpful	  as	  we	  consider	  differences	  between	  
genders,	  race/ethnicity	  groups,	  and	  socioeconomic	  groups,	  but	  little	  attention	  has	  been	  
paid	  to	  other	  factors	  such	  as	  MCC	  that	  create	  context	  at	  both	  individual	  and	  institutional	  
levels.	  	  At	  the	  individual	  level,	  patients	  with	  MCC	  face	  increasing	  physical,	  emotional,	  
and	  financial	  burdens	  that	  may	  reduce	  an	  individual’s	  likelihood	  to	  engage	  in	  screening.	  	  
At	  the	  institutional	  level,	  MCC	  can	  influence	  the	  priorities	  of	  care.	  	  Instead	  of	  preventive	  
care,	  physicians	  of	  patients	  with	  MCC	  may	  instead	  focus	  on	  more	  serious	  illnesses,	  
conditions	  that	  require	  immediate	  attention,	  disease	  management	  and	  flares.	  	  Finally,	  
MCC	  may	  explain	  some	  of	  the	  sociodemographic	  disparities	  in	  CRC	  screening	  literature.	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More	  than	  25%	  of	  Americans	  live	  with	  MCC,	  but	  MCC	  is	  unequally	  distributed	  across	  
racial	  and	  socioeconomic	  groups,	  with	  greater	  burden	  in	  those	  with	  less	  social	  and	  
economic	  privilege.	  	  If	  MCC	  interferes	  with	  CRC	  screening,	  it	  may	  account	  for	  part	  of	  the	  
screening	  disparities	  between	  groups	  as	  well	  as	  the	  predictive	  value	  of	  those	  
sociodemographic	  categories	  in	  multivariate	  models.	  
Answering	  the	  questions	  of	  MCC’s	  association	  with	  screening	  and	  physician	  
recommendations	  will	  be	  critical	  to	  enriching	  the	  existing	  literature	  that	  is	  largely	  
focused	  on	  sociodemographic	  and	  psychosocial	  predictors	  of	  screening.	  	  To	  my	  
knowledge,	  this	  is	  the	  first	  study	  to	  approach	  MCC	  as	  a	  predictor	  of	  CRC	  screening	  using	  
a	  nationally	  representative	  dataset.	  	  	  
In	  summary,	  in	  an	  effort	  to	  add	  valuable	  information	  to	  the	  conversation	  on	  CRC	  
screening,	  this	  dissertation	  explores	  the	  following	  research	  questions:	  
Chapter	  2	  –	  Is	  this	  really	  screening?:	  	  Are	  rates	  of	  screening	  behaviors	  
overestimated	  by	  conflation	  of	  diagnostic	  testing	  and	  true	  screening?	  	  If	  
so,	  does	  the	  degree	  of	  overestimation	  vary	  by	  sociodemographic	  group?	  	  
How	  do	  predictors	  of	  screening	  change	  when	  the	  outcome	  is	  correctly	  
specified	  and	  does	  not	  include	  diagnostic	  testing?	  
	  
Chapter	  3	  –	  Is	  this	  really	  a	  physician	  recommendation	  for	  screening?:	  	  
Are	  rates	  of	  screening	  recommendation	  behaviors	  overestimated	  by	  
conflating	  referrals	  for	  diagnostic	  testing	  and	  recommendations	  for	  true	  
screening?	  	  If	  so,	  does	  the	  degree	  of	  overestimation	  vary	  by	  
sociodemographic	  group?	  	  How	  do	  predictors	  of	  screening	  
recommendations	  change	  when	  the	  outcome	  is	  correctly	  specified	  and	  
does	  not	  include	  referrals	  for	  diagnostic	  testing?	  
	  
Chapter	  4	  –	  The	  influence	  of	  MCC	  on	  screening:	  	  Is	  the	  presence	  of	  
multiple	  chronic	  conditions	  associated	  with	  patients’	  and	  physicians’	  CRC	  
screening	  behaviors?	  	  How	  does	  accounting	  for	  MCC	  in	  predictive	  models	  
impact	  the	  associations	  between	  sociodemographic	  characteristics	  and	  
the	  outcomes	  of	  interest?	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This	  research	  will	  add	  valuable	  information	  to	  the	  CRC	  screening	  literature	  and	  assist	  
researchers,	  practitioners	  and	  policymakers	  as	  we	  seek	  to	  reduce	  the	  burden	  of	  CRC	  
morbidity	  and	  mortality.	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CHAPTER	  TWO	  
	  
Methodological	  Issues	  in	  Colorectal	  Cancer	  Research:	  	  	  




Colorectal	  cancer	  (CRC)	  is	  the	  third	  leading	  cause	  of	  cancer-­‐related	  death	  in	  the	  
United	  States.	  	  It	  is	  estimated	  that	  143,460	  new	  cases	  of	  the	  disease	  and	  51,690	  deaths	  
(~10%	  of	  all	  cancer	  deaths)	  will	  be	  attributable	  to	  CRC	  in	  2012	  (American	  Cancer	  Society,	  
2012).	  	  Colorectal	  cancer	  mortality	  is	  highly	  correlated	  with	  stage	  at	  diagnosis,	  with	  five-­‐
year	  survival	  rates	  ranging	  from	  90%	  for	  local-­‐stage	  disease	  to	  68%	  for	  regional-­‐stage	  
disease	  and	  only	  11%	  for	  distant-­‐stage	  disease	  (American	  Cancer	  Society,	  2010;	  Doubeni	  
et	  al.,	  2006;	  Emmons	  et	  al.,	  2008).	  	  Unlike	  other	  tumor	  cancers,	  CRC	  is	  largely	  
preventable	  with	  early	  detection	  and	  removal	  of	  pre-­‐cancerous	  polyps	  (American	  
Cancer	  Society,	  2012).	  	  Research	  suggests	  that	  nine	  of	  ten	  deaths	  from	  CRC	  could	  be	  
prevented	  with	  early	  detection	  through	  use	  of	  one	  or	  more	  screening	  modalities	  
(Subramanian,	  Klosterman,	  Amonkar,	  &	  Hunt,	  2004).	  	  By	  definition,	  cancer	  screening	  
occurs	  at	  a	  stage	  of	  disease	  at	  which	  no	  symptoms	  are	  present	  (we	  will	  refer	  to	  this	  as	  
‘true	  screening’)	  (National	  Cancer	  Institute,	  2013).	  	  Tests	  for	  disease	  after	  symptoms	  
appear	  are	  diagnostic	  in	  nature,	  and	  are	  associated	  with	  diagnosis	  at	  a	  later	  stage	  of	  
disease	  and	  a	  greater	  morbidity	  and	  mortality	  burden.	  	  In	  order	  to	  improve	  public	  health	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by	  reducing	  CRC	  morbidity	  and	  mortality,	  we	  want	  high	  rates	  of	  true	  screening	  and	  low	  
rates	  of	  diagnostic	  testing.	  	  	  	  
Historically,	  methods	  to	  measure	  rates	  of	  screening	  have	  focused	  on	  self-­‐
reported	  data	  from	  national	  surveys.	  	  National	  organizations	  including	  the	  Centers	  for	  
Disease	  Control	  and	  Prevention	  (CDC),	  the	  American	  Cancer	  Society	  (ACS),	  the	  Agency	  
for	  Healthcare	  Research	  Quality	  (AHRQ),	  and	  Healthy	  People	  2020	  rely	  on	  these	  surveys	  
to	  provide	  comprehensive	  data	  on	  cancer	  screening	  rates	  and	  trends.	  These	  surveys	  ask	  
respondents	  about	  their	  engagement	  with	  screening	  for	  cancers	  of	  the	  colon/rectum,	  
cervix,	  breast	  or	  prostate	  including	  if	  their	  physician	  or	  other	  health	  care	  provider	  
recommended	  screening.	  	  	  
A	  distinguishing	  feature	  of	  two	  of	  the	  most	  cited	  national	  surveys,	  the	  Behavioral	  
Risk	  Factor	  Surveillance	  Survey	  (BRFSS)	  and	  the	  National	  Health	  Interview	  Survey	  (NHIS),	  
is	  their	  varying	  ability	  to	  differentiate	  true	  screening	  from	  diagnostic	  testing.	  Survey	  
researchers	  utilizing	  BRFSS	  data	  often	  cite	  an	  inability	  to	  distinguish	  between	  these	  
behaviors	  as	  a	  limitation	  to	  their	  studies	  (Centers	  for	  Disease	  Control,	  2010;	  D.	  A.	  
Joseph,	  King,	  Miller,	  &	  Richardson,	  2012;	  Soneji,	  Armstrong,	  &	  Asch,	  2012).	  	  BRFSS	  does	  
not	  ask	  respondents	  why	  they	  engaged	  in	  testing.	  	  In	  contrast	  to	  BRFSS,	  NHIS	  affords	  
researchers	  the	  opportunity	  to	  distinguish	  between	  the	  two	  by	  asking	  respondents	  not	  
only	  what	  test	  they	  had	  and	  when,	  but	  why	  they	  had	  it.	  NHIS	  methodology	  allows	  us	  to	  
better	  differentiate	  screening	  from	  diagnostic	  testing,	  as	  depicted	  in	  Figure	  1.	  	  	  
A	  review	  of	  the	  cancer	  screening	  literature	  reveals	  a	  potential	  problem	  in	  
interpreting	  the	  results	  of	  cancer	  screening	  studies	  due	  to	  the	  irregular	  measurement	  of	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screening.	  	  Specifically,	  methodological	  choices	  in	  survey	  design	  and/or	  analysis	  often	  
result	  in	  a	  conflation	  of	  true	  (pre-­‐symptomatic)	  screening	  with	  diagnostic	  testing	  when	  
specifying	  the	  behavioral	  outcome	  of	  interest.	  
	  
Empirical	  research	  has	  explored	  several	  facets	  of	  screening	  including	  predictors	  
of	  screening,	  rates	  of	  screening	  across	  sociodemographic	  and	  geographic	  characteristics,	  
trends	  in	  rates	  over	  time	  and	  disparities	  in	  screening.	  	  In	  addition	  to	  these	  areas,	  
intervention	  evaluation	  and	  health	  services	  research	  focusing	  on	  adherence	  to	  a	  
physician	  recommendation	  to	  screen	  are	  also	  subject	  to	  survey	  design	  and	  analysis	  
decisions.	  	  Finally,	  we	  need	  to	  be	  cautious	  when	  comparing	  and	  contrasting	  rates	  from	  
behavioral	  studies	  cited	  in	  meta-­‐analyses	  and	  review	  articles	  when	  the	  behavioral	  
outcome	  is	  specified	  differently	  across	  studies	  (see	  Pruitt	  et	  al.	  (2009)	  and	  Beydoun	  &	  
Beydoun	  (2008)).	  In	  addition	  to	  publishing	  inaccurate	  screening	  data	  by	  incorrectly	  
estimating	  rates	  of	  these	  outcomes	  by	  conflating	  diagnostic	  testing	  and	  screening,	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of	  screening;	  and	  b)	  the	  degree	  to	  which	  screening	  rates	  are	  improving.	  	  	  
Even	  when	  the	  data	  are	  available	  (as	  in	  NHIS),	  researchers	  often	  choose	  to	  
conflate	  diagnostic	  testing	  and	  true	  screening.	  	  Coups	  and	  colleagues	  (2007)	  utilize	  NHIS	  
data	  in	  their	  analysis	  of	  behavioral	  risk	  factors	  for	  screening,	  but	  fail	  to	  utilize	  available	  
data	  to	  account	  for	  the	  impetus	  for	  testing	  when	  defining	  their	  outcome	  variable.	  	  
James	  et	  al.	  (2006)	  utilized	  NHIS	  data	  to	  examine	  disparities	  in	  screening	  but	  failed	  to	  
utilize	  available	  data	  on	  the	  impetus	  for	  testing,	  noting,	  	  
“Both	  diagnostic	  and	  screening	  exams	  were	  included	  in	  adherence	  
calculations	  to	  create	  the	  most	  lenient	  definition	  of	  up-­‐to-­‐date	  with	  CRC	  
screening	  recommendations	  and	  to	  be	  consistent	  with	  Healthy	  People	  
2010	  goal	  measurement	  methods.”	  	  	  
	  
There	  are	  very	  few	  examples	  of	  research	  that	  accurately	  specifies	  the	  outcome	  of	  
interest.	  	  Of	  many	  studies	  utilizing	  NHIS	  data,	  we	  found	  three	  that	  do	  not	  conflate	  
diagnostic	  testing	  and	  true	  screening.	  	  In	  their	  work	  examining	  screening	  rate	  trends	  
across	  time,	  Breen	  and	  colleagues	  (2001)	  specify	  their	  analyses	  across	  three	  cycles	  of	  
NHIS	  (spanning	  eleven	  years)	  to	  tests	  reported	  as	  part	  of	  a	  routine	  exam.	  	  Meissner	  and	  
colleagues	  (2006)	  exclude	  respondents	  who	  reported	  CRC	  testing	  for	  diagnostic	  
purposes,	  while	  Subramanian	  and	  colleagues	  (2004)	  reported	  separate	  rates	  for	  any	  
type	  of	  testing	  and	  true	  screening,	  but	  did	  not	  measure	  the	  impact	  of	  conflating	  the	  
two.	  	  	  
The	  majority	  of	  studies	  that	  fail	  to	  account	  for	  the	  impetus	  for	  testing	  are	  
important	  because	  they	  are	  representative	  of	  a	  broader	  issue.	  	  In	  CRC	  screening	  
literature,	  researchers	  often	  misspecify	  behavioral	  outcomes	  in	  a	  way	  that	  fails	  to	  
recognize	  the	  most	  fundamental	  characteristic	  of	  screening:	  	  namely,	  that	  cancer	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screening	  occurs	  at	  the	  pre-­‐symptomatic	  stage	  of	  disease.	  	  
The	  goals	  of	  this	  study	  are	  to	  understand	  a)	  the	  amount	  of	  error	  that	  may	  exist	  in	  
screening	  rates	  by	  conflating	  diagnostic	  testing	  and	  true	  screening;	  b)	  whether	  the	  
degree	  of	  error	  in	  screening	  rates	  varies	  across	  sociodemographic	  categories	  and	  c)	  how	  
predictive	  models	  vary	  when	  the	  outcome	  is	  correctly	  specified.	  	  We	  explore	  these	  
questions	  through	  an	  analysis	  of	  colorectal	  cancer	  screening	  behaviors	  reported	  in	  the	  
2008	  NHIS	  and	  Cancer	  Control	  and	  Sun	  Protection	  Supplement	  (CCSPS).	  
Methods	  
Data	  source.	  	  We	  examined	  cross-­‐sectional	  survey	  data	  from	  the	  2008	  NHIS	  and	  
CSSPS.	  	  Although	  there	  are	  other	  options	  for	  collecting	  preventative	  care	  data	  (including	  
other	  nationally	  representative	  datasets	  and	  electronic	  health	  record	  data),	  we	  are	  
using	  NHIS	  for	  the	  specific	  aims	  and	  broader	  goals	  of	  this	  study	  for	  several	  reasons.	  	  
First,	  it	  allows	  us	  to	  consider	  multiple	  factors	  simultaneously	  as	  we	  consider	  influences	  
on	  screening	  recommendation	  and	  screening	  behaviors.	  Second,	  NHIS	  is	  the	  only	  
nationally	  representative	  dataset	  that	  allows	  us	  to	  capture	  data	  on	  the	  impetus	  for	  
testing,	  a	  critical	  component	  of	  our	  analyses.	  	  And	  finally,	  due	  to	  its	  frequent	  use	  in	  
survey	  research,	  we	  can	  compare	  and	  contrast	  results	  from	  this	  study	  with	  a	  large	  body	  
of	  literature	  in	  CRC	  and	  other	  cancer	  screening	  behaviors.	  	  Since	  its	  inception	  in	  1957,	  
the	  NHIS	  has	  been	  the	  principal	  source	  of	  information	  on	  the	  health	  and	  health	  
behaviors	  of	  civilian,	  non-­‐institutionalized	  households	  in	  the	  United	  States.	  	  The	  survey	  
is	  administered	  annually	  by	  the	  National	  Center	  for	  Health	  Statistics	  (NCHS)	  of	  the	  
Centers	  for	  Disease	  Control	  and	  Prevention	  (CDC)	  and	  uses	  a	  stratified	  multistage	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probability	  sample	  design	  (Centers	  for	  Disease	  Control	  and	  Prevention,	  2012).	  	  The	  2008	  
Cancer	  Screening	  and	  Sun	  Protection	  Supplement	  (CSSPS)	  was	  sponsored	  by	  the	  
National	  Cancer	  Institute	  (NCI)	  and	  includes	  questions	  on	  physician	  recommendations	  
for	  screening,	  screening	  behaviors,	  and	  reasons	  for	  screening	  tests.	  	  The	  2008	  
NHIS/CSSPS	  was	  selected	  over	  the	  more	  recent	  2010	  NHIS	  due	  to	  the	  fact	  that	  questions	  
on	  physician	  recommendations	  for	  screening	  were	  linked	  to	  respondents’	  screening	  
behaviors	  rather	  than	  in	  a	  more	  general	  manner.	  	  This	  allowed	  us	  to	  identify	  the	  
impetus	  for	  the	  physician	  recommendation	  as	  well	  as	  CRC	  testing.	  
The	  NHIS	  sampling	  strategies	  result	  in	  an	  oversample	  of	  self-­‐identified	  Black,	  
Hispanic	  and	  Asian	  Americans.	  	  Weights	  constructed	  for	  the	  NHIS	  respondents	  reflect	  
the	  resulting	  unequal	  probabilities	  of	  selection	  and	  also	  incorporate	  adjustments	  for	  
non-­‐response	  and	  post-­‐stratification	  procedures	  designed	  to	  align	  survey	  estimates	  with	  
population	  distributions	  from	  the	  2000	  Census.	  	  The	  application	  of	  these	  weights	  in	  
secondary	  analyses	  of	  the	  NHIS	  data	  results	  in	  estimates	  that	  are	  representative	  of	  the	  
adult	  civilian	  non-­‐institutionalized	  population	  of	  the	  U.S.	  (Inter-­‐University	  Consortium	  
for	  Political	  and	  Social	  Research,	  2012).	  	  The	  annual	  NHIS	  response	  rate	  averages	  close	  
to	  ninety	  percent	  of	  the	  eligible	  households	  in	  the	  sample	  (Centers	  for	  Disease	  Control	  
and	  Prevention,	  2012).	  	  
Study	  population.	  Our	  study	  population	  included	  non-­‐Hispanic	  White	  and	  non-­‐
Hispanic	  Black	  respondents	  ages	  50-­‐80	  with	  no	  history	  of	  colorectal	  cancer.	  	  We	  chose	  
these	  two	  groups	  because	  Non-­‐Hispanic	  Whites	  and	  Non-­‐Hispanic	  Blacks	  suffer	  the	  
highest	  rates	  of	  cancers	  of	  the	  colon	  and	  rectum	  in	  the	  United	  States	  (American	  Cancer	  
	  	   21	  
Society,	  2011)	  and	  are	  the	  most	  common	  population	  groups	  studied	  in	  CRC	  screening	  
literature	  (Ananthakrishnan,	  Schellhase,	  Sparapani,	  Laud,	  &	  Neuner,	  2007;	  Bellizzi,	  
Breslau,	  Burness,	  &	  Waldron,	  2011;	  Breen,	  Wagener,	  Brown,	  Davis,	  &	  Ballard-­‐Barbash,	  
2001;	  Centers	  for	  Disease	  Control	  and	  Prevention	  (CDC),	  2001;	  James,	  2006;	  Klabunde	  et	  
al.,	  2005).	  	  Individuals	  with	  a	  history	  of	  colorectal	  cancer	  were	  excluded	  since	  
colonoscopic	  testing	  is	  used	  as	  disease	  surveillance	  and	  not	  preventative	  care.	  	  We	  
defined	  a	  subpopulation	  for	  our	  analysis	  of	  true	  screening	  to	  individuals	  who	  reported	  
ACS	  guideline-­‐adherent	  screening	  since	  the	  question	  regarding	  impetus	  for	  testing	  was	  
limited	  to	  those	  respondents.	  	  
This	  study	  received	  an	  exempt	  status	  designation	  from	  the	  University	  of	  
Michigan	  Institutional	  Review	  Board	  (Study	  HUM00062074).	  	  
Measures	  
	  
Dependent	  variables.	  	  	  
Any	  ACS	  guideline	  adherent	  testing.	  	  To	  assess	  ACS	  guideline	  adherence,	  we	  
created	  a	  dichotomous	  variable	  using	  respondents’	  self-­‐reports	  of	  the	  type	  of	  testing	  
they	  underwent	  and	  the	  timeframe	  in	  which	  the	  procedure	  occurred.	  	  To	  assess	  
engagement	  with	  non-­‐invasive	  testing,	  respondents	  were	  asked,	  “The	  following	  
questions	  are	  about	  the	  blood	  stool	  or	  occult	  blood	  test,	  a	  test	  to	  determine	  whether	  
you	  have	  blood	  in	  your	  stool	  or	  bowel	  movement.	  The	  blood	  stool	  test	  can	  be	  done	  at	  
home	  using	  a	  kit.	  You	  use	  a	  stick	  or	  brush	  to	  obtain	  a	  small	  amount	  of	  stool	  at	  home	  and	  
send	  it	  back	  to	  the	  doctor	  or	  lab.	  Have	  you	  EVER	  HAD	  a	  blood	  stool	  test,	  using	  a	  HOME	  
test	  kit?”	  	  Responses	  of	  “yes”	  or	  “no”	  were	  coded	  as	  such,	  while	  responses	  of	  “refused”	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or	  “don’t	  know”	  were	  coded	  as	  missing	  data	  and	  excluded	  from	  analysis.	  	  However,	  in	  
the	  case	  of	  respondents	  whose	  response	  was	  coded	  as	  missing	  for	  non-­‐invasive	  testing	  
but	  “yes”	  or	  “no”	  for	  invasive	  testing	  (see	  following	  paragraph),	  missing	  data	  from	  the	  
	  non-­‐invasive	  testing	  question	  were	  ignored1	  (missing	  n	  =	  52).	  Respondents	  reporting	  
testing	  also	  reported	  testing	  timelines	  in	  one	  of	  the	  following	  formats:	  	  month/year,	  
number	  of	  days,	  weeks,	  months	  or	  years	  since	  testing,	  or	  by	  using	  years	  since	  testing	  (a	  
year	  ago	  or	  less/more	  than	  1	  year	  but	  not	  more	  than	  2	  years/more	  than	  2	  years	  but	  not	  
more	  than	  3	  years/more	  than	  3	  years	  but	  not	  more	  than	  5	  years/more	  than	  5	  years	  but	  
not	  more	  than	  10	  years/over	  10	  years	  ago.	  	  The	  dependent	  variable	  was	  coded	  as	  1	  if	  
FOBT	  testing	  was	  reported	  within	  one	  year	  of	  survey	  administration,	  0	  if	  no	  testing	  or	  
FOBT	  testing	  was	  earlier	  than	  one	  year	  from	  survey	  administration,	  and	  missing	  
otherwise	  (see	  note	  above	  regarding	  handling	  of	  missing	  data).	  	  All	  FOBT	  testing	  was	  
coded	  as	  true	  screening,	  as	  it	  is	  used	  exclusively	  for	  that	  purpose.	  
To	  assess	  engagement	  with	  invasive	  testing,	  respondents	  were	  asked,	  “Have	  you	  
ever	  had	  a	  sigmoidoscopy,	  colonoscopy,	  or	  proctoscopy?	  	  	  These	  are	  exams	  in	  which	  a	  
health	  care	  professional	  inserts	  a	  tube	  into	  the	  rectum	  to	  look	  for	  signs	  of	  cancer	  or	  
other	  problems.”	  	  Responses	  of	  “yes”	  or	  “no”	  were	  coded	  as	  such,	  while	  responses	  of	  
“refused”	  or	  “don’t	  know”	  were	  coded	  as	  missing	  data	  and	  excluded	  from	  analysis.	  	  
However,	  in	  the	  case	  of	  respondents	  whose	  response	  was	  coded	  as	  missing	  for	  invasive	  
testing	  but	  “yes”	  or	  “no”	  for	  non-­‐invasive	  testing	  (see	  preceding	  paragraph),	  missing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  As	  an	  example,	  a	  respondent	  did	  not	  provide	  an	  answer	  to	  the	  question	  concerning	  whether	  they	  had	  
engaged	  in	  FOBT	  testing	  but	  indicated	  that	  ACS	  guideline	  adherent	  testing	  was	  done	  via	  colonoscopy.	  	  
This	  respondent’s	  testing	  status	  was	  coded	  as	  ‘yes’	  despite	  the	  missing	  data	  for	  the	  FOBT	  question.	  	  	  	  
	  	   23	  
data	  from	  the	  invasive	  testing	  question	  were	  ignored1	  (missing	  n	  =	  23).	  	  	  
Respondents	  reporting	  testing	  also	  reported	  testing	  timelines	  in	  one	  of	  the	  
following	  formats:	  	  month/year,	  number	  of	  days,	  weeks,	  months	  or	  years	  since	  testing,	  
or	  by	  using	  years	  since	  testing	  (a	  year	  ago	  or	  less/more	  than	  1	  year	  but	  not	  more	  than	  2	  
years/more	  than	  2	  years	  but	  not	  more	  than	  3	  years/more	  than	  3	  years	  but	  not	  more	  
than	  5	  years/more	  than	  5	  years	  but	  not	  more	  than	  10	  years/over	  10	  years	  ago.	  	  	  Invasive	  
testing	  (sigmoidoscopy,	  proctoscopy,	  colonoscopy)	  was	  coded	  as	  ACS	  guideline	  
adherent	  if	  the	  testing	  was	  reported	  to	  be	  within	  five,	  five	  and	  ten	  years,	  respectively.	  	  
One	  dependent	  variable	  was	  created	  for	  each	  mode	  of	  testing,	  coded	  as	  1	  if	  ACS	  
guideline	  adherent,	  0	  if	  no	  testing	  or	  non-­‐adherent,	  and	  missing	  otherwise.	  
Data	  from	  these	  four	  variables	  (FOBT	  and	  three	  invasive	  testing	  variables)	  
informed	  the	  combined	  dependent	  variable	  measuring	  ACS	  guideline	  adherence.	  	  If	  any	  
mode	  of	  testing	  was	  ACS	  guideline	  adherent,	  the	  variable	  was	  coded	  as	  1,	  if	  no	  mode	  of	  
testing	  was	  ACS	  guideline	  adherent,	  the	  variable	  was	  coded	  as	  0,	  and	  missing	  otherwise.	  	  	  
Alone,	  this	  variable	  reflects	  the	  methodology	  of	  BRFSS	  as	  it	  conflates	  diagnostic	  testing	  
and	  true	  screening.	  
True	  screening.	  	  To	  measure	  reports	  of	  true	  screening	  versus	  diagnostic	  testing,	  
we	  created	  a	  dichotomous	  variable	  combining	  data	  on	  ACS	  guideline-­‐adherent	  
screening	  behavior	  variable	  described	  above	  and	  NHIS	  data	  on	  the	  impetus	  for	  the	  
reported	  testing.	  	  In	  order	  to	  determine	  the	  impetus	  for	  the	  reported	  testing	  for	  
individuals	  who	  reported	  invasive	  tests	  (sigmoidoscopy,	  proctoscopy,	  or	  colonoscopy),	  
we	  assessed	  responses	  to	  the	  question	  “What	  was	  the	  MAIN	  reason	  you	  had	  this	  exam	  -­‐	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was	  it	  part	  of	  a	  routine	  exam,	  because	  of	  a	  problem,	  or	  some	  other	  reason?”	  The	  
dependent	  variable	  was	  coded	  as	  ‘true	  screening’	  for	  responses	  of	  “part	  of	  a	  routine	  
exam”	  and	  as	  ‘diagnostic	  testing’	  for	  responses	  of	  “because	  of	  a	  problem,	  or	  some	  other	  
reason.”	  	  Responses	  of	  “refused”	  or	  “don’t	  know”	  were	  coded	  as	  missing	  data	  and	  
excluded	  from	  analysis	  if	  non-­‐invasive	  testing	  was	  not	  a	  “yes”	  (missing	  n	  =	  4).	  
If	  respondents	  reported	  both	  non-­‐invasive	  and	  invasive	  modes	  of	  ACS	  guideline	  
adherent	  testing,	  their	  answer	  to	  the	  question	  above	  with	  respect	  to	  the	  impetus	  for	  the	  
invasive	  tests	  determined	  whether	  or	  not	  it	  was	  ‘true	  screening’	  or	  ‘diagnostic	  testing.’	  	  
A	  total	  of	  559	  respondents	  fit	  these	  criteria:	  	  131	  were	  coded	  as	  diagnostic	  and	  428	  
were	  coded	  as	  true	  screeners.	  	  	  
These	  processes	  resulted	  in	  two	  dependent	  variables:	  	  CREHADACS,	  measuring	  
any	  ACS	  guideline	  adherent	  testing	  (1-­‐yes,	  0-­‐no,	  missing),	  and	  TRUSCRACS,	  measuring	  
ACS	  guideline	  adherent	  true	  screening	  (1-­‐yes	  (true	  screening)	  2-­‐no	  (diagnostic	  testing),	  
missing).	  	  	  
Demographic	  and	  control	  variables.	  
We	  utilized	  NHIS	  data	  directly	  for	  variables	  indicating	  race/ethnicity	  (non-­‐
Hispanic	  White/non-­‐Hispanic	  Black),	  sex	  (male/female),	  age	  (continuous	  50-­‐80,	  
categorical	  50-­‐54/55-­‐59/60-­‐64/65-­‐69/70-­‐74/75-­‐80,	  and	  categorical	  50-­‐64/65-­‐80),	  
educational	  attainment	  (less	  than	  a	  high	  school	  diploma/high	  school	  graduate	  or	  
GED/some	  college	  no	  degree	  or	  associate	  degree/bachelor’s	  degree/master	  
professional	  or	  doctorate),	  poverty	  ratio	  (tertiles	  (measured	  as	  ratio	  of	  family	  income	  to	  
poverty	  threshold):	  	  low	  (under	  .50	  to	  2.49)/medium	  (2.50	  to	  4.99)/high	  (5.00	  and	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over)),	  	  insurance	  status	  (covered/not	  covered),	  and	  usual	  source	  of	  health	  care	  
(yes/no).	  	  The	  poverty	  ratio	  variable	  came	  from	  NHIS	  with	  no	  missing	  values	  as	  the	  
result	  of	  multiple	  imputation	  done	  by	  the	  survey	  administrator.	  	  Missing	  values	  for	  all	  
variables	  except	  poverty	  ratio	  were	  below	  3%,	  a	  threshold	  determined	  to	  be	  acceptable	  
with	  this	  sample	  size.	  	  	  
Statistical	  Analysis	  	  
	  
All	  data	  analyses	  for	  this	  chapter	  were	  performed	  with	  the	  SAS/STAT	  statistical	  
software,	  version	  9.3_M1	  of	  the	  SAS	  System	  for	  Windows,	  Copyright	  ©	  2002-­‐2010	  SAS	  
Institute	  Inc.	  	  SAS	  employs	  procedures	  capable	  of	  computing	  appropriate	  variance	  
estimates	  for	  survey	  estimates	  generated	  from	  analyses	  of	  complex	  sample	  survey	  data	  
sets	  such	  as	  the	  2008	  NHIS	  (Heeringa	  et	  al.,	  2010;	  SAS	  Institute	  Inc.,	  2014).	  	  Due	  to	  the	  
fact	  that	  SAS	  estimates	  variance	  in	  a	  way	  that	  excludes	  strata	  with	  only	  one	  primary	  
sampling	  unit	  (PSU)	  from	  its	  variance	  estimates,	  we	  ran	  selected	  models	  in	  Stata	  13.0.	  	  
Stata	  enables	  multiple	  ad-­‐hoc	  variance	  estimation	  methods	  for	  dealing	  with	  “singleton”	  
PSUs	  to	  compare	  estimated	  standard	  errors	  between	  the	  two	  program’s	  procedures	  
(StataCorp,	  2013).	  For	  the	  logistic	  regression	  models	  including	  main	  effects,	  of	  268	  
estimates	  only	  ten	  had	  greater	  than	  or	  equal	  to	  a	  10%	  difference	  in	  standard	  errors,	  
with	  the	  greatest	  difference	  at	  17%.	  In	  most	  cases,	  Stata	  produced	  higher	  standard	  
errors;	  none	  of	  these	  differences	  resulted	  in	  changes	  in	  statistical	  inferences.	  
We	  began	  our	  analysis	  with	  computation	  of	  weighted	  and	  unweighted	  
frequencies	  of	  all	  testing	  (including	  diagnostic	  testing	  and	  true	  screening2)	  for	  each	  of	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  ‘True	  screening’	  refers	  to	  pre-­‐symptomatic	  screening	  (and	  not	  diagnostic	  testing).	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the	  independent	  variables	  of	  interest	  in	  the	  full	  subpopulation	  as	  defined	  above.	  	  We	  
then	  obtained	  weighted	  and	  unweighted	  frequencies	  of	  true	  screening	  for	  each	  of	  the	  
independent	  variables	  of	  interest	  in	  the	  smaller	  subpopulation	  of	  ACS	  guideline-­‐
adherent	  screeners.	  We	  calculated	  estimates	  of	  true	  screening	  rates	  for	  the	  full	  study	  
population	  by	  applying	  the	  rates	  of	  true	  recommendations	  from	  the	  smaller	  
subpopulation	  to	  the	  unadjusted3	  testing	  rates	  of	  the	  full	  study	  population.	  	  For	  
example,	  the	  unadjusted	  testing	  rate	  for	  the	  full	  study	  population	  was	  55.46%.	  	  In	  the	  
smaller	  subpopulation	  of	  respondents	  who	  engaged	  in	  guideline	  adherent	  CRC	  testing,	  
the	  true	  screening	  rate	  was	  74.12%.	  	  We	  applied	  this	  rate	  to	  the	  unadjusted	  testing	  rate	  
(55.46	  x	  74.12%)	  to	  estimate	  an	  adjusted	  true	  screening	  rate	  for	  the	  full	  population	  of	  
41.10%.	  	  This	  same	  process	  was	  repeated	  for	  each	  subgroup	  of	  the	  full	  study	  population.	  	  
Since	  this	  calculation	  reflects	  the	  diagnostic	  testing	  rates	  of	  only	  respondents	  reporting	  
ACS	  guideline	  adherent	  testing,	  the	  adjusted	  true	  screening	  rate	  for	  the	  full	  population	  
is	  likely	  a	  conservative	  estimate.	  	  We	  calculated	  estimates	  of	  the	  confidence	  intervals	  
and	  resulting	  tests	  of	  significance	  for	  the	  adjusted	  true	  screening	  rate	  of	  the	  full	  
population.	  	  In	  this	  process,	  we	  were	  unable	  to	  account	  for	  the	  fact	  that	  we	  derived	  the	  
true	  screening	  rate	  for	  the	  full	  population	  from	  two	  estimates.	  	  This	  resulted	  in	  narrower	  
confidence	  intervals	  and	  inferences	  that	  were	  more	  likely	  to	  result	  in	  statistically	  
significant	  values.	  	  However,	  given	  the	  precise	  nature	  of	  the	  subpopulation	  rate	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  ‘Unadjusted	  testing	  rate’	  refers	  to	  a	  rate	  that	  conflates	  diagnostic	  testing	  and	  true	  screening	  (and	  fails	  to	  
account	  for	  the	  impetus	  for	  testing,	  and	  is	  comparable	  to	  BRFSS	  methodology),	  while	  ‘adjusted	  true	  
screening	  rate’	  refers	  to	  a	  rate	  that	  properly	  accounts	  for	  the	  impetus	  for	  testing	  (and	  excludes	  diagnostic	  
testing,	  utilizing	  NHIS	  methodology).	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estimate,	  this	  issue	  is	  likely	  negligible.	  	  Finally,	  we	  calculated	  the	  overestimation	  of	  true	  
screening	  recommendation	  rate	  by	  dividing	  the	  difference	  between	  the	  unadjusted	  and	  
adjusted	  rates	  by	  the	  adjusted	  rate.	  	  For	  example,	  the	  unadjusted	  testing	  rate	  for	  the	  
general	  population	  is	  55.46%	  and	  the	  adjusted	  true	  screening	  rate	  for	  the	  same	  
population	  is	  45.06%.	  	  We	  calculated	  the	  overestimation	  of	  the	  true	  screening	  rate	  as	  
(.5546-­‐.4506)/.4506	  =	  23.08%.	  
In	  preparation	  for	  fitting	  multivariate	  logistic	  regression	  models	  to	  the	  
dependent	  variables	  of	  interest,	  we	  examined	  weighted	  bivariate	  associations	  between	  
independent	  and	  dependent	  variables	  for	  each	  aim	  using	  the	  Rao-­‐Scott	  chi-­‐square	  test	  
to	  account	  for	  the	  features	  of	  the	  complex	  NHIS	  sampling	  design.	  	  Predictors	  that	  had	  an	  
association	  at	  p	  <	  0.25	  were	  included	  in	  the	  initial	  multivariate	  logistic	  regression	  model.	  	  
In	  models	  including	  two-­‐way	  interaction	  terms,	  both	  variables	  defining	  the	  interactions	  
will	  be	  included	  in	  each	  model,	  irrespective	  of	  bivariate	  associations	  (Hosmer	  &	  
Lemeshow,	  2000).	  	  	  
In	  the	  second	  stage	  of	  analysis,	  we	  performed	  a	  four-­‐step	  fitting	  of	  weighted	  
multivariate	  logistic	  regression	  models	  to	  the	  odds	  of	  reporting	  true	  screening,	  adjusting	  
for	  sociodemographic	  factors	  including	  sex,	  race,	  age,	  education,	  poverty	  ratio,	  health	  
insurance	  status,	  and	  usual	  source	  of	  health	  care	  (Breen	  et	  al.,	  2001;	  O’Malley,	  Forrest,	  
Feng,	  &	  Mandelblatt,	  2005;	  Rosen	  &	  Schneider,	  2004).	  	  First,	  we	  fit	  a	  main	  effects	  model	  
with	  all	  covariates.	  	  Second,	  we	  fit	  an	  interaction	  model	  with	  demographic	  interactions.	  	  
Third,	  we	  fit	  an	  interaction	  model	  with	  socioeconomic	  interactions.	  	  Finally,	  we	  fit	  a	  full	  
model	  with	  statistically	  significant	  main	  effects	  and	  interaction	  terms.	  	  We	  estimated	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the	  regression	  parameters	  using	  pseudo-­‐maximum	  likelihood	  estimation,	  due	  to	  the	  
complex	  sampling	  nature	  of	  the	  NHIS	  (Heeringa,	  West,	  &	  Berglund,	  2010),	  and	  we	  used	  
Taylor	  Series	  Linearization	  to	  compute	  design-­‐based	  estimates	  of	  standard	  errors	  for	  the	  
estimated	  regression	  parameters.	  	  Hypothesis	  tests	  were	  performed	  using	  design-­‐
adjusted	  Wald	  X2	  tests.	  	  	  We	  report	  estimated	  odds	  ratios	  and	  their	  95%	  confidence	  
intervals.	  	  	  
Results	  
Please	  refer	  to	  Table	  2.1	  for	  estimated	  demographic	  characteristics	  for	  the	  full	  
study	  population	  and	  subpopulation.	  	  Distribution	  of	  NHB	  in	  the	  full	  population	  was	  17%	  
higher	  than	  in	  the	  subpopulation,	  and	  the	  full	  population	  was	  weighted	  more	  heavily	  to	  
the	  younger	  end	  of	  the	  age	  range,	  with	  22.18%	  ages	  50-­‐54	  versus	  16.92%	  in	  the	  
subpopulation.	  	  Overall,	  the	  full	  population	  is	  distributed	  more	  heavily	  in	  the	  lower	  
socioeconomic	  categories.	  	  The	  full	  population	  has	  24%	  more	  respondents	  in	  the	  lowest	  
level	  of	  education	  (13.97%	  versus	  11.27%)	  and	  20%	  less	  in	  the	  highest	  (11.45%	  versus	  
14.36%),	  and	  across	  poverty	  ratio	  tertiles,	  the	  full	  population	  has	  17%	  more	  respondents	  
in	  the	  low	  tertile	  than	  the	  subpopulation,	  and	  12%	  fewer	  in	  the	  highest	  tertile.	  
Weighted	  frequencies.	  	  Table	  2.2	  displays	  estimated	  rates	  of	  true	  screening	  and	  
diagnostic	  testing	  for	  the	  subpopulation	  of	  respondents	  who	  reported	  ACS	  guideline	  
adherent	  testing.	  	  Table	  2.3	  displays	  estimated	  rates	  of	  true	  screening	  received	  by	  the	  
full	  study	  population,	  with	  unadjusted	  estimates	  that	  conflate	  diagnostic	  testing	  and	  
true	  screening	  as	  well	  as	  adjusted	  estimates	  that	  properly	  specify	  true	  screening	  as	  the	  
outcome.	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Study	  Population.	  	  The	  estimated	  unadjusted	  testing	  rate	  for	  the	  study	  
population	  was	  55.46%.	  	  Adjusting	  for	  the	  impetus	  for	  testing	  resulted	  in	  a	  true	  
screening	  estimate	  of	  45.06%,	  resulting	  in	  an	  23.08%	  overestimation	  of	  the	  true	  
screening	  rate.	  
Race/ethnicity.	  	  Estimates	  of	  unadjusted	  rates	  of	  testing	  in	  NHW	  were	  higher	  
than	  in	  NHB.	  	  Adjusting	  for	  the	  impetus	  for	  the	  test	  reduced	  both	  the	  overall	  rates	  and	  
between-­‐group	  estimates.	  	  True	  screening	  rates	  were	  significantly	  different	  for	  NHW	  
and	  NHB,	  at	  45.69%	  and	  40.51%	  (p	  =	  0.001),	  respectively.	  	  Compared	  to	  NHB,	  the	  rate	  of	  
diagnostic	  testing	  was	  greater	  in	  NHW	  (19.11%	  versus	  15.68%,	  p	  =	  0.0957),	  leading	  to	  
overestimation	  of	  true	  screening	  rates	  in	  NHW	  by	  23.62%	  and	  NHB	  by	  18.60%.	  	  	  
Sex.	  	  Unadjusted	  testing	  rates	  were	  slightly	  higher	  in	  males	  than	  females	  but	  the	  
difference	  was	  not	  statistically	  significant	  (p	  =	  0.6812).	  	  After	  adjustment	  for	  the	  impetus	  
for	  testing,	  this	  advantage	  increased	  and	  became	  statistically	  significant	  (true	  screening	  
rates	  of	  46.87%	  versus	  43.63%,	  p	  =	  0.004).	  	  Females	  reported	  higher	  rates	  of	  diagnostic	  
testing	  than	  males	  (20.98%	  versus	  15.96%),	  yielding	  an	  overestimation	  of	  true	  screening	  
rates	  in	  26.55%	  for	  females	  and	  18.99%	  for	  males.	  	  
Race/ethnicity	  and	  sex.	  	  In	  addition	  to	  race/ethnicity	  and	  sex,	  we	  also	  examined	  
patterns	  of	  testing	  rates	  by	  these	  variables	  together.	  NHWF	  and	  NHWM	  reported	  the	  
highest	  unadjusted	  rates	  of	  testing.	  	  Once	  adjusted,	  the	  advantage	  of	  NHW	  over	  NHB	  
persisted	  for	  each	  sex.	  	  However,	  NHWF	  reported	  the	  highest	  rates	  of	  diagnostic	  testing	  
(21.53%),	  followed	  by	  NHBF	  (16.61%),	  NHWM	  (16.14%),	  and	  the	  lowest	  rate	  of	  
diagnostic	  testing	  was	  in	  NHBM	  (14.34%).	  	  Adjusted	  rates	  of	  true	  screening	  were	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substantially	  overestimated	  for	  all	  groups,	  ranging	  from	  16.74%	  (NHBM)	  to	  27.44%	  
(NHWF).	  	  	  
Age.	  	  With	  one	  exception,	  both	  unadjusted	  testing	  rates	  and	  adjusted	  true	  
screening	  rates	  increased	  with	  age.	  	  The	  lowest	  unadjusted	  testing	  rates	  were	  in	  50-­‐54	  
year	  olds	  and	  the	  highest	  unadjusted	  testing	  rates	  in	  70-­‐74	  year	  olds.	  Differences	  in	  
unadjusted	  and	  adjusted	  rates	  were	  statistically	  significant	  at	  the	  p	  <	  .0001	  level.	  	  The	  
greatest	  overestimation	  of	  true	  screening	  rates	  was	  in	  50-­‐54	  year-­‐old	  respondents	  who	  
reported	  a	  diagnostic	  testing	  rate	  of	  24.24%,	  resulting	  in	  overestimation	  of	  true	  
screening	  rates	  by	  32.00%.	  	  Respondents	  who	  were	  70-­‐74	  years	  old	  reported	  the	  lowest	  
rate	  of	  diagnostic	  testing	  (16.05%),	  resulting	  in	  the	  least	  overestimation	  of	  true	  
screening	  rates	  (19.12%).	  	  	  
	   In	  order	  to	  provide	  data	  on	  group	  differences	  by	  age	  that	  would	  be	  comparable	  
with	  existing	  literature,	  we	  also	  analyzed	  pre-­‐	  and	  post-­‐Medicare	  populations	  and	  found	  
that	  respondents	  aged	  50-­‐64	  years	  reported	  lower	  unadjusted	  testing	  rates	  and	  lower	  
true	  screening	  rates	  compared	  with	  their	  older	  counterparts	  (p	  <	  .0001	  in	  both	  
analyses).	  	  Respondents	  aged	  50-­‐64	  years	  reported	  a	  higher	  rate	  of	  diagnostic	  testing	  
than	  those	  aged	  65-­‐80	  years	  (20.06%	  versus	  17.01%),	  resulting	  in	  an	  overestimation	  of	  
true	  screening	  rates	  of	  25.09%	  and	  20.50%,	  respectively.	  	  
Educational	  attainment.	  Both	  unadjusted	  testing	  rates	  and	  adjusted	  true	  
screening	  rates	  increased	  as	  educational	  attainment	  increased.	  Unadjusted	  rates	  ranged	  
from	  44.91%	  to	  69.53%	  (p	  <	  .0001)	  while	  adjusted	  rates	  ranged	  from	  34.23%	  to	  58.99%	  
(p	  <	  .0001).	  	  Individuals	  at	  the	  lowest	  level	  of	  educational	  attainment	  reported	  the	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highest	  rate	  of	  diagnostic	  testing	  (23.77%)	  while	  those	  at	  the	  highest	  level	  reported	  the	  
lowest	  rate	  (15.16%).	  	  Overestimation	  of	  true	  screening	  rates	  was	  inversely	  associated	  
with	  educational	  attainment	  level	  and	  ranged	  from	  31.18%	  to	  17.87%.	  	  	  
Poverty	  ratio.	  	  Both	  unadjusted	  testing	  rates	  and	  adjusted	  true	  screening	  rates	  
increased	  as	  the	  ratio	  of	  family	  income	  to	  the	  poverty	  threshold	  increased	  across	  
tertiles,	  and	  adjusted	  true	  screening	  rates	  ranged	  from	  36.09%	  in	  the	  lowest	  tertile	  to	  
46.18%	  in	  the	  medium	  tertile	  and	  53.51%	  in	  the	  highest	  tertile	  (p	  <	  .0001).	  	  Individuals	  in	  
the	  lowest	  tertile	  reported	  the	  highest	  rate	  of	  diagnostic	  testing	  (24.33%),	  while	  those	  in	  
the	  highest	  tertile	  reported	  the	  lowest	  (14.75%).	  	  The	  greatest	  rate	  of	  screening	  rate	  
overestimation	  was	  in	  the	  lowest	  poverty	  ratio	  tertile	  at	  17.30%.	  	  	  
Insurance.	  	  Respondents	  reporting	  insurance	  coverage	  reported	  higher	  
unadjusted	  testing	  rates	  than	  those	  without	  insurance	  coverage	  (57.84%	  versus	  24.10%)	  
as	  well	  as	  higher	  adjusted	  rates	  of	  true	  screening	  (47.27%	  versus	  15.91%).	  	  Respondents	  
reporting	  no	  coverage	  were	  more	  likely	  to	  receive	  diagnostic	  testing,	  resulting	  in	  a	  
51.52%	  overestimation	  of	  true	  screening	  rates	  for	  the	  uninsured	  population	  compared	  
to	  22.37%	  for	  those	  with	  insurance.	  	  
Physician	  recommendation.	  	  Respondents	  reporting	  a	  physician	  
recommendation	  reported	  much	  higher	  unadjusted	  testing	  rates	  than	  those	  who	  did	  not	  
(84.35%	  versus	  11.54%)	  as	  well	  as	  higher	  adjusted	  rates	  of	  true	  screening	  (62.70%	  
versus	  8.22%).	  	  Respondents	  reporting	  no	  recommendation	  were	  slightly	  more	  likely	  to	  
receive	  diagnostic	  testing,	  resulting	  in	  a	  40.32%	  overestimation	  of	  true	  screening	  rates	  
for	  those	  reporting	  no	  recommendation.	  	  






Chi*Square Pr%>%ChiSq n % CI%of%
Rao*Scott
Chi*Square Pr%>%ChiSq
Non*Hispanic%White 5780 87.83 (86.96,%88.70) 3132 <.0001 3214 89.57 (88.65,%90.49 2670.14 <.0001
Non*Hispanic%Black 1278 12.17 (11.30,%13.04) 583 10.43 (9.51,%11.36)
%
Male 3094 44.20 (43.04,%45.37) 94.08 <.0001 1669 44.50 (42.83,%46.18) 41.28 <.0001
Female 3964 55.80 (54.63,%56.96) 2128 55.50 (53.82,%57.17)
%
Non*Hispanic%White%Male 2575 39.23 (38.04,%40.43) 3836.50 <.0001 1433 40.25 (38.57,%41.93) 2391.45 <.0001
Non*Hispanic%Black%Male 519 4.97 (4.49,%5.46) 236 4.26 (3.64,%4.88)
Non*Hispanic%White%Female 3205 48.60 (47.37,%49.83) 1781 49.32 (47.60,%51.04)
Non*Hispanic%Black%Female 759 7.20 (6.52,%7.87) 347 6.17 (5.42,%6.93)
% %
Ages%50*54 1565 22.18 (21.18,%23.17) 382.70 <.0001 629 16.92 (15.57,%18.26) 98.49 <.0001
Ages%55*59 1511 20.97 (19.92,%22.02) 796 20.41 (19.02,%21.80)
Ages%60*64 1279 18.41 (17.40,%19.42) 745 19.77 (18.34,%21.20)
Ages%65*69 1070 15.07 (14.20,%15.95) 643 16.72 (15.46,%17.98)
Ages%70*74 794 11.25 (10.42,%12.08) 511 13.11 (11.97,%14.26)
Ages%75*80 839 12.12 (11.31,%12.93) 473 13.08 (12.04,%14.11)
%
Ages%50*64 4355 61.56 (60.32,%62.79) 322.23 <.0001 2170 57.09 (55.38,%58.80) 65.13 <.0001
Ages%65*80 2703 38.44 (37.21,%39.68) 1627 42.91 (41.20,%44.62)
% %
Less%than%High%School%Diploma 1017 13.97 (12.89,%15.04) 820.36 <.0001 433 11.27 (10.12,%12.42) 433.73 <.0001
High%School%Degree%or%GED 2184 30.39 (29.15,%31.63) 1101 28.52 (26.93,%30.12)
Some%College%No%Degree%or%Associate%Degree 2004 28.51 (27.34,%29.67) 1100 29.32 (27.69,%30.94)
Bachelor's%Degree 1047 15.13 (14.23,%16.03) 620 16.21 (14.96,%17.45)
Master's,%Professional%or%Doctorate%Degree 761 11.45 (10.59,%12.31) 527 14.36 (13.09,%15.64)
%
Poverty%Ratio%*%Low%Tertile 2587 35.15 (33.56,%36.74) 1172 30.09 (28.12,%32.06)
Poverty%Ratio%*%Medium%Tertile 2227 31.65 (30.31,%32.99) 1231 32.27 (30.42,%34.13)
Poverty%Ratio%*%High%Tertile 2243 33.20 (31.69,%34.71) 1390 37.64 (35.74,%39.54)
%
Insurance%*%Not%Covered 525 7.02 (6.35,%7.69) 4146.62 <.0001 123 3.03 (2.36,%3.71) 2193.76 <.0001
Insurance%*%Covered 6526 92.98 (92.31,%93.65) 3672 96.97 (96.29,%97.65)
%
Marital%Spouse%not%in%HH%or%Separated 274 3.71 (3.23,%4.19) 3412.65 <.0001 121 3.03 (2.42,%3.64) 2202.24 <.0001
Widowed%or%Divorced 2471 34.68 (33.28,%36.08) 1248 32.60 (30.89,%34.31)
Never%Married%/%Unknown%Status 632 8.44 (7.73,%9.15) 283 7.27 (6.33,%8.21)
Living%with%Marital%Spouse%or%Unmarried%Partner 3681 53.17 (51.68,%54.66) 2145 57.11 (55.20,%59.01)
Usual%Source%of%Health%Care%*%No 477 6.80 (6.17,%7.43) 4564.11 <.0001 90 2.32 (1.80,%2.84) 2957.08 <.0001
Usual%Source%of%Health%Care%*%Yes 6476 93.20 (92.57,%93.83) 3707 97.68 (97.16,%98.20)
%
Physician%Recommendation%*%No 2534 36.40 (34.95,%37.84) 317.08 <.0001 283 7.22 (6.31,%8.13) 2313.67 <.0001

















Subpopulation 3793 81.25 (79.76,!82.74) 18.75 (17.26,!20.24)
Non;Hispanic!White 3210 80.89 (79.29,!82.50) 19.11 (17.50,!20.71) 2.78 0.0957
Non;Hispanic!Black 583 84.32 (80.80,!87.84) 15.68 (12.16,!19.20)
Female 2125 79.02 (76.95,!81.08) 20.98 (18.92,!23.05) 13.49 0.0003
Male 1668 84.04 (82.13,!85.94) 15.96 (14.06,!17.87)
Non;Hispanic!White!Male 1432 83.86 (81.84,!85.89) 16.14 (14.11,!18.16) 17.37 0.0006
Non;Hispanic!Black!Male 236 85.66 (79.51,!91.82) 14.34 (8.18,!20.49)
Non;Hispanic!White!Female 1778 78.47 (76.26,!80.67) 21.53 (19.33,!23.74)
Non;Hispanic!Black!Female 347 83.39 (78.95,!87.84) 16.61 (12.16,!21.05)
!
Ages!50;54 629 75.76 (72.13,!79.39) 24.24 (20.61,!27.87) 15.84 0.0073
Ages!55;59 796 80.79 (77.66,!83.91) 19.21 (16.09,!22.34)
Ages!60;64 743 82.66 (79.77,!85.56) 17.34 (14.44,!20.23)
Ages!65;69 641 82.22 (79.33,!85.11) 17.78 (14.89,!20.67)
Ages!70;74 511 83.95 (80.58,!87.32) 16.05 (12.68,!19.42)
Ages!75;80 473 83.01 (79.10,!86.93) 16.99 (13.07,!20.90)
!
Ages!50;64 2168 79.94 (77.94,!81.94) 20.06 (18.06,!22.06) 5.07 0.0243
Ages!65;80 1625 82.99 (81.02,!84.96) 17.01 (15.04,!18.98)
!
Less!than!High!School!Diploma 433 76.23 (71.76,!80.70) 23.77 (19.30,!28.24) 11.24 0.024
High!School!Degree!or!GED 1098 80.30 (77.62,!82.98) 19.70 (17.02,!22.38)
Some!College!No!Degree!or!Associate!Degree 1100 81.71 (79.06,!84.37) 18.29 (15.63,!20.94)
Bachelor's!Degree 620 82.56 (79.50,!85.62) 17.44 (14.38,!20.50)
Master's,!Professional!or!Doctorate!Degree 526 84.84 (81.46,!88.22) 15.16 (11.78,!18.54)
!
Poverty!Ratio!;!Low!Tertile 1172 75.67 (72.77,!78.35) 24.33 (21.65,!27.23)
Poverty!Ratio!;!Medium!Tertile 1231 81.77 (79.30,!84.01) 18.23 (15.99,!20.70)
Poverty!Ratio!;!High!Tertile 1390 85.25 (83.10,!87.17) 14.75 (79.71,!82.70)
!
Insurance!;!Not!Covered 123 66.00 (56.14,!75.86) 34.00 (24.14,!43.86) 14.63 0.0001
Insurance!;!Covered 3668 81.72 (80.25,!83.20) 18.28 (16.80,!19.75)
Living!with!Marital!Spouse!or!Unmarried!Partner 2143 82.51 (80.58,!84.43) 17.50 (15.57,!19.42) 12.53 0.0058
Never!Married!/!Unknown!Status 283 84.82 (80.33,!89.31) 15.18 (10.69,!19.67)
Marital!Spouse!not!in!HH!or!Separated 120 71.37 (62.11,!80.64) 28.63 (19.36,!37.89)
Widowed!or!Divorced 1247 79.16 (76.55,!81.78) 20.84 (18.22,!23.45)
Usual!Source!of!Health!Care!;!No 90 64.62 (53.59,!75.64) 35.38 (24.36,!46.41) 13.02 0.0003
Usual!Source!of!Health!Care!;!Yes 3703 81.65 (81.13,!83.17) 18.35 (16.83,!19.87)
Physician!Recommendation!;!No 283 78.34 (73.11,!83.56) 21.67 (16.44,!26.89) 1.42 0.2333














Full!Study!Population 6984 55.46 (54.04,!56.88) 45.06 (43.91,!46.22) 23.08
!
Non=Hispanic!White 5727 56.48 (54.98,!57.98) 23.47 <.0001 45.69 (44.47,!46.90) 23.62
Non=Hispanic!Black 1257 48.04 (44.77,!51.30) 40.51 (37.75,!43.26) 18.60
!
Female 3922 55.21 (53.43,!56.99) 0.1688 0.6812 43.63 (42.22,!45.04) 26.55
Male 3062 55.77 (53.63,!57.92) 46.87 (45.07,!48.68) 18.99
! !
Non=Hispanic!White!Male 2551 56.77 (54.49,!59.05) 20.39 0.0001 47.61 (36.91,!45.08) 19.25
Non=Hispanic!Black!Male 511 47.86 (43.09,!52.63) 41.00 (36.43,!43.90) 16.74
Non=Hispanic!White!Female 3176 56.24 (54.33,!58.15) 44.13 (42.64,!45.63) 27.44
Non=Hispanic!Black!Female 746 48.16 (43.69,!52.63) 40.16 (36.43,!43.90) 19.92
! ! !
Ages!50=54 1556 42.12 (39.14,!45.09) 148.98 <.0001 31.91 (29.65,!34.16) 32.00
Ages!55=59 1497 53.92 (51.19,!56.65) 43.56 (41.35,!45.77) 23.78
Ages!60=64 1262 59.74 (56.76,!62.73) 49.38 (46.91,!51.85) 20.98
Ages!65=69 1058 61.59 (58.45,!64.73) 50.64 (48.06,!53.22) 21.62
Ages!70=74 787 64.40 (60.68,!68.12) 54.06 (50.94,!57.18) 19.12
Ages!75=80 824 60.27 (58.82,!63.72) 50.03 (47.16,!52.89) 20.47
! !
Ages!50=64 4315 51.39 (49.63,!53.15) 64.27 <.0001 41.08 (49.73,!53.18) 25.09
Ages!65=80 2669 62.00 (59.93,!64.08) 51.45 (39.67,!42.49) 20.50
! !
Less!than!High!School!Diploma 1002 44.91 (41.66,!48.16) 103.31 <.0001 34.23 (31.76,!36.72) 31.18
High!School!Degree!or!GED 2162 52.00 (49.65,!54.36) 41.76 (39.87,!43.65) 24.53
Some!College!No!Degree!or!Associate!Degree 1987 56.92 (54.38,!59.46) 46.51 (44.43,!48.59) 22.38
Bachelor's!Degree 1039 59.35 (55.73,!62.98) 49.00 (46.01,!52.00) 21.12
Master's,!Professional!or!Doctorate!Degree 753 69.53 (65.95,!73.10) 58.99 (55.95,!62.02) 17.87
! !
Poverty!Ratio!=!Low!Tertile 2549 47.69 (45.49,!49.89) 36.09 (34.48,!37.70) 32.15
Poverty!Ratio!=!Medium!Tertile 2211 56.47 (54.01,!58.73) 46.18 (44.25,!47.94) 22.29
Poverty!Ratio!=!High!Tertile 2224 62.77 (60.54,!64.99) 53.51 (51.61,!55.37) 17.30
! !
Insurance!=!Not!Covered 517 24.10 (19.34,!28.85) 131.2 <.0001 15.91 (12.76,!19.04) 51.52
Insurance!=!Covered 6461 57.84 (56.36,!59.32) 47.27 (46.05,!48.47) 22.37
! !
Living!with!Marital!Spouse!or!Unmarried!Partner 3646 59.49 (57.64,!61.34) 47.14 <.0001 49.09 (47.56,!50.61) 21.20
Never!Married!/!Unknown!Status 622 47.96 (43.40,!52.52) 40.68 (36.81,!44.55) 17.90
Marital!Spouse!not!in!HH!or!Separated 271 45.34 (38.24,!52.43) 32.36 (27.29,!37.42) 40.11
Widowed!or!Divorced 2445 52.17 (49.94,!54.41) 41.30 (39.53,!43.07) 26.33
! !
Usual!Source!of!Health!Care!=!No 470 19.29 (15.38,!23.20) 229.29 <.0001 12.47 (9.94,!14.99) 54.75
Usual!Source!of!Health!Care!=!Yes 6409 58.97 (57.57,!60.44) 48.15 (46.96,!49.35) 22.47
! !
Physician!Recommendation!=!No 2534 11.54 (10.14,!12.94) 3298.18 <.0001 9.04 (7.95,!10.14) 27.65
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Multivariate	  logistic	  regression	  modeling.	  Table	  2.4	  shows	  the	  final	  logistic	  
regression	  models	  predicting	  any	  ACS	  guideline	  adherent	  testing	  (including	  diagnostic	  
testing	  and	  true	  screening	  when	  specifying	  the	  behavioral	  outcome)	  in	  the	  full	  
population	  and	  true	  screening	  (excluding	  diagnostic	  testing	  when	  specifying	  the	  
behavioral	  outcome)	  in	  the	  subpopulation	  of	  respondents	  reporting	  ACS	  guideline	  
adherent	  screening.	  	  	  
The	  estimates	  from	  multivariate	  models	  of	  any	  ACS	  guideline	  adherent	  testing	  
versus	  true	  screening	  reveal	  important	  information	  about	  how	  the	  same	  predictor	  varies	  
across	  the	  two	  outcomes.	  The	  most	  startling	  change	  in	  predictors	  of	  any	  ACS	  guideline	  
adherent	  testing	  versus	  true	  screening	  is	  the	  physician	  recommendation	  to	  screen,	  
which	  is	  highly	  predictive	  of	  any	  ACS	  guideline	  adherent	  testing,	  but	  is	  not	  statistically	  
Full$Study$Population$/$Outcome:$$Any$ACS$guideline$adherent$testing$n$=$7058
Predictor* Category Odds0Ratio0(OR) Wald%Chi)Square Pr0>0ChiSq
Intercept 0.075 0.051 0.110 177.65 <.0001
Race/Ethnicity Non8Hispanic;Black 0.584 0.373 0.837 6.86 0.0088
Age Continuous;(Centered;(65)) 1.034 1.030 1.053 17.01 <.0001
Education High;School;Graduate;or;GED 1.219 0.990 1.500 3.49 0.0619
Some;College;No;Degree;or;Associate;Degree 1.388 1.111 1.735 8.34 0.0039
Bachelors;Debree 1.651 1.260 2.164 13.24 0.0003
Master;Professional;or;Doctorate 2.250 1.650 3.070 26.23 <.0001
Usual;Source;of;Health;Care Yes 1.586 1.127 2.230 7.02 0.0081
Physician;Recommendation Yes 38.122 31.328 46.395 1321.41 <.0001
Race;*;Age Non8Hispanic;Black;*;Age;(Continuous;(Centered;65)) 0.972 0.946 0.999 4.18 0.041
Race;*;Physician;Recommendation Non8Hispanic;Black;*;Yes 1.768 1.106 2.824 5.67 0.0172
Age;*;Physician;Recommendation Age;(Continuous;(Centered;65));*;Yes 1.020 1.001 1.040 4.11 0.0427
Subpopulation$/Outcome:$$ACS$guideline$adherent$True$Screening$n$/$3791
Predictor* Category Odds0Ratio0(OR) t Pr0>0|t|
Intercept 1.273 0.768 2.111 0.94 0.3489
Race/Ethnicity Non8Hispanic;Black 1.412 1.046 1.906 2.25 0.0242
Age Continuous;(Centered;(65)) 1.031 1.019 1.044 5 <.0001
Sex Male 1.346 1.120 1.617 3.17 0.0015
Poverty;Ratio Medium;Tertile 1.529 1.184 1.975 3.31 0.0015
Poverty;Ratio High;Tertile 2.100 1.666 2.647 6.28 <.0001
Usual;Source;of;Health;Care Yes 2.112 1.276 3.496 2.91 0.0036








	  	   36	  
significant	  (and	  was	  removed	  from	  the	  model)	  when	  predicting	  true	  screening.	  	  	  
Level	  of	  educational	  attainment	  is	  predictive	  of	  any	  ACS	  guideline	  adherent	  
testing,	  but	  not	  predictive	  of	  true	  screening.	  In	  contrast	  to	  educational	  attainment,	  
poverty	  ratio	  is	  not	  predictive	  of	  any	  ACS	  guideline	  adherent	  testing,	  but	  is	  only	  
statistically	  significant	  in	  the	  model	  predicting	  true	  screening	  (overall	  test	  of	  poverty	  
ratio	  p	  <	  .0001,	  not	  in	  table).	  Increases	  in	  poverty	  ratio	  result	  in	  increased	  adjusted	  odds	  
ratios	  for	  medium	  and	  high	  tertile	  categories	  (1.529,	  95%	  CI	  [1.184,	  1.975]	  and	  2.100,	  
95%	  CI	  [1.666,	  2.647],	  respectively.	  	  
Discussion	  
Colorectal	  cancer	  is	  a	  disease	  that	  is	  largely	  preventable	  with	  screening,	  yet	  
screening	  rates	  remain	  low	  across	  population	  groups,	  risking	  a	  high	  burden	  of	  the	  
disease	  over	  the	  next	  decades.	  	  By	  choice	  or	  by	  data	  limitations,	  researchers	  often	  
conflate	  diagnostic	  testing	  and	  true	  screening	  when	  defining	  their	  behavioral	  outcome	  
as	  they	  measure	  screening	  rates,	  disparities,	  predictors,	  and	  trends	  over	  time.	  	  In	  
addition,	  intervention	  evaluators	  and	  policymakers	  routinely	  conflate	  diagnostic	  testing	  
with	  true	  screening	  in	  their	  assessments	  of	  both	  intervention	  effectiveness	  and	  their	  
own	  success	  in	  reaching	  federal	  screening	  benchmarks.	  	  In	  this	  study,	  we	  investigated	  
whether	  this	  practice	  of	  conflating	  diagnostic	  testing	  and	  true	  screening	  overestimates	  
screening	  rates,	  whether	  that	  overestimation	  varies	  across	  sociodemographic	  groups,	  
and	  whether	  the	  predictors	  of	  any	  ACS	  guideline	  adherent	  testing	  (including	  diagnostic	  
testing	  and	  true	  screening)	  vary	  from	  those	  predicting	  true	  screening.	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Using	  data	  from	  the	  National	  Health	  Interview	  Survey,	  we	  showed	  that	  the	  
practice	  of	  conflating	  diagnostic	  testing	  and	  true	  screening	  results	  in	  substantial	  
overestimation	  of	  screening	  rates.	  	  This	  overestimation	  varied	  considerably	  across	  
sociodemographic	  characteristics.	  	  Finally,	  we	  found	  that	  correctly	  specifying	  the	  
behavioral	  outcome	  of	  interest	  as	  true	  screening	  changed	  predictors	  of	  the	  behavior	  
when	  compared	  to	  predictors	  of	  a	  behavioral	  outcome	  that	  conflates	  diagnostic	  testing	  
and	  true	  screening.	  	  These	  results	  inform	  the	  CRC	  literature	  in	  some	  unexpected	  and	  
expected	  ways.	  
Before	  discussing	  implications	  for	  researchers,	  practitioners,	  and	  policymakers	  
more	  broadly,	  we	  would	  like	  to	  highlight	  two	  unexpected	  findings	  in	  our	  study,	  namely	  
the	  pre-­‐	  and	  post-­‐adjustment	  rates	  of	  male	  and	  female	  respondents,	  and	  the	  extent	  to	  
which	  females	  (and	  NHW	  females	  in	  particular)	  engage	  in	  diagnostic	  testing	  and	  true	  
screening.	  We	  found	  that	  although	  the	  pre-­‐adjustment	  rates	  are	  nearly	  identical	  
between	  sexes	  (consistent	  with	  data	  from	  the	  National	  Center	  for	  Health	  Statistics,	  
2011,	  which	  ignores	  the	  impetus	  for	  testing),	  a	  statistically	  significant	  difference	  
emerges	  after	  adjusting	  for	  the	  impetus	  for	  testing,	  with	  males	  having	  a	  statistically	  
significant	  advantage	  in	  true	  screening	  rates	  over	  their	  female	  counterparts	  (46.87%	  vs.	  
43.63%,	  p	  =	  0.001).	  	  This	  difference	  in	  true	  screening	  rates	  may	  result	  from	  several	  
factors.	  	  Males	  may	  have	  a	  higher	  level	  of	  risk	  perception	  than	  females,	  they	  may	  be	  
underutilizing	  diagnostic	  testing	  compared	  to	  females,	  or	  there	  may	  be	  contributing	  
factors	  at	  the	  health	  care	  level	  that	  influence	  engagement	  with	  true	  screening.	  	  This	  may	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also	  result	  from	  gendered	  differences	  in	  the	  interpretation	  of	  what	  the	  survey	  
instrument	  is	  asking	  when	  it	  differentiates	  true	  screening	  from	  diagnostic	  testing.	  	  	  
We	  can	  contrast	  this	  finding	  with	  both	  data	  on	  disease	  incidence	  as	  well	  as	  the	  
broader	  literature	  of	  sex	  differences	  in	  help	  seeking.	  	  Males	  suffer	  significantly	  higher	  
CRC	  incidence	  and	  mortality	  rates	  than	  females.	  	  Although	  some	  gender	  differences	  are	  
theorized	  to	  originate	  in	  risk	  factor	  and	  hormone	  exposures,	  lower	  rates	  of	  screening	  
are	  broadly	  hypothesized	  to	  contribute	  to	  higher	  disease	  burden	  (American	  Cancer	  
Society,	  2012).	  	  Considering	  these	  data,	  we	  would	  expect	  to	  find	  lower	  true	  screening	  
rates	  in	  males;	  we	  found	  the	  opposite.	  	  If	  the	  results	  of	  this	  study	  are	  not	  due	  to	  
differences	  in	  self	  report,	  this	  suggests	  that	  there	  may	  be	  alternate	  explanations	  for	  
higher	  incidence	  and	  mortality	  differences	  between	  genders	  including	  biological	  
differences	  in	  tumor	  occurrence,	  growth,	  and	  location.	  	  
We	  can	  also	  position	  this	  gender	  gap	  finding	  in	  a	  broader	  help	  seeking	  literature	  
that	  consistently	  demonstrates	  that	  females	  seek	  help	  and	  see	  health	  care	  practitioners	  
at	  a	  higher	  rate	  than	  their	  male	  counterparts.	  This	  is	  theorized	  to	  originate	  in	  
psychosocial	  differences	  between	  sexes,	  with	  males	  being	  more	  likely	  to	  delay	  or	  avoid	  
help	  seeking	  for	  illnesses.	  	  It	  is	  widely	  reported	  that	  men	  in	  the	  United	  States	  have	  fewer	  
contacts	  with	  physicians	  across	  the	  life	  span	  (see	  Mansfield,	  Addis	  &	  Mahalik,	  2003).	  	  In	  
2008	  (close	  temporally	  to	  the	  time	  at	  which	  this	  study’s	  data	  was	  collected),	  over	  20%	  of	  
men	  in	  the	  United	  States	  had	  no	  visits	  to	  a	  health	  care	  provider	  in	  the	  preceding	  12	  
months,	  compared	  to	  10.8%	  of	  women	  (National	  Center	  for	  Health	  Statistics,	  2010).	  	  
Considering	  that	  CRC	  screening	  requires	  the	  coordination	  between	  physician	  and	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patient,	  we	  expected	  to	  find	  lower	  rates	  of	  true	  screening	  in	  males,	  as	  they	  have	  fewer	  
opportunities	  to	  discuss	  screening	  with	  their	  physicians;	  again,	  our	  results	  contradict	  our	  
hypotheses	  and	  show	  that	  males	  engage	  in	  true	  screening	  at	  a	  higher	  rate	  than	  females.	  	  	  
This	  suggests	  that	  quantity	  of	  health	  care	  practitioner	  contact	  may	  be	  less	  predictive	  of	  
preventative	  health	  behaviors	  such	  as	  CRC	  screening.	  	  Instead,	  quality	  of	  care	  and	  
adherence	  to	  established	  risk-­‐based	  behavior	  recommendations	  (including	  CRC	  
screening)	  may	  prove	  to	  be	  more	  predictive	  of	  these	  behaviors.	  	  Although	  females	  see	  
physicians	  more	  frequently	  than	  males,	  this	  may	  be	  less	  relevant	  for	  CRC	  screening,	  as	  
many	  of	  the	  invasive	  options	  are	  repeated	  only	  every	  five	  or	  ten	  years.	  
Although	  our	  study	  sample	  is	  made	  of	  individuals	  with	  no	  history	  of	  CRC,	  we	  
expected	  to	  see	  patterns	  in	  diagnostic	  testing	  that	  reflect	  disease	  incidence,	  with	  higher	  
rates	  of	  diagnostic	  testing	  in	  males	  and	  in	  NHB.	  Instead,	  we	  found	  the	  highest	  rates	  of	  
diagnostic	  testing	  by	  females.	  Our	  findings	  contradict	  our	  hypotheses	  as	  well	  as	  the	  
findings	  in	  the	  CRC	  and	  help	  seeking	  literature.	  	  A	  possible	  explanation	  for	  this	  may	  be	  
that	  females	  are	  responding	  more	  aggressively	  to	  changes	  in	  bowel	  habits	  and	  are	  more	  
likely	  to	  be	  referred	  for	  diagnostic	  testing	  than	  males,	  who	  are	  more	  likely	  to	  delay	  help	  
seeking	  until	  a	  condition	  interferes	  with	  their	  daily	  life	  (Galdas,	  Cheater	  &	  Marsall,	  
2005).	  	  This	  can	  explain	  the	  higher	  rate	  of	  diagnostic	  testing	  in	  females,	  but	  the	  origin	  of	  
the	  higher	  rate	  of	  true	  screening	  in	  males	  is	  still	  unclear.	  Unfortunately	  much	  of	  the	  help	  
seeking	  literature	  focuses	  on	  curative,	  not	  preventative	  care,	  and	  it	  is	  unclear	  how	  much	  
of	  the	  gendered	  patterning	  of	  help	  seeking	  for	  curative	  care	  relates	  to	  preventative	  care	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including	  CRC	  screening.	  	  Further	  exploration	  both	  qualitatively	  and	  quantitatively	  is	  
necessary	  to	  understand	  these	  unexpected	  patterns	  in	  diagnostic	  testing	  and	  screening.	  	  	  
These	  findings	  are	  of	  great	  concern	  to	  users	  of	  NHIS	  data.	  	  Despite	  the	  
methodological	  advantage	  of	  NHIS	  through	  its	  ability	  to	  differentiate	  true	  screening	  
from	  diagnostic	  testing,	  many	  researchers	  fail	  to	  use	  all	  available	  data	  in	  their	  analyses,	  
or	  use	  it	  differently	  across	  studies.	  	  For	  example,	  in	  a	  study	  of	  colorectal	  cancer	  
screening	  disparities,	  researchers	  note,	  
“…both	  diagnostic	  and	  screening	  exams	  were	  included	  in	  adherence	  
calculations	  to	  create	  the	  most	  lenient	  definition	  of	  up-­‐to-­‐date	  with	  CRC	  
screening	  recommendations	  and	  to	  be	  consistent	  with	  Healthy	  People	  
2010	  goal	  measurement	  methods”	  (James,	  2006).	  	  	  
	  
Klabunde	  et	  al.	  (2011)	  and	  Shapiro	  et	  al.	  (2008)	  use	  similar	  language,	  noting	  that	  	  
“we	  included…tests	  done	  for	  any	  reason,	  not	  just	  as	  part	  of	  a	  routine	  
exam,	  because	  the	  reported	  reason	  for	  having	  the	  test	  may	  not	  be	  
accurate,	  and	  having	  the	  test	  within	  the	  recommended	  time	  interval,	  
regardless	  of	  the	  reason,	  essentially	  means	  that	  the	  individual	  has	  been	  
screened”	  (Klabunde	  et	  al.	  (2011),	  p.	  1612).	  	  
	  
Articles	  such	  as	  these	  inform	  the	  CRC	  literature	  (including	  research,	  
interventions,	  and	  policy)	  in	  a	  potentially	  damaging	  way,	  overestimating	  rates,	  
miscalculating	  trends	  over	  time,	  misspecifying	  behavioral	  predictors	  and	  more.	  
Our	  results	  provide	  evidence	  that	  is	  of	  most	  concern	  to	  users	  of	  BRFSS	  data,	  as	  
our	  results	  demonstrate	  that	  ignoring	  the	  impetus	  for	  testing	  and	  the	  resulting	  
misspecification	  of	  the	  outcome	  of	  interest	  result	  in	  grossly	  overestimated	  rates	  of	  true	  
CRC	  screening.	  	  Misspecification	  of	  the	  outcome	  is	  especially	  problematic	  for	  users	  of	  
BRFSS	  data,	  as	  the	  study’s	  methodology	  results	  in	  data	  that	  cannot	  account	  for	  impetus	  
for	  testing.	  	  BRFSS	  data	  are	  used	  for	  reports	  in	  Morbidity	  and	  Mortality	  Weekly	  Reports	  
	  	   41	  
by	  the	  Centers	  for	  Disease	  Control	  and	  Prevention	  as	  well	  as	  state-­‐level	  data	  for	  Healthy	  
People	  goals	  and	  benchmarks.	  	  In	  this	  study	  sample,	  overall	  population	  rates	  were	  
inflated	  by	  23.08%	  without	  accounting	  for	  the	  impetus	  for	  testing,	  with	  the	  least	  
advantaged	  socioeconomic	  groups’	  rate	  overestimation	  at	  31.18%,	  32.15%	  and	  51.52%.	  	  
This	  alone	  has	  the	  potential	  for	  undermining	  decades	  of	  data	  from	  MMWR,	  Healthy	  
People	  and	  AHRQ.	  	  	  
Although	  the	  limitations	  of	  BRFSS	  data	  are	  frequently	  acknowledged	  by	  
researchers	  (including	  users	  of	  data	  for	  MMWR	  reports	  -­‐-­‐	  see	  Joseph,	  Rim,	  &	  Seeff,	  
2008),	  that	  is	  simply	  not	  enough.	  	  This	  is	  a	  preventable	  limitation	  with	  the	  addition	  of	  
one	  simple	  question	  –	  “Why	  did	  you	  engage	  in	  the	  CRC	  testing?”	  	  Our	  study	  
demonstrates	  that	  without	  that	  one	  question,	  we	  risk	  overestimation	  of	  screening	  rates	  
and	  failure	  to	  accurately	  assess	  predictors	  of	  the	  optimal	  behavioral	  outcome.	  	  We	  
showed	  evidence	  of	  gross	  overestimation	  rates	  ranging	  from	  16.74%	  (NHBM)	  to	  54.75%	  
(no	  usual	  source	  of	  health	  care).	  	  
Inaccurate	  rate	  estimation	  has	  implications	  for	  disparities	  research	  as	  well.	  One	  
of	  the	  most	  common	  disparities	  discussed	  in	  the	  CRC	  literature	  is	  between	  NHW	  and	  
NHB.	  	  In	  this	  sample,	  failure	  to	  account	  for	  the	  impetus	  for	  testing	  resulted	  in	  an	  
overestimation	  of	  disparities	  between	  NHW	  and	  NHB	  of	  37.40%	  (17.57%	  NHW	  
advantage	  to	  12.79%	  NHW	  advantage),	  and	  other	  sociodemographic	  disparities	  were	  
mildly	  and	  grossly	  under-­‐	  or	  overestimated	  as	  well.	  	  	  
Finally,	  there	  was	  substantial	  change	  in	  the	  nature	  of	  the	  predictors	  of	  true	  
screening	  versus	  any	  ACS	  guideline	  adherent	  testing,	  with	  both	  education	  and	  physician	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recommendation	  no	  longer	  significantly	  associated	  with	  the	  correctly	  specified	  
outcome,	  and	  sex	  and	  poverty	  ratio	  predictive	  of	  true	  screening	  but	  not	  an	  outcome	  
that	  conflated	  diagnostic	  testing	  and	  true	  screening.	  	  In	  sum,	  correct	  specification	  of	  the	  
behavioral	  outcome	  contributes	  to	  a	  more	  accurate	  assessment	  of	  the	  behavior	  that	  we	  
need	  for	  improved	  public	  health	  –	  true	  screening	  –	  and	  allows	  us	  to	  better	  assess	  
predictors	  of	  that	  behavior.	  	  
As	  we	  consider	  the	  design	  and	  evaluation	  of	  CRC	  screening	  interventions,	  the	  
results	  from	  multivariate	  models	  predicting	  incorrectly	  and	  correctly	  specified	  outcomes	  
provide	  evidence	  that	  longstanding	  predictors	  of	  ‘screening’	  may,	  in	  fact,	  not	  predict	  
true	  screening.	  	  In	  particular,	  the	  physician	  recommendation	  to	  screen	  is	  not,	  in	  fact,	  
predictive	  of	  true	  screening	  in	  the	  subpopulation	  of	  respondents	  who	  reported	  ACS	  
guideline-­‐adherent	  testing.	  	  This	  evidence	  suggests	  that	  focusing	  interventions	  at	  the	  
health	  services	  level	  may	  not,	  in	  fact,	  increase	  individuals’	  odds	  of	  engaging	  in	  CRC	  
screening.	  	  	  
Another	  interesting	  finding	  in	  the	  multivariate	  models	  is	  that	  among	  the	  
subpopulation	  who	  engaged	  in	  ACS	  guideline	  adherent	  testing,	  NHB	  were	  at	  greater	  
odds	  of	  engaging	  in	  true	  screening	  than	  their	  NHW	  counterparts.	  This	  highlights	  the	  
critical	  importance	  of	  correctly	  specifying	  the	  outcome	  of	  interest	  through	  inclusion	  of	  
the	  impetus	  for	  testing—what	  we	  thought	  was	  a	  strong	  disadvantage	  in	  NHB	  in	  the	  full	  
population	  was	  instead	  a	  strong	  advantage	  in	  the	  subpopulation.	  	  As	  discussed	  earlier,	  
NHW/NHB	  disparities	  pre-­‐	  and	  post-­‐adjustment	  decreased	  by	  over	  37%	  after	  adjusting	  
for	  the	  impetus	  for	  testing.	  	  This	  finding	  suggests	  that	  the	  perceptions	  of	  racial	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disparities	  discussed	  in	  the	  literature	  to	  date	  (showing	  a	  strong	  advantage	  for	  NHW)	  
may	  be	  the	  result	  of	  higher	  diagnostic	  testing	  in	  NHW,	  specifically	  NHW	  women.	  	  
Interventions	  targeting	  NHB	  populations	  may	  still	  be	  useful,	  as	  even	  with	  a	  lower	  rate	  of	  
diagnostic	  testing,	  they	  are	  still	  engaging	  in	  CRC	  screening	  at	  a	  lower	  rate,	  but	  the	  
degree	  to	  which	  they	  differ	  is	  substantially	  less	  once	  we	  account	  for	  the	  impetus	  for	  
testing.	  
	   In	  order	  to	  accurately	  assess	  whether	  or	  not	  we	  are	  meeting	  federally	  
established	  benchmarks	  for	  CRC	  screening	  at	  individual	  and	  institutional	  levels,	  we	  need	  
to	  derive	  estimates	  from	  data	  that	  properly	  differentiate	  diagnostic	  testing	  from	  true	  
screening.	  	  However,	  we	  are	  falling	  short	  of	  that	  by	  using	  NHIS	  data	  without	  considering	  
the	  impetus	  for	  testing	  and	  by	  using	  BRFSS	  data	  that	  is	  unable	  to	  differentiate	  the	  two	  
behaviors.	  	  Estimated	  population	  rates	  from	  BRFSS	  are	  already	  below	  federal	  goals	  for	  
many	  sociodemographic	  groups,	  but	  are	  likely	  far	  lower	  since	  BRFSS	  includes	  diagnostic	  
testing	  in	  their	  screening	  measures.	  	  As	  James	  et	  al.	  (2006)	  allude	  to,	  Healthy	  People	  
utilizes	  NHIS	  for	  national-­‐level	  data,	  but	  there	  is	  no	  evidence	  that	  the	  impetus	  for	  testing	  
is	  accounted	  for	  in	  their	  estimates.	  	  And	  we	  must	  remember	  that	  this	  applies	  not	  only	  to	  
overall	  population	  rates	  but	  to	  rates	  by	  demographic	  and	  socioeconomic	  group	  as	  well.	  	  
Examining	  variation	  within	  or	  between	  groups	  using	  BRFSS	  data,	  especially	  across	  levels	  
of	  socioeconomic	  status	  indicators	  of	  education,	  poverty	  ratio	  and	  insurance,	  is	  
problematic	  due	  to	  differential	  rates	  of	  diagnostic	  testing.	  	  In	  our	  sample,	  diagnostic	  
testing	  accounted	  for	  as	  much	  as	  35.38%	  of	  screening	  behaviors	  (in	  those	  with	  no	  usual	  
source	  of	  health	  care)	  and	  varied	  considerably	  across	  sociodemographic	  and	  age	  groups.	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   This	  significant	  variability	  in	  diagnostic	  testing	  and	  true	  screening	  across	  
sociodemographic	  groups	  calls	  into	  question	  the	  relevance	  and	  effectiveness	  of	  a	  one-­‐
size-­‐fits-­‐all	  federal	  goal	  such	  as	  Healthy	  People	  2020.	  	  Consider,	  for	  example,	  the	  
variability	  in	  true	  screening	  rate	  estimates	  across	  levels	  of	  education:	  	  from	  34.23%	  (the	  
lowest	  level)	  to	  58.99%	  (the	  highest	  level).	  	  This	  is	  a	  72%	  difference	  comparing	  the	  
higher	  rate	  to	  the	  lower.	  	  Does	  a	  federal	  benchmark	  that	  averages	  these	  types	  of	  rates	  
across	  the	  entire	  population	  serve	  the	  public	  most	  effectively?	  	  We	  argue	  that	  instead	  of	  
one	  goal,	  we	  seek	  to	  improve	  rates	  across	  sociodemographic	  categories,	  putting	  
resources	  into	  assessing	  and	  addressing	  the	  barriers	  to	  CRC	  screening	  to	  each	  of	  these	  
groups.	  	  Averaging	  the	  population	  as	  a	  whole	  ignores	  significant	  variation	  across	  
population	  groups	  and	  allows	  us	  to	  perceive	  progress	  when,	  in	  fact,	  only	  those	  with	  
great	  socioeconomic	  privilege	  enjoy	  the	  highest	  rates	  of	  screening.	  
	   The	  final	  policy	  implication	  resulting	  from	  this	  data	  is	  the	  need	  for	  data	  collection	  
by	  SEER	  to	  capture	  data	  on	  how	  individuals	  with	  CRC	  disease	  were	  diagnosed	  –	  from	  
diagnostic	  testing	  or	  true	  screening.	  	  Ideally,	  we	  could	  place	  our	  findings	  in	  the	  
conversation	  of	  stage	  and	  survival	  of	  CRC	  disease.	  	  However,	  this	  is	  difficult	  to	  do	  since	  
we	  would	  be	  comparing	  individuals	  without	  cancer	  (as	  defined	  by	  our	  population	  
parameters)	  with	  those	  with	  cancer.	  	  In	  order	  to	  determine	  if	  there	  is	  a	  relationship	  
between	  diagnostic	  testing	  and	  stage	  of	  disease,	  we	  must	  collect	  data	  at	  the	  time	  of	  
diagnosis	  on	  how	  patients	  were	  diagnosed	  (diagnostic	  testing	  vs.	  true	  screening)	  and	  
their	  disease	  stage	  to	  determine	  if	  there	  is	  an	  association	  between	  timeliness	  of	  
screening	  and	  stage.	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This	  study	  is	  subject	  to	  several	  unavoidable	  limitations.	  	  First,	  we	  analyzed	  data	  
collected	  in	  2008,	  as	  analyses	  began	  as	  the	  2010	  survey	  was	  being	  released.	  	  2008	  data	  
remained	  the	  best	  option,	  however,	  due	  to	  its	  specificity	  with	  its	  questions	  pertaining	  to	  
physician	  recommendations.	  	  A	  general	  limitation	  of	  using	  NHIS	  data	  is	  the	  inability	  to	  
conduct	  analyses	  by	  geographic	  region	  with	  much	  certainty;	  other	  data	  collected	  by	  
state-­‐level	  entities	  such	  as	  the	  Department	  of	  Public	  Health	  or	  data	  that	  are	  
representative	  to	  each	  state’s	  population	  (including	  BRFSS	  data)	  would	  be	  more	  
appropriate.	  	  CRC	  screening	  rates	  vary	  considerably	  by	  state,	  and	  within	  state	  by	  county;	  
this	  variation	  should	  be	  considered	  in	  future	  studies	  of	  CRC	  screening	  (Rim	  et	  al.,	  2011;	  
Weir	  et	  al.,	  2003).	  
Common	  to	  survey	  data,	  NHIS	  data	  are	  subject	  to	  recall	  bias	  on	  the	  part	  of	  the	  
respondents	  for	  both	  dependent	  and	  independent	  variables.	  	  Prior	  studies	  have	  found	  
that	  self-­‐report	  of	  CRC	  screening	  are	  moderate	  to	  high	  in	  both	  sensitivity	  and	  specificity	  
with	  no	  clear	  patterns	  in	  differences	  in	  the	  accuracy	  of	  self-­‐report	  by	  age,	  sex,	  race	  or	  
family	  history	  (Baier	  et	  al.,	  2000).	  	  Another	  potential	  source	  of	  bias	  in	  this	  study	  is	  
selection	  bias	  due	  to	  differential	  nonresponse	  among	  specific	  subgroups	  of	  individuals,	  
which	  is	  addressed	  via	  nonresponse	  adjustments	  of	  the	  weights	  provided	  by	  NHIS	  to	  
survey	  analysts	  (Centers	  for	  Disease	  Control	  and	  Prevention,	  2012).	  	  	  
In	  addition,	  there	  may	  be	  differential	  bias	  in	  comprehension	  of	  survey	  questions.	  	  
Differential	  interpretation	  of	  questions	  by	  race,	  gender,	  and	  socioeconomic	  status	  may	  
explain	  some	  of	  our	  findings.	  	  However,	  the	  survey	  questions	  of	  interest	  were	  follow-­‐up	  
questions	  to	  screening	  responses.	  	  These	  questions	  received	  very	  little	  attention	  in	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testing,	  as	  the	  majority	  of	  the	  cognitive	  testing	  subjects	  (which	  numbered	  only	  9	  over	  
age	  40)	  indicated	  they	  did	  not	  undergo	  CRC	  testing,	  resulting	  in	  little	  to	  no	  cognitive	  
testing	  on	  the	  follow-­‐up	  questions	  (B.	  Taylor,	  personal	  communication,	  June	  17,	  2014).	  	  
Finally,	  our	  practice	  of	  deriving	  full	  population	  rates	  using	  unadjusted	  testing	  rates	  and	  
true	  screening	  rate	  estimates	  from	  the	  subpopulation	  resulted	  in	  estimates	  that	  may	  
have	  confidence	  intervals	  narrower	  than	  what	  they	  should	  be.	  	  This	  is	  due	  to	  the	  fact	  
that	  we	  are	  unable	  to	  account	  for	  the	  fact	  that	  we	  are	  treating	  the	  rate	  used	  in	  
estimation	  as	  fixed	  when	  it	  is,	  in	  fact,	  an	  estimate.	  	  The	  confidence	  interval	  for	  the	  true	  
screening	  rate	  of	  the	  full	  population	  excludes	  the	  variance	  estimates	  of	  the	  true	  
screening	  rate	  of	  the	  study’s	  subpopulation.	  Therefore,	  the	  resulting	  tests	  of	  statistical	  
significance	  will	  be	  more	  likely	  to	  show	  statistical	  significance	  than	  they	  would	  have	  had	  
the	  results	  not	  been	  derived	  from	  two	  estimates.	  	  In	  the	  future,	  researchers	  should	  
explore	  the	  use	  of	  jackknifing	  as	  a	  tool	  to	  incorporate	  the	  variance	  of	  both	  estimates	  
when	  calculating	  confidence	  intervals	  and	  resulting	  statistical	  tests	  for	  the	  full	  
population.	  
In	  sum,	  what	  has	  been	  called	  ‘screening’	  in	  the	  majority	  of	  the	  CRC	  literature	  is	  
erroneous	  and	  misleading	  as	  it	  conflates	  diagnostic	  testing	  and	  true	  screening.	  	  This	  
practice	  ignores	  the	  most	  fundamental	  aspect	  of	  CRC	  screening,	  namely	  that	  it	  occurs	  at	  
a	  pre-­‐symptomatic,	  or	  asymptomatic,	  stage	  of	  disease.	  	  The	  evidence	  from	  this	  study	  
shows	  the	  importance	  of	  immediate	  changes	  in	  survey	  methodology	  to	  correctly	  specify	  
the	  behavioral	  outcome	  that	  promotes	  public	  health:	  	  true	  screening.	  	  Quick	  action	  to	  
resolve	  avoidable	  methodological	  limitations	  of	  BRFSS	  and	  other	  surveys	  is	  required	  to	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help	  ensure	  collection	  of	  accurate	  screening	  data.	  	  Furthermore,	  we	  need	  to	  reexamine	  
data	  across	  the	  past	  decades.	  	  Research	  has	  shown	  that	  increased	  use	  of	  CRC	  screening	  
over	  time	  is	  attributable	  to	  increased	  use	  of	  colonoscopies,	  which	  are	  the	  most	  frequent	  
test	  for	  diagnostic	  testing.	  	  Research	  showing	  increased	  screening	  over	  time	  may,	  in	  fact,	  
be	  erroneous	  and	  represent	  increases	  in	  diagnostic	  testing	  instead.	  	  As	  we	  consider	  
intervention	  and	  policy	  evaluation	  approaches,	  it	  will	  be	  critical	  to	  accurately	  measure	  
the	  behavioral	  outcome.	  	  Excessive	  diagnostic	  testing	  does	  not	  promote	  public	  health	  
goals	  and	  should	  not	  be	  counted	  as	  true	  screening.	  	  Finally,	  policymakers	  should	  use	  
these	  results	  as	  a	  starting	  point	  to	  evaluate	  the	  benefits	  and	  drawbacks	  of	  one-­‐size-­‐fits-­‐
all	  goals.	  	  The	  dangers	  of	  conflating	  diagnostic	  testing	  and	  CRC	  screening	  are	  clear.	  	  
Researchers,	  practitioners	  and	  policymakers	  must	  take	  steps	  now	  to	  ensure	  accurate	  
assessment	  of	  rates,	  trends,	  disparities	  and	  other	  facets	  of	  CRC	  screening	  so	  that	  we	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CHAPTER	  THREE	  
	  
Methodological	  Issues	  in	  Colorectal	  Cancer	  Research:	  




Colorectal	  cancer	  (CRC)	  screening	  reduces	  the	  burden	  of	  CRC	  morbidity	  and	  
mortality.	  	  In	  population	  surveys	  of	  patients	  who	  have	  engaged	  in	  CRC	  screening,	  the	  
receipt	  of	  a	  physician	  recommendation	  to	  screen4	  has	  been	  shown	  to	  be	  a	  strong	  
predictor	  of	  screening	  (Coughlin	  &	  Thompson,	  2005;	  Klabunde,	  Breen,	  &	  Meissner,	  
2005).	  Historically,	  methods	  to	  measure	  recommendation	  rates	  have	  focused	  on	  self-­‐
reported	  data	  from	  national	  surveys.	  	  National	  organizations	  including	  the	  Centers	  for	  
Disease	  Control	  and	  Prevention	  (CDC),	  the	  American	  Cancer	  Society	  (ACS),	  and	  Healthy	  
People	  2020	  rely	  on	  these	  surveys	  to	  provide	  comprehensive	  data	  on	  cancer	  screening.	  	  
The	  data	  collected	  allows	  researchers	  to	  assess	  rates	  of	  screening	  engagement,	  rates	  of	  
recommendations	  from	  physicians	  to	  patients,	  disparities	  in	  screening	  and	  
recommendation	  patterns	  between	  groups,	  trends	  in	  screening	  and	  recommendations	  
over	  time,	  and	  adherence	  to	  recommendations.	  	  The	  Behavioral	  Risk	  Factor	  Surveillance	  
Survey	  (BRFSS)	  and	  the	  National	  Health	  Interview	  Survey	  (NHIS)	  are	  among	  the	  most	  
cited	  surveys	  in	  cancer	  screening	  research.	  	  
In	  cancer	  screening	  research,	  we	  are	  interested	  in	  physician	  recommendations	  to	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  With	  few	  exceptions,	  from	  this	  point	  forward	  a	  physician	  or	  other	  health	  care	  provider’s	  
recommendation	  to	  screen	  will	  be	  referred	  to	  as	  simply	  a	  ‘recommendation.’	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screen	  in	  two	  contexts	  (see	  Figure	  3.1).	  	  First,	  we	  are	  concerned	  with	  recommendations	  
as	  a	  behavioral	  outcome:	  	  whether	  or	  not	  physicians	  are	  recommending	  cancer	  
screening	  to	  their	  patients.	  Second,	  we	  are	  concerned	  with	  physician	  recommendations	  
to	  screen	  as	  a	  predictor	  of	  guideline-­‐adherent	  cancer	  screening:	  	  whether	  or	  not	  the	  
recommendation	  to	  screen	  is	  associated	  with,	  and	  predictive	  of,	  screening	  engagement	  
of	  their	  patients.	  
A	  review	  of	  the	  literature	  in	  both	  of	  these	  contexts	  reveals	  irregular	  measurement	  of	  
physician	  recommendations.	  	  Specifically,	  methodological	  choices	  and	  limitations	  of	  
surveys	  result	  in	  a	  conflation	  of	  referrals	  for	  diagnostic	  testing	  with	  recommendations	  
for	  pre-­‐symptomatic	  screening	  (which	  we	  will	  refer	  to	  as	  true	  screening	  
recommendation).	  	  The	  resulting	  literature	  on	  physician	  recommendations	  to	  screen	  
results	  in	  inaccurate	  estimates	  of	  the	  behavior,	  both	  as	  an	  outcome	  and	  predictor.	  
This	  conflation	  of	  diagnostic	  referrals	  and	  true	  screening	  recommendations	  is	  not	  
surprising	  given	  that	  the	  some	  of	  the	  actual	  tests,	  including	  colonoscopy,	  serve	  as	  an	  
important	  screening	  test	  option	  as	  well	  as	  a	  diagnostic	  tool.	  However,	  conflating	  
diagnostic	  testing	  recommendations	  with	  true	  screening	  recommendations	  may	  lead	  to	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effectiveness	  of	  health	  services	  interventions.	  	  	  
Most	  often,	  empirical	  research	  on	  these	  outcomes	  in	  CRC	  screening	  fall	  victim	  to	  
the	  methodological	  choices	  of	  national	  surveys.	  	  In	  their	  work	  exploring	  factors	  
associated	  with	  racial	  and	  ethnic	  differences	  in	  screening	  recommendations,	  Ahmed	  &	  
colleagues	  (2013)	  failed	  to	  account	  for	  the	  impetus	  for	  the	  recommendation.	  	  Though	  
their	  findings	  included	  associations	  between	  respondents’	  socioeconomic	  status	  and	  
health	  care	  access	  with	  differences	  between	  racial	  and	  ethnic	  groups,	  these	  
relationships	  are	  likely	  misestimated	  due	  to	  the	  conflation	  of	  referrals	  for	  diagnostic	  
testing	  and	  true	  screening	  recommendations.	  	  James	  et	  al.	  (2006)	  utilized	  NHIS	  data	  to	  
examine	  disparities	  in	  screening	  and	  recommendations,	  but	  failed	  to	  utilize	  available	  
data	  from	  NHIS	  that	  asks	  respondents	  to	  report	  the	  impetus	  for	  testing	  (as	  part	  of	  a	  
routine	  exam	  or	  due	  to	  a	  problem),	  noting,	  	  
“Both	  diagnostic	  and	  screening	  exams	  were	  included	  in	  adherence	  
calculations	  to	  create	  the	  most	  lenient	  definition	  of	  up-­‐to-­‐date	  with	  CRC	  
screening	  recommendations	  and	  to	  be	  consistent	  with	  Healthy	  People	  
2010	  goal	  measurement	  methods.”	  	  	  
	  
Finally,	  in	  an	  analysis	  of	  the	  2005	  NHIS,	  Shapiro	  and	  colleagues	  (2008)	  examine	  physician	  
recommendations	  as	  a	  predictor	  of	  screening	  and	  note,	  	  
“Colorectal	  cancer	  tests	  done	  for	  any	  indication	  were	  included	  in	  the	  
analysis	  because	  …	  even	  if	  a	  test	  were	  conducted	  for	  nonscreening	  
purposes,	  a	  person	  would	  have	  been	  considered	  effectively	  screened.”	  	  	  
	  
These	  studies	  are	  important	  because	  they	  are	  representative	  of	  a	  broader	  issue:	  	  the	  
persistent	  misspecification	  of	  behavioral	  outcomes	  in	  cancer	  screening	  research	  that	  
often	  fails	  to	  recognize	  the	  most	  fundamental	  characteristic	  of	  screening;	  namely,	  that	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true	  screening	  occurs	  at	  the	  pre-­‐symptomatic	  stage	  of	  disease.	  A	  physician	  referral	  for	  
diagnostic	  testing	  is	  not	  a	  physician	  recommendation	  to	  screen.	  	  Therefore,	  multivariate	  
models	  from	  these	  and	  other	  studies	  are	  likely	  misestimating	  a)	  predictors	  of	  physician	  
recommendations	  and	  b)	  the	  degree	  to	  which	  a	  recommendation	  is	  associated	  with	  
screening	  behaviors.	  	  	  
A	  distinguishing	  feature	  of	  two	  of	  the	  most	  cited	  national	  surveys,	  the	  Behavioral	  
Risk	  Factor	  Surveillance	  Survey	  (BRFSS)	  and	  the	  National	  Health	  Interview	  Survey	  (NHIS),	  
is	  their	  varying	  ability	  to	  differentiate	  referrals	  for	  diagnostic	  testing	  and	  true	  screening	  
recommendations.	  Survey	  researchers	  utilizing	  BRFSS	  data	  often	  cite	  an	  inability	  to	  
distinguish	  between	  these	  behaviors	  as	  a	  limitation	  to	  their	  studies	  (Centers	  for	  Disease	  
Control,	  2010;	  Joseph,	  King,	  Miller,	  &	  Richardson,	  2012;	  Soneji,	  Armstrong,	  &	  Asch,	  
2012).	  	  BRFSS	  does	  not	  ask	  respondents	  why	  they	  engaged	  in	  testing	  (Centers	  for	  
Disease	  Control	  and	  Prevention,	  2013).	  	  In	  contrast	  to	  BRFSS,	  NHIS	  affords	  researchers	  
the	  opportunity	  to	  distinguish	  between	  the	  two	  by	  asking	  respondents	  not	  only	  what	  
test	  they	  had	  and	  when,	  but	  why	  they	  had	  it	  (Centers	  for	  Disease	  Control	  and	  
Prevention,	  2012).	  NHIS	  methodology	  allows	  us	  to	  better	  differentiate	  physician	  
recommendations	  to	  screen	  versus	  physician	  referrals	  for	  diagnostic	  testing,	  as	  depicted	  
in	  Figure	  3.2.	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The	  goals	  of	  the	  current	  study	  are	  a)	  to	  quantify	  the	  potential	  error	  in	  CRC	  
screening	  recommendation	  rates	  that	  results	  from	  conflating	  referrals	  for	  diagnostic	  
testing	  and	  true	  screening	  recommendations;	  b)	  to	  determine	  whether	  the	  quantity	  of	  
error	  in	  CRC	  recommendation	  rates	  varies	  across	  sociodemographic	  categories;	  and	  c)	  
to	  examine	  how	  predictive	  models	  of	  true	  screening	  recommendations	  for	  CRC	  differ	  
from	  predictive	  models	  of	  an	  outcome	  variable	  that	  conflates	  referrals	  for	  diagnostic	  
testing	  with	  true	  screening	  recommendations.	  	  We	  explore	  these	  questions	  through	  an	  
analysis	  of	  colorectal	  cancer	  (CRC)	  screening	  behaviors	  reported	  in	  the	  2008	  NHIS	  and	  
Cancer	  Control	  and	  Sun	  Protection	  Supplement	  (CCSPS).	  
Methods	  
Data	  source.	  	  We	  examined	  cross-­‐sectional	  survey	  data	  from	  the	  2008	  NHIS	  and	  
CCSPS.	  	  Although	  there	  are	  other	  options	  for	  collecting	  preventative	  care	  data	  (including	  
other	  nationally	  representative	  datasets	  and	  electronic	  health	  record	  data),	  we	  are	  
using	  NHIS	  for	  the	  specific	  aims	  and	  broader	  goals	  of	  this	  study	  for	  several	  reasons.	  	  
First,	  it	  allows	  us	  to	  consider	  multiple	  factors	  simultaneously	  as	  we	  consider	  influences	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nationally	  representative	  dataset	  that	  allows	  us	  to	  capture	  data	  on	  the	  impetus	  for	  
testing,	  a	  critical	  component	  of	  our	  analyses.	  	  And	  finally,	  due	  to	  its	  frequent	  use	  in	  
survey	  research,	  we	  can	  compare	  and	  contrast	  results	  from	  this	  study	  with	  a	  large	  body	  
of	  literature	  in	  CRC	  and	  other	  cancer	  screening	  behaviors.	  	  Since	  its	  inception	  in	  1957,	  
the	  NHIS	  has	  been	  the	  principal	  source	  of	  information	  on	  the	  health	  and	  health	  
behaviors	  of	  civilian,	  non-­‐institutionalized	  households	  in	  the	  United	  States	  (Centers	  for	  
Disease	  Control	  and	  Prevention,	  2012).	  	  The	  survey	  is	  administered	  annually	  by	  the	  
National	  Center	  for	  Health	  Statistics	  (NCHS)	  of	  the	  Centers	  for	  Disease	  Control	  and	  
Prevention	  (CDC)	  and	  uses	  a	  stratified	  multistage	  probability	  sample	  design	  (Centers	  for	  
Disease	  Control	  and	  Prevention,	  2012).	  	  The	  2008	  CCSPS	  was	  sponsored	  by	  the	  National	  
Cancer	  Institute	  (NCI)	  and	  includes	  questions	  on	  physician	  recommendations	  for	  
screening,	  screening	  behaviors,	  and	  reasons	  for	  screening	  tests.	  	  The	  2008	  NHIS/CSSPS	  
was	  selected	  over	  the	  more	  recent	  2010	  NHIS	  due	  to	  the	  fact	  that	  questions	  on	  
physician	  recommendations	  for	  screening	  were	  linked	  to	  respondents’	  screening	  
behaviors	  rather	  than	  in	  a	  more	  general	  manner.	  	  This	  allowed	  us	  to	  identify	  the	  
impetus	  for	  the	  physician	  recommendation	  as	  well	  as	  CRC	  testing.	  
The	  NHIS	  sampling	  strategies	  result	  in	  an	  oversample	  of	  self-­‐identified	  Black,	  
Hispanic	  and	  Asian	  Americans.	  	  Weights	  constructed	  for	  the	  NHIS	  respondents	  reflect	  
the	  resulting	  unequal	  probabilities	  of	  selection	  and	  also	  incorporate	  adjustments	  for	  
non-­‐response	  and	  post-­‐stratification	  procedures	  designed	  to	  align	  survey	  estimates	  with	  
population	  distributions	  from	  the	  2000	  Census.	  	  The	  application	  of	  these	  weights	  in	  
secondary	  analyses	  of	  the	  NHIS	  data	  results	  in	  estimates	  that	  are	  representative	  of	  the	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adult	  civilian	  non-­‐institutionalized	  population	  of	  the	  U.S.	  (Inter-­‐University	  Consortium	  
for	  Political	  and	  Social	  Research,	  2012).	  	  The	  annual	  NHIS	  response	  rate	  averages	  close	  
to	  ninety	  percent	  of	  the	  eligible	  households	  in	  the	  sample	  (Centers	  for	  Disease	  Control	  
and	  Prevention,	  2012).	  	  	  
Study	  population.	  We	  calculated	  estimates	  of	  overall	  population	  
recommendation	  rates	  using	  the	  full	  subpopulation,	  defined	  as	  non-­‐Hispanic	  White	  and	  
non-­‐Hispanic	  Black	  respondents	  ages	  50-­‐80	  with	  no	  history	  of	  colorectal	  cancer.	  	  We	  
chose	  these	  two	  groups	  because	  Non-­‐Hispanic	  Whites	  and	  Non-­‐Hispanic	  Blacks	  suffer	  
the	  highest	  rates	  of	  cancers	  of	  the	  colon	  and	  rectum	  in	  the	  United	  States	  (American	  
Cancer	  Society,	  2011)	  and	  are	  the	  most	  common	  population	  groups	  studied	  in	  CRC	  
screening	  literature	  (Ananthakrishnan,	  Schellhase,	  Sparapani,	  Laud,	  &	  Neuner,	  2007;	  
Bellizzi,	  Breslau,	  Burness,	  &	  Waldron,	  2011;	  Breen,	  Wagener,	  Brown,	  Davis,	  &	  Ballard-­‐
Barbash,	  2001;	  Centers	  for	  Disease	  Control	  and	  Prevention	  (CDC),	  2001;	  James,	  2006;	  
Klabunde	  et	  al.,	  2005).	  	  Individuals	  with	  a	  history	  of	  colorectal	  cancer	  were	  excluded	  
since	  testing	  is	  used	  as	  disease	  management	  or	  control	  and	  not	  preventative	  care.	  	  We	  
defined	  a	  subpopulation	  for	  our	  analysis	  of	  true	  screening	  recommendation	  rates	  of	  
individuals	  who	  reported	  a	  recommendation	  to	  screen	  and	  ACS	  guideline-­‐adherent	  
screening	  since	  only	  they	  were	  asked	  about	  the	  impetus	  for	  the	  testing.	  	  
This	  study	  received	  an	  exempt	  status	  designation	  from	  the	  University	  of	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Physician	  recommendation.	  	  To	  measure	  rates	  of	  recommendations	  that	  would	  
reflect	  the	  methodology	  of	  BRFSS,	  we	  used	  questions	  derived	  from	  the	  NHIS.	  	  	  
Respondents	  who	  reported	  any	  type	  of	  testing	  (including	  FOBT)	  in	  the	  past	  ten	  years	  
were	  asked,	  "Was	  your	  most	  recent	  [screening]	  test	  recommended	  by	  a	  doctor	  or	  other	  
health	  professional?"	  Respondents	  who	  did	  not	  report	  testing	  in	  the	  past	  ten	  years	  were	  
asked,	  "In	  the	  past	  twelve	  months,	  has	  a	  doctor	  or	  other	  health	  professional	  
recommended	  that	  you	  be	  tested	  to	  look	  for	  problems	  in	  your	  colon	  or	  rectum?"	  	  A	  
response	  of	  “yes”	  or	  “no”	  was	  coded	  as	  such,	  while	  a	  response	  of	  “did	  not	  see	  a	  doctor	  
in	  the	  past	  12	  months”	  was	  coded	  as	  “no.”	  	  A	  response	  of	  “refused”	  or	  “don’t	  know”	  
was	  coded	  as	  missing	  data	  and	  excluded	  from	  analysis.	  	  However,	  in	  the	  case	  of	  
respondents	  who	  were	  asked	  the	  question	  twice	  due	  to	  affirmative	  responses	  to	  both	  
non-­‐invasive	  and	  invasive	  testing,	  an	  answer	  resulting	  in	  a	  code	  of	  ‘yes’	  or	  ‘no’	  for	  any	  
question	  resulted	  in	  missing	  data	  from	  the	  other	  being	  ignored5	  (total	  missing	  n	  =	  91).	  	  	  
Physician	  referral	  for	  diagnostic	  testing	  vs.	  true	  screening	  recommendations.	  	  
To	  measure	  rates	  of	  referrals	  for	  diagnostic	  testing	  and	  true	  screening	  
recommendations	  that	  would	  reflect	  the	  methodology	  of	  NHIS,	  we	  created	  a	  
dichotomous	  variable	  combining	  data	  on	  reports	  of	  recommendations	  for	  testing	  (see	  
above)	  and	  the	  impetus	  for	  the	  reported	  testing.	  Individuals	  who	  reported	  invasive	  tests	  
(sigmoidoscopy,	  proctoscopy,	  or	  colonoscopy)	  were	  asked,	  “What	  was	  the	  MAIN	  reason	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  5	  As	  an	  example,	  a	  respondent	  did	  not	  provide	  an	  answer	  to	  the	  question	  concerning	  whether	  or	  not	  a	  
recommendation	  was	  received	  for	  FOBT	  testing	  but	  indicated	  that	  a	  physician	  had	  recommended	  a	  form	  
of	  invasive	  testing.	  	  This	  respondent’s	  recommendation	  status	  was	  coded	  as	  ‘yes’	  despite	  the	  missing	  data	  
for	  the	  FOBT	  question.	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you	  had	  this	  exam	  -­‐	  was	  it	  part	  of	  a	  routine	  exam,	  because	  of	  a	  problem,	  or	  some	  other	  
reason?”	  The	  dependent	  variable	  was	  coded	  as	  ‘true	  screening’	  for	  responses	  of	  “part	  of	  
a	  routine	  exam”	  and	  as	  ‘diagnostic	  testing’	  for	  responses	  of	  “because	  of	  a	  problem,	  or	  
some	  other	  reason.”	  	  Responses	  of	  “refused”	  or	  “don’t	  know”	  were	  coded	  as	  missing	  
data	  and	  excluded	  from	  this	  step.	  	  If	  the	  respondent’s	  answer	  to	  this	  question	  was	  
coded	  as	  missing	  data	  but	  the	  respondent	  did	  report	  engagement	  in	  ACS	  guideline-­‐
adherent	  FOBT	  testing,	  the	  missing	  data	  were	  ignored2	  (total	  missing	  n	  =	  4).	  	  Since	  non-­‐
invasive	  FOBT	  testing	  is	  used	  exclusively	  for	  screening,	  most	  reports	  of	  FOBT	  testing	  
were	  coded	  as	  ‘true	  screening.’	  	  However,	  if	  respondents	  reported	  both	  FOBT	  and	  
invasive	  modes	  of	  ACS	  guideline	  adherent	  testing,	  the	  impetus	  for	  testing	  was	  
categorized	  solely	  on	  the	  impetus	  for	  the	  invasive	  testing.	  A	  total	  of	  559	  respondents	  fit	  
this	  criterion:	  	  131	  were	  coded	  as	  diagnostic	  and	  428	  were	  coded	  as	  true	  screeners.	  	  The	  
resulting	  dependent	  variable	  is	  a	  binary	  measure	  indicating	  whether	  or	  not	  the	  
recommendation	  was	  a	  referral	  for	  diagnostic	  testing	  or	  a	  true	  screening	  
recommendation.	  	  
Demographic	  and	  control	  variables.	  We	  utilized	  NHIS	  data	  directly	  for	  variables	  
of	  race/ethnicity	  (non-­‐Hispanic	  White/non-­‐Hispanic	  Black),	  sex	  (male/female),	  age	  
(continuous	  50-­‐80,	  categorical	  50-­‐54/55-­‐59/60-­‐64/65-­‐69/70-­‐74/75-­‐80,	  and	  categorical	  
50-­‐64/65-­‐80),	  educational	  attainment	  (less	  than	  a	  high	  school	  diploma/high	  school	  
graduate	  or	  GED/some	  college	  no	  degree	  or	  associate	  degree/bachelor’s	  degree/master	  
professional	  or	  doctorate),	  poverty	  ratio	  (tertiles	  (measured	  as	  ratio	  of	  family	  income	  to	  
poverty	  threshold):	  	  low	  (under	  .50	  to	  2.49)/medium	  (2.50	  to	  4.99)/high	  (5.00	  and	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over)),	  insurance	  status	  (covered/not	  covered),	  and	  usual	  source	  of	  health	  care	  (yes/no).	  
There	  were	  no	  missing	  values	  for	  poverty	  ratio	  as	  the	  data	  are	  the	  result	  of	  multiple	  
imputations	  done	  by	  the	  survey	  administrator.	  	  Missing	  value	  rates	  for	  all	  variables	  
except	  poverty	  ratio	  were	  below	  3%,	  a	  threshold	  determined	  to	  be	  acceptable	  with	  this	  
sample	  size.	  	  	  
Statistical	  analysis.	  
	  
Data	  analysis.	  	  All	  data	  analyses	  for	  this	  chapter	  were	  performed	  with	  the	  
SAS/STAT	  statistical	  software,	  version	  9.3_M1	  of	  the	  SAS	  System	  for	  Windows,	  Copyright	  
©	  2002-­‐2010	  SAS	  Institute	  Inc.	  	  SAS	  employs	  procedures	  capable	  of	  computing	  
appropriate	  variance	  estimates	  for	  survey	  estimates	  generated	  from	  analyses	  of	  
complex	  sample	  survey	  data	  sets	  such	  as	  the	  2008	  NHIS	  (Heeringa,	  West,	  &	  Berglund,	  
2010;	  SAS	  Institute	  Inc.,	  2014).	  	  Due	  to	  the	  fact	  that	  SAS	  excludes	  strata	  with	  only	  one	  
primary	  sampling	  unit	  (PSU)	  including	  sample	  from	  the	  subpopulation	  of	  interest	  from	  
its	  variance	  estimates,	  we	  ran	  selected	  models	  in	  a	  different	  software	  package,	  Stata	  
13.0,	  which	  enables	  multiple	  ad-­‐hoc	  variance	  estimation	  methods	  for	  dealing	  with	  
“singleton”	  PSU	  to	  compare	  estimated	  standard	  errors	  (StataCorp,	  2013).	  	  For	  the	  
logistic	  regression	  models	  including	  main	  effects,	  of	  268	  estimates	  only	  ten	  had	  greater	  
than	  or	  equal	  to	  a	  10%	  difference	  in	  standard	  errors,	  with	  the	  greatest	  difference	  at	  
17%.	  	  In	  most	  cases,	  Stata	  produced	  higher	  standard	  errors;	  none	  of	  these	  differences	  
resulted	  in	  changes	  in	  statistical	  inferences.	  
We	  began	  our	  analysis	  with	  weighted	  and	  unweighted	  frequencies	  of	  all	  
recommendations	  (including	  true	  screening	  recommendations	  and	  referrals	  for	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diagnostic)	  for	  each	  of	  the	  independent	  variables	  of	  interest	  in	  the	  full	  subpopulation	  as	  
defined	  above.	  	  We	  then	  obtained	  weighted	  and	  unweighted	  frequencies	  of	  true	  
screening	  recommendations	  for	  each	  of	  the	  independent	  variables	  of	  interest	  in	  the	  
smaller	  subpopulation	  of	  ACS	  guideline-­‐adherent	  screeners.	  We	  calculated	  estimated	  
rates	  of	  true	  screening	  recommendations	  for	  the	  full	  population	  by	  applying	  the	  rates	  of	  
true	  screening	  recommendations	  from	  the	  smaller	  subpopulation	  to	  the	  unadjusted	  
recommendation	  rates	  of	  the	  full	  study	  population.	  	  For	  example,	  the	  unadjusted	  
recommendation	  rate	  for	  the	  full	  study	  population	  was	  63.60%.	  	  In	  the	  smaller	  
subpopulation	  of	  respondents	  reporting	  ACS	  guideline	  adherent	  testing,	  the	  true	  
screening	  recommendation	  rate	  was	  74.24%.	  	  We	  applied	  this	  estimate	  to	  the	  
unadjusted	  testing	  rate	  (63.60	  x	  74.24%)	  to	  estimate	  an	  adjusted	  true	  screening	  
recommendation	  rate	  for	  the	  full	  population	  of	  47.21%.	  	  This	  same	  process	  was	  
repeated	  for	  each	  subgroup	  of	  the	  full	  study	  population.	  	  Since	  this	  calculation	  reflects	  
the	  diagnostic	  testing	  rates	  of	  only	  respondents	  reporting	  ACS	  guideline	  adherent	  
testing,	  it	  is	  likely	  a	  conservative	  estimate	  of	  the	  true	  estimate	  for	  the	  full	  study	  
population.	  	  We	  calculated	  estimates	  of	  the	  confidence	  intervals	  and	  resulting	  tests	  of	  
significance	  for	  the	  adjusted	  true	  screening	  recommendation	  rate	  of	  the	  full	  population.	  	  
In	  this	  process,	  we	  were	  unable	  to	  account	  for	  the	  fact	  that	  we	  derived	  the	  true	  
screening	  recommendation	  rate	  for	  the	  full	  population	  from	  two	  estimates.	  	  This	  
resulted	  in	  the	  possibility	  of	  narrower	  confidence	  intervals	  and	  inferences	  that	  were	  
more	  likely	  to	  result	  in	  statistically	  significant	  values.	  	  However,	  given	  the	  precise	  nature	  
of	  the	  subpopulation	  rate	  estimate,	  this	  issue	  is	  likely	  negligible.	  	  Finally,	  we	  calculated	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the	  overestimation	  of	  true	  screening	  recommendation	  rate	  by	  dividing	  the	  difference	  
between	  the	  unadjusted	  and	  adjusted	  rates	  by	  the	  adjusted	  rate.	  	  For	  example,	  the	  
unadjusted	  recommendation	  rate	  for	  the	  general	  population	  is	  63.60%	  and	  the	  adjusted	  
true	  screening	  recommendation	  rate	  for	  the	  same	  population	  is	  47.21%.	  	  We	  calculated	  
the	  overestimation	  of	  the	  true	  screening	  recommendation	  rate	  as	  (.6360-­‐.4721)/.4721	  =	  
34.70%.	  
In	  preparation	  for	  fitting	  multivariate	  logistic	  regression	  models,	  we	  examined	  
weighted	  bivariate	  associations	  between	  independent	  and	  dependent	  variables	  using	  
the	  Rao-­‐Scott	  chi-­‐square	  test	  to	  account	  for	  the	  features	  of	  the	  complex	  sampling	  
design.	  	  Predictors	  that	  had	  a	  bivariate	  association	  with	  p	  <	  0.25	  were	  included	  in	  the	  
initial	  multivariate	  logistic	  regression	  model.	  	  In	  models	  including	  two-­‐way	  interaction	  
terms,	  both	  variables	  defining	  the	  interactions	  will	  be	  included	  in	  each	  model,	  
irrespective	  of	  bivariate	  associations	  (Hosmer	  &	  Lemeshow,	  2000).	  	  
In	  the	  second	  stage	  of	  analysis,	  we	  used	  a	  four-­‐step	  design-­‐based	  logistic	  
regression	  approach	  to	  model	  the	  odds	  of	  receiving	  a	  true	  screening	  recommendation,	  
adjusting	  for	  sociodemographic	  factors	  including	  sex,	  race,	  age,	  education,	  poverty	  ratio,	  
health	  insurance	  status,	  and	  usual	  source	  of	  health	  care	  (Breen	  et	  al.,	  2001;	  O’Malley,	  
Forrest,	  Feng,	  &	  Mandelblatt,	  2005;	  Rosen	  &	  Schneider,	  2004).	  	  First,	  we	  fit	  a	  main	  
effects	  model	  with	  all	  covariates.	  	  Second,	  we	  fit	  an	  interaction	  model	  with	  demographic	  
interactions.	  	  Third,	  we	  fit	  an	  interaction	  model	  with	  socioeconomic	  interactions.	  	  
Finally,	  we	  fit	  a	  full	  model	  with	  statistically	  significant	  main	  effects	  and	  interaction	  
terms.	  	  We	  estimated	  the	  regression	  parameters	  using	  pseudo-­‐maximum	  likelihood	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estimation,	  due	  to	  the	  complex	  sampling	  nature	  of	  the	  NHIS	  sampled	  design	  (Heeringa	  
et	  al.,	  2010),	  and	  we	  used	  Taylor	  Series	  Linearization	  to	  compute	  design-­‐based	  
estimates	  of	  standard	  errors	  for	  the	  estimated	  regression	  parameters.	  	  Hypothesis	  tests	  
were	  performed	  using	  design-­‐adjusted	  Wald	  X2	  tests.	  	  	  We	  report	  estimated	  odds	  ratios	  
and	  their	  95%	  confidence	  intervals.	  	  
Results	  
Please	  refer	  to	  Table	  3.1	  for	  estimated	  demographic	  characteristics	  for	  the	  full	  
study	  population	  and	  subpopulation.	  	  Overall,	  the	  distributions	  of	  demographic	  
characteristics	  are	  similar	  between	  the	  populations.	  	  The	  full	  population	  is	  slightly	  
younger	  (22.18%	  versus	  16.75%	  in	  ages	  50-­‐54)	  and	  is	  weighted	  more	  heavily	  toward	  the	  
lower	  ends	  of	  educational	  attainment	  and	  poverty	  ratio.	  	  The	  full	  population’s	  
distribution	  in	  the	  top	  two	  tiers	  of	  educational	  attainment	  totaled	  26.58%	  versus	  30.00%	  
in	  the	  subpopulation.	  	  The	  highest	  poverty	  ratio	  tertile	  represents	  33.20%	  of	  the	  full	  
population	  distribution,	  versus	  37.81%	  of	  the	  subpopulation.	  
Weighted	  frequencies.	  	  Table	  3.2	  displays	  estimated	  rates	  of	  true	  screening	  
recommendations	  and	  diagnostic	  testing	  referrals	  for	  the	  subpopulation	  of	  respondents	  
who	  reported	  both	  ACS	  guideline	  adherent	  testing	  and	  a	  physician	  recommendation.	  	  
Table	  3.3	  displays	  estimated	  rates	  of	  true	  screening	  recommendations	  received	  by	  the	  
full	  study	  population,	  with	  unadjusted	  estimates	  that	  conflate	  diagnostic	  testing	  
recommendations	  and	  true	  screening	  recommendations	  as	  well	  as	  adjusted	  estimates	  
that	  properly	  specify	  true	  screening	  recommendations	  as	  the	  outcome.	  
Study	  Population.	  	  The	  estimated	  unadjusted	  testing	  referral	  rate	  for	  the	  study	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population	  was	  63.60%.	  	  Adjusting	  for	  the	  impetus	  for	  the	  recommendation	  reduced	  
this	  rate	  estimate	  to	  47.21%,	  resulting	  in	  an	  overestimation	  of	  the	  true	  screening	  
recommendation	  rate	  of	  34.70%.	  
Race/ethnicity.	  Rate	  estimates	  of	  recommendations	  for	  Non-­‐Hispanic	  
Whites	  (NHW)	  were	  significantly	  higher	  than	  for	  non-­‐Hispanic	  Blacks	  (NHB)	  both	  pre-­‐	  
and	  post-­‐adjustment.	  True	  screening	  recommendation	  rates	  for	  NHW	  were	  47.89%	  and	  
42.29%	  for	  NHB.	  	  Compared	  to	  NHB,	  the	  rate	  of	  referrals	  for	  diagnostic	  testing	  was	  
greater	  for	  NHW,	  leading	  to	  a	  greater	  overestimation	  of	  true	  screening	  recommendation	  
rates	  for	  NHW	  than	  NHB.	  	  	  
Sex.	  	  Prior	  to	  adjustment	  for	  the	  impetus	  for	  the	  recommendation,	  estimates	  of	  
unadjusted	  testing	  referral	  rates	  were	  higher	  for	  females	  than	  for	  males	  (p	  =	  0.22).	  	  
However,	  after	  adjustment	  this	  advantage	  changed	  to	  a	  disadvantage,	  and	  adjusted	  true	  
screening	  recommendation	  rates	  were	  significantly	  higher	  for	  males	  than	  for	  females	  (p	  
=	  0.004).	  	  Female	  respondents	  reported	  higher	  rates	  of	  referrals	  for	  diagnostic	  testing	  
than	  males,	  leading	  to	  an	  overestimation	  of	  true	  screening	  recommendation	  rates	  of	  
40.07%	  for	  females	  and	  28.53%	  for	  males.	  	  
Race/ethnicity	  and	  sex.	  	  In	  addition	  to	  examining	  race/ethnicity	  and	  sex	  
independently,	  we	  also	  examined	  patterns	  of	  recommendation	  rates	  by	  combinations	  of	  
these	  variables.	  	  Non-­‐Hispanic	  White	  females	  (NHWF)	  and	  non-­‐Hispanic	  White	  males	  
(NHWM)	  reported	  the	  highest	  unadjusted	  testing	  referral	  rates.	  	  Once	  adjusted,	  the	  
advantage	  of	  NHW	  over	  NHB	  persisted	  for	  each	  sex.	  	  However,	  NHWF	  reported	  the	  
highest	  rates	  of	  referrals	  for	  diagnostic	  testing	  (29.06%),	  and	  the	  lowest	  rates	  of	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referrals	  for	  diagnostic	  testing	  were	  for	  non-­‐Hispanic	  Black	  males	  (NHBM)	  (21.42%).	  	  
Overestimation	  of	  true	  screening	  recommendation	  rates	  was	  substantial	  for	  all	  groups,	  
ranging	  from	  27.27%	  (NHBM)	  to	  40.96%	  (NHWF).	  	  	  
Age.	  	  With	  one	  exception,	  estimates	  of	  both	  unadjusted	  and	  adjusted	  rates	  
increase	  with	  age.	  	  The	  lowest	  unadjusted	  testing	  referral	  rates	  are	  for	  50-­‐54	  year	  olds	  
(54.05%)	  and	  the	  highest	  overall	  rates	  for	  70-­‐74	  year	  olds	  (69.86%).	  	  The	  oldest	  age	  
group,	  ages	  75-­‐80,	  reported	  slightly	  lower	  unadjusted	  rates	  of	  testing	  referrals.	  	  The	  
greatest	  overestimation	  of	  true	  screening	  recommendation	  rates	  is	  for	  50-­‐54	  year-­‐old	  
respondents,	  who	  report	  a	  rate	  of	  referrals	  for	  diagnostic	  testing	  of	  32.83%,	  resulting	  in	  
overestimation	  of	  true	  screening	  recommendation	  rates	  by	  48.88%.	  	  Respondents	  
between	  the	  ages	  of	  75	  and	  80	  report	  a	  diagnostic	  testing	  rate	  of	  only	  21.75%	  resulting	  
in	  the	  least	  overestimation	  of	  true	  screening	  recommendation	  rates	  at	  27.77%.	  	  	  
	   In	  order	  to	  provide	  data	  on	  group	  differences	  by	  age	  that	  would	  be	  comparable	  
with	  existing	  literature	  focusing	  on	  pre-­‐	  and	  post-­‐Medicare	  populations,	  we	  also	  
analyzed	  these	  groups	  and	  found	  that	  those	  ages	  50-­‐64	  reported	  the	  lowest	  rates	  
before	  and	  after	  adjustment,	  and	  differences	  between	  groups	  were	  statistically	  
significant	  (p	  <	  .0001)	  in	  both	  estimates.	  	  Those	  ages	  50-­‐64	  reported	  a	  higher	  rate	  of	  
referrals	  for	  diagnostic	  testing	  than	  those	  ages	  65-­‐80,	  resulting	  in	  an	  overestimation	  of	  
true	  screening	  recommendation	  rates	  of	  39.26%	  and	  29.08%,	  respectively.	  	  	  
Educational	  attainment.	  Both	  unadjusted	  and	  adjusted	  rates	  increased	  as	  
educational	  attainment	  increased.	  Estimates	  of	  unadjusted	  testing	  referral	  rates	  ranged	  
from	  51.69%	  to	  77.20%	  while	  adjusted	  true	  screening	  recommendation	  rates	  ranged	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from	  34.14%	  to	  61.44%.	  	  Individuals	  at	  the	  lowest	  level	  of	  educational	  attainment	  
reported	  the	  highest	  rate	  of	  referrals	  for	  diagnostic	  testing	  while	  those	  at	  the	  highest	  
level	  reported	  the	  lowest	  rate.	  	  Overestimations	  of	  true	  screening	  recommendation	  
rates	  were	  inversely	  associated	  with	  educational	  attainment	  level	  and	  ranged	  from	  
51.39%	  to	  25.66%.	  	  	  
Poverty	  ratio.	  Estimates	  of	  both	  unadjusted	  and	  adjusted	  rates	  of	  
recommendations	  increased	  as	  level	  of	  poverty	  ratio	  increased.	  	  Unadjusted	  rates	  
ranged	  from	  54.83%	  to	  72.98%	  while	  adjusted	  rates	  ranged	  from	  36.41%	  to	  58.65%.	  	  
The	  highest	  rates	  of	  referrals	  for	  diagnostic	  testing	  were	  in	  the	  lowest	  tertile	  (33.59%).	  	  
Overestimation	  of	  true	  screening	  recommendation	  rates	  was	  inversely	  associated	  with	  
poverty	  ratio	  level	  and	  ranged	  from	  24.42%	  (high	  poverty	  ratio	  tertile)	  to	  50.58%	  (low	  
poverty	  ratio	  tertile),	  indicating	  that	  screening	  was	  most	  likely	  to	  be	  overestimated	  
among	  the	  most	  impoverished.	  	  	  
Insurance.	  	  Respondents	  reporting	  insurance	  coverage	  reported	  higher	  
unadjusted	  testing	  referral	  rates	  than	  those	  without	  insurance	  coverage	  as	  well	  as	  
higher	  adjusted	  rates	  of	  true	  screening	  recommendations.	  	  Respondents	  reporting	  no	  
coverage	  were	  significantly	  more	  likely	  to	  receive	  a	  referral	  for	  diagnostic	  testing	  
(47.68%	  versus	  25.15%,	  p	  <	  .0001);	  overestimation	  of	  rates	  of	  true	  screening	  
recommendation	  are	  91.13%	  for	  the	  uninsured	  population	  compared	  to	  33.6%	  for	  those	  
with	  insurance.	  	  
Marital	  status.	  	  Respondents	  who	  reported	  living	  with	  a	  marital	  spouse	  or	  
unmarried	  partner	  reported	  the	  lowest	  rates	  of	  referrals	  for	  diagnostic	  testing	  (24.14%),	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while	  respondents	  with	  a	  marital	  spouse	  not	  in	  the	  household	  or	  separated	  from	  their	  
spouse	  reported	  the	  highest	  rates	  at	  39.57%.	  	  Overestimation	  of	  true	  screening	  
recommendation	  rates	  by	  marital	  status	  ranged	  from	  31.81%	  for	  those	  living	  with	  their	  















Chi*Square Pr%>%ChiSq n % CI%of%
Rao*Scott%%%%%%%
Chi*Square Pr%>%ChiSq
Non*Hispanic%White 5780 87.83 (86.96,%88.70) 3132.20 <.0001 2971 89.50 (88.57,%90.43) 2632.84 <.0001
Non*Hispanic%Black 1278 12.17 (11.30,%13.04) 543 10.50 (9.57,%11.43)
%
Male 3094 44.20 (43.04,%45.37) 94.08 <.0001 1542 44.41 (42.72,%46.10) 41.77 <.0001
Female 3964 55.80 (54.63,%56.96) 1972 55.59 (53.90,%57.28)
%
Non*Hispanic%White%Male 2575 39.23 (38.04,%40.43) 3836.50 <.0001 1325 40.18 (38.47,%41.89) 2270.89 <.0001
Non*Hispanic%Black%Male 519 4.97 (4.49,%5.46) 217 4.23 (3.58,%4.87)
Non*Hispanic%White%Female 3205 48.60 (47.37,%49.83) 1646 49.32 (47.60,%51.05)
Non*Hispanic%Black%Female 759 7.20 (6.52,%7.87) 326 6.27 (5.49,%7.05)
%
Ages%50*54 1565 22.18 (21.18,%23.17) 382.70 <.0001 575 16.75 (15.36,%18.15) 94.85 <.0001
Ages%55*59 1511 20.97 (19.92,%22.02) 739 20.49 (19.06,%21.93)
Ages%60*64 1279 18.41 (17.40,%19.42) 694 19.85 (18.40,%21.31)
Ages%65*69 1070 15.07 (14.20,%15.95) 591 16.66 (15.36,%17.96)
Ages%70*74 794 11.25 (10.42,%12.08) 475 13.08 (11.92,%14.24)
Ages%75*80 839 12.12 (11.31,%12.93) 440 13.16 (12.10,%14.22)
%
Ages%50*64 4355 61.56 (60.32,%62.79) 322.23 <.0001 2008 57.10 (55.37,%58.84) 63.61 <.0001
Ages%65*80 2703 38.44 (37.21,%39.68) 1506 42.90 (41.16,%44.64)
% %
Less%than%High%School%Diploma 1017 13.97 (12.89,%15.04) 820.36 <.0001 403 11.31 (10.10,%12.53) 411.27 <.0001
High%School%Degree%or%GED 2184 30.39 (29.15,%31.63) 1026 28.84 (27.17,%30.50)
Some%College%No%Degree%or%Associate%Degree 2004 28.51 (27.34,%29.67) 1026 29.51 (27.78,%31.24)
Bachelor's%Degree 1047 15.13 (14.23,%16.03) 558 15.60 (14.31,%16.89)
Master's,%Professional%or%Doctorate%Degree 761 11.45 (10.59,%12.31) 486 14.40 (13.07,%15.73)
%
Poverty%Ratio%*%Low%Tertile 2587 35.15 (33.56,%36.74) 1087 30.08 (28.06,%32.10)
Poverty%Ratio%*%Medium%Tertile 2227 31.65 (30.31,%32.99) 1135 32.11 (30.21,%34.02)
Poverty%Ratio%*%High%Tertile 2243 33.20 (31.69,%34.71) 1292 37.81 (35.85,%39.77)
%
Insurance%*%Not%Covered 525 7.02 (6.35,%7.69) 4146.62 <.0001 104 2.76 (2.07,%3.46) 1938.64 <.0001
Insurance%*%Covered 6526 92.98 (92.31,%93.65) 3408 97.24 (96.54,%97.93)
%
Living%with%Marital%Spouse%or%Unmarried%Partner 3681 53.17 (51.68,%54.66) 3412.65 <.0001 1984 57.11 (55.15,%59.08) 2088.84 <.0001
Never%Married%/%Unknown%Status 632 8.44 (7.73,%9.15) 256 7.11 (6.14,%8.08)
Marital%Spouse%not%in%HH%or%Separated 274 3.71 (3.23,%4.19) 109 2.95 (2.34,%3.57)
Widowed%or%Divorced 2471 34.68 (33.28,%36.08) 1165 32.82 (31.06,%34.59)
%
Usual%Source%of%Health%Care%*%No 477 6.80 (6.17,%7.43) 4564.11 <.0001 70 1.91 (1.45,%2.37) 3185.33 <.0001
Usual%Source%of%Health%Care%*%Yes 6476 93.20 (92.57,%93.83) 3444 98.09 (97.63,%98.55)
%
Physician%Recommendation%*%No 2534 36.40 (34.95,%37.84) 317.08 <.0001





















Subpopulation 3514 74.24 (72.65,575.82) 25.76 (24.18,527.35)
Non9Hispanic5White 2971 73.99 (72.29,575.68) 26.01 (24.32,527.71) 1.29 0.2579
Non9Hispanic5Black 543 76.38 (72.60,580.17) 23.62 (19.83,527.40)
Male 1542 77.80 (75.65,579.95) 22.20 (20.05,524.35) 17.57 <.0001
Female 1972 71.39 (69.21,573.57) 28.61 (26.43,530.79)
Non9Hispanic5White5Male 1325 77.72 (75.46,579.98) 22.28 (20.02,524.54) 20.76 0.0001
Non9Hispanic5Black5Male 217 78.58 (71.26,585.90) 21.42 (14.11,528.74)
Non9Hispanic5White5Female 1646 70.94 (68.61,573.28) 29.06 (26.72,531.39)
Non9Hispanic5Black5Female 326 74.91 (70.28,579.53) 25.09 (20.47,529.72)
Ages550954 575 67.17 (63.24,571.09) 32.83 (28.91,536.76) 22.9 0.0004
Ages555959 739 73.14 (69.70,576.59) 26.86 (23.41,530.30)
Ages560964 694 74.35 (70.98,577.71) 25.65 (22.29,529.02)
Ages565969 591 76.58 (73.21,579.94) 23.42 (20.06,526.79)
Ages570974 475 77.81 (73.88,581.73) 22.19 (18.27,526.12)
Ages575980 440 78.26 (74.00,582.53) 21.74 (17.47,526.00)
Ages550964 2008 71.81 (69.60,574.02) 28.19 (25.98,530.40) 14.01 0.0002
Ages565980 1506 77.47 (75.38,579.56) 22.53 (20.44,524.62)
Less5than5High5School5Diploma 403 66.05 (60.74,571.37) 33.95 (28.63,539.26) 18.65 0.0009
High5School5Degree5or5GED 1026 73.79 (70.86,576.72) 26.21 (23.28,529.14)
Some5College5No5Degree5or5Associate5Degree 1026 74.43 (71.51,577.34) 25.57 (22.66,528.49)
Bachelor's5Degree 558 76.09 (72.21,579.98) 23.91 (20.02,527.79)
Master's,5Professional5or5Doctorate5Degree 486 79.58 (75.68,583.48) 20.42 (16.52,524.32)
5
Poverty5Ratio595Low5Tertile 1087 66.41 (63.13,569.69) 33.59 (30.31,536.87) F(2,588.79)5=524.64 Pr5>5F5<.0001
Poverty5Ratio595Medium5Tertile 1135 74.34 (71.17,577.51) 25.66 (22.49,528.83)
Poverty5Ratio595High5Tertile 1292 80.37 (77.92,582.83) 19.63 (17.17,522.08)
5 5 5
Insurance595Not5Covered 104 52.32 (41.48,563.16) 47.68 (36.84,558.52) 22.14 <.0001
Insurance595Covered 3408 74.85 (73.29,576.41) 25.15 (23.59,526.71)
Living5with5Marital5Spouse5or5Unmarried5Partner 1984 75.86 (73.81,577.92) 24.14 (22.08,526.19) 13.82 0.0032
Never5Married5/5Unknown5Status 256 75.32 (69.50,581.14) 24.68 (18.86,530.50)
Marital5Spouse5not5in5HH5or5Separated 109 60.43 (50.79,570.07) 39.57 (29.93,549.21)
Widowed5or5Divorced 1165 72.41 (69.69,575.13) 27.59 (24.87,530.31)
5 5 5
Usual5Source5of5Health5Care595No 70 65.84 (54.45,577.23) 34.16 (22.77,545.55) 2.48 0.1153
Usual5Source5of5Health5Care595Yes 3444 74.40 (72.79,576.01) 25.60 (23.99,527.21)
15Exception:55test5of5significance5for5Poverty5Ratio5is5Global5F5Test,5computed5with5Stata.
Note:55unweighted5n,5weighted5%5and5CI5of5%.55












Full$Population 6740 63.60 (62.16,$65.05) 47.21 34.70
$ $
Non9Hispanic$White 5537 64.73 (63.21,$66.26) 32.55 <.0001 47.89 (46.77,$49.02) 35.16
Non9Hispanic$Black 1203 55.37 (52.22,$58.53) 42.29 (39.88,$44.71) 30.92
$ $
Male 2965 62.71 (60.64,$64.78) 1.52 0.22 48.79 (47.18,$50.40) 28.53
Female 3775 64.31 (62.51,$66.12) $ $ 45.91 (44.62,$47.20) $ $ 40.07
$ $ $ $
Non9Hispanic$White$Male 2474 63.79 (61.53,$66.05) 27.59 <.0001 49.58 (47.82,$51.33) 28.67
Non9Hispanic$Black$Male 491 54.18 (49.00,$59.36) $ $ 42.57 (38.50,$46.64) $ $ 27.27
Non9Hispanic$White$Female 3063 65.50 (63.60,$67.40) $ $ 46.47 (45.12,$47.81) $ $ 40.96
Non9Hispanic$Black$Female 712 56.21 (51.84,$60.57) $ $ 42.11 (38.83,$45.38) $ $ 33.50
$ $ $
Ages$50954 1505 54.05 (51.08,$57.02) 79.65 <.0001 36.30 (34.30,$38.30) 48.88
Ages$55959 1433 63.43 (60.65,$66.21) $ $ 46.39 (44.36,$48.43) $ $ 36.72
Ages$60964 1220 66.86 (64.07,$69.65) $ $ 49.71 (47.64,$51.78) $ $ 34.51
Ages$65969 1025 67.06 (64.01,$70.10) $ $ 51.35 (49.02,$53.68) $ $ 30.59
Ages$70974 769 69.86 (66.42,$73.30) $ $ 54.36 (51.68,$57.03) $ $ 28.52
Ages$75980 788 66.40 (63.04,$69.75) $ $ 51.97 (49.34,$54.59) $ $ 27.77
$ $ $
Ages$50964 4158 61.04 (59.27,$62.82) 27.95 <.0001 43.83 (42.56,$45.11) 39.26
Ages$65980 2582 67.68 (65.67,$69.69) $ $ 52.43 (50.88,$53.99) $ $ 29.08
$ $
Less$than$High$School$Diploma 962 51.69 (48.18,$55.20) 118.87 <.0001 34.14 (31.82,$36.46) 51.39
High$School$Degree$or$GED 2085 60.31 (57.78,$62.84) 44.50 (42.64,$46.37) 35.52
Some$College$No$Degree$or$Associate$Degree 1929 65.60 (63.23,$67.96) 48.82 (47.06,$50.59) 34.36
Bachelor's$Degree 1002 67.78 (64.52,$71.05) 51.58 (49.09,$54.06) 31.42
Master's,$Professional$or$Doctorate$Degree 724 77.20 (74.02,$80.39) 61.44 (58.90,$63.97) 25.66
$ $ $
Poverty$Ratio$9$Low$Tertile 2457 54.83 (52.49,$57.17) 36.41 (34.91,$37.92) 50.58
Poverty$Ratio$9$Medium$Tertile 2143 63.47 (61.00,$65.94) 47.18 (45.51,$48.85) 34.52
Poverty$Ratio$9$High$Tertile 2140 72.98 (70.85,$75.10) 58.65 (57.00,$60.30) 24.42
$ $ $
Insurance$9$Not$Covered 500 28.26 (23.50,$33.03) 198.76 <.0001 14.79 (12.30,$17.28) 91.13
Insurance$9$Covered 6233 66.27 (64.78,$67.75) 49.60 (48.49,$50.71) 33.60
$ $
Living$with$Marital$Spouse$or$Unmarried$Partner 3533 67.30 (65.45,$69.16) 39.78 <.0001 51.06 (49.65,$52.46) 31.81
Never$Married$/$Unknown$Status 601 55.90 (51.30,$60.51) 42.11 (38.64,$45.57) 32.76
Marital$Spouse$not$in$HH$or$Separated 262 56.28 (49.19,$63.38) 34.01 (29.73,$38.30) 65.48
Widowed$or$Divorced 2344 60.54 (58.20,$62.89) 43.84 (42.14,$45.54) 38.10
$ $
Usual$Source$of$Health$Care$9$No 458 18.94 (15.11,$22.76) 362.87 <.0001 12.47 (9.95,$14.98) 51.88
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Multivariate	  logistic	  regression	  modeling.	  Table	  3.4	  shows	  the	  final	  logistic	  
regression	  models	  predicting	  1)	  any	  referral	  for	  diagnostic	  testing	  or	  true	  screening	  
recommendation	  in	  the	  full	  study	  population;	  and	  2)	  true	  screening	  recommendation	  in	  
the	  subpopulation	  of	  respondents	  reporting	  ACS	  guideline	  adherent	  testing.	  	  	  
The	  multivariate	  models	  predicting	  all	  recommendations	  (conflating	  referrals	  for	  
diagnostic	  testing	  and	  true	  screening	  recommendations)	  versus	  a	  true	  screening	  
recommendation	  demonstrate	  the	  importance	  of	  correctly	  specifying	  the	  behavioral	  
Full$Study$Population$/$Outcome:$$Any$Physician$Recommendation$for$Testing
Predictor* Category Odds0Ratio0(OR) t Pr0>0|t|
Intercept 0.363 0.243 0.541 04.97 <.0001
Race/Ethnicity Non0Hispanic?Black 1.369 0.833 2.250 1.24 0.215
Age Continuous?(Centered?(65)) 1.019 1.010 1.028 4.11 <.0001
Sex Male 0.605 0.386 0.948 02.19 0.0283
Education High?School?Graduate?or?GED 1.342 1.116 1.615 3.12 0.0018
Some?College?No?Degree?or?Associate?Degree 1.655 1.381 1.983 5.46 <.0001
Bachelor's?Degree 1.632 1.295 2.056 4.15 <.0001
Master's,?Professional?or?Doctorate 2.368 1.845 3.039 6.78 <.0001
Poverty?Ratio Medium?Tertile 1.212 1.040 1.412 2.47 0.014
High?Tertile 1.715 1.464 2.009 6.69 <.0001
Insurance Covered 3.152 2.161 4.597 5.96 <.0001
Age?*?Sex Continuous?(Centered?(65))?*?Male 1.015 1.002 1.029 2.19 0.0287
Race?*?Insurance Non0Hispanic?Black?*?Covered 0.593 0.354 0.992 01.99 0.0465
Sex?*?Insurance Male?*?Covered 1.611 1.023 2.535 2.06 0.0395
Subpopulation$/$Outcome:$$True$Physician$Recommendation$for$Screening
Predictor* Category Odds0Ratio0(OR) t Pr0>0|t|
Intercept 1.088 0.687 1.723 0.36 0.7201
Race/Ethnicity Non0Hispanic?Black 1.476 1.163 1.872 3.21 0.0013
Age Continuous?(Centered?(65)) 1.046 1.032 1.060 6.63 <.0001
Sex Male 1.251 1.053 1.486 2.54 0.011
Poverty?Ratio Medium?Tertile 1.560 1.218 1.998 3.59 0.0006
High?Tertile 2.364 1.873 2.985 7.24 <.0001
Insurance Covered 1.606 1.008 2.559 1.99 0.0462
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outcome	  of	  interest.	  	  We	  found	  several	  important	  differences	  in	  comparing	  predictors	  of	  
any	  recommendation	  versus	  a	  true	  screening	  recommendation.	  	  Most	  notably,	  
educational	  attainment	  is	  predictive	  of	  the	  incorrectly	  specified	  outcome,	  but	  not	  
predictive	  of	  true	  screening	  recommendations.	  These	  results	  also	  show	  that	  among	  the	  
subpopulation	  of	  those	  who	  reported	  ACS	  guideline	  adherent	  testing	  and	  a	  physician	  
recommendation,	  respondents	  are	  more	  likely	  to	  report	  a	  true	  screening	  
recommendation	  if	  they	  are	  non-­‐Hispanic	  Black,	  older,	  male,	  higher	  poverty	  ratio,	  and	  
covered	  by	  insurance.	  	  There	  is	  a	  significant	  age-­‐sex	  interaction	  in	  this	  model	  at	  an	  OR	  of	  
0.973	  (p=0.0068).	  
Discussion	  
Accurate	  data	  on	  physician	  recommendation	  rates,	  disparities,	  and	  trends	  is	  
critical	  to	  the	  continued	  improvement	  of	  CRC	  morbidity	  and	  mortality.	  	  The	  results	  of	  
this	  study	  show	  that	  reported	  rates	  of	  CRC	  screening	  recommendation	  are	  grossly	  
distorted	  when	  we	  fail	  to	  account	  for	  the	  impetus	  for	  recommendation.	  	  By	  
misspecifying	  diagnostic	  referrals	  as	  true	  screening	  recommendations,	  researchers	  have	  
published	  inaccurate	  screening	  recommendation	  rates,	  trends,	  and	  predictors.	  	  While	  
the	  unadjusted	  estimate	  of	  the	  recommendation	  rate	  for	  the	  full	  study	  population	  was	  
63.60%,	  the	  adjusted	  true	  recommendation	  rates	  fell	  to	  47.21%,	  an	  overestimation	  of	  
34.70%.	  	  	  However,	  across	  sociodemographic	  groups	  the	  rate	  of	  overestimation	  of	  true	  
screening	  recommendation	  rates	  ranged	  from	  24.42%	  to	  91.13%	  (mean	  37.29%,	  median	  
34.36%).	  Especially	  troubling	  is	  the	  low	  rate	  of	  true	  screening	  recommendation	  and	  high	  
rates	  of	  referrals	  for	  diagnostic	  testing	  in	  the	  youngest	  respondents,	  as	  this	  is	  a	  critical	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age	  of	  onset	  of	  risk.	  	  True	  screening	  recommendation	  rates	  did	  not	  exceed	  50%	  of	  the	  
study	  population	  until	  after	  age	  65.	  	  To	  put	  both	  of	  these	  findings	  into	  context,	  the	  
Healthy	  People	  2010	  goal	  for	  provider	  counseling	  for	  CRC	  screening	  was	  85%,	  and	  a	  
developmental	  goal	  for	  Healthy	  People	  2020	  is	  for	  an	  increase	  from	  Healthy	  People	  
2010.	  Unadjusted	  and	  adjusted	  recommendation	  rates	  fall	  far	  short	  of	  both	  of	  these	  
federal	  goals.	  
The	  degree	  to	  which	  screening	  recommendation	  rates	  are	  distorted	  varies	  across	  
socioeconomic	  subgroups.	  	  We	  found	  strong	  evidence	  of	  overestimation	  in	  groups	  with	  
lower	  educational	  attainment	  and	  lower	  poverty	  ratio.	  Surprisingly,	  we	  found	  more	  
diagnostic	  testing	  in	  non-­‐Hispanic	  Whites	  compared	  to	  non-­‐Hispanic	  Blacks	  as	  well	  as	  
higher	  rates	  in	  females	  compared	  to	  males.	  	  We	  expected	  patterns	  of	  referrals	  for	  
diagnostic	  testing	  to	  mirror	  risk	  of	  later	  stage	  diagnosis	  in	  the	  SEER	  data,	  where	  we	  see	  
that	  irrespective	  of	  gender,	  Blacks	  suffer	  higher	  rates	  of	  later	  stage	  disease	  
(Surveillance,	  Epidemiology,	  and	  End	  Results	  Program,	  2014).	  	  Although	  it	  is	  difficult	  to	  
compare	  our	  findings	  with	  SEER	  data	  since	  our	  study	  population	  is	  made	  up	  of	  
individuals	  with	  no	  history	  of	  CRC,	  it	  does	  highlight	  the	  need	  to	  investigate	  methods	  of	  
diagnosis	  in	  those	  patients	  with	  CRC	  disease.	  	  This	  finding	  is	  also	  contrary	  to	  empirical	  
research	  on	  the	  patterning	  of	  health	  services	  utilization	  by	  race	  and	  sex	  that	  consistently	  
demonstrates	  higher	  use	  of	  preventative	  care	  in	  NHW	  when	  compared	  to	  NHB	  and	  
women	  when	  compared	  to	  men	  (House	  &	  Williams,	  2000;	  Kaplan,	  Everson,	  &	  Lynch,	  
2000;	  Smedley,	  Stith,	  &	  Nelson,	  2002).	  	  These	  unexpected	  findings	  are	  difficult	  to	  fully	  
explain	  and	  require	  further	  exploration	  with	  respect	  to	  attribution	  of	  impetus	  of	  testing	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(are	  there	  differences	  in	  interpretation	  of	  ‘diagnostic	  testing’	  across	  groups)	  and	  
psychosocial	  and	  instrumental	  barriers	  to	  screening	  recommendations	  at	  the	  
institutional	  and	  individual	  levels.	  
Two	  of	  the	  most	  cited	  predictors	  of	  screening	  recommendations	  in	  the	  literature	  
are	  patient	  educational	  attainment	  and	  having	  a	  usual	  source	  of	  health	  care.	  In	  prior	  
work	  by	  Bao	  and	  colleagues	  (2007),	  they	  report	  that	  individuals	  with	  lower	  levels	  of	  
educational	  attainment	  were	  less	  likely	  to	  report	  physician	  counseling	  for	  CRC	  testing	  
than	  their	  counterparts	  with	  higher	  educational	  attainment.	  	  This	  effect	  was	  statistically	  
significant	  and	  persisted	  in	  analyses	  looking	  at	  within-­‐physician	  and	  between-­‐physician	  
differences.	  	  Similar	  effects	  of	  an	  inverse	  association	  between	  educational	  attainment	  
and	  odds	  of	  reporting	  a	  physician	  recommendation	  for	  CRC	  testing	  are	  demonstrated	  in	  
research	  by	  Ye	  and	  colleagues	  (2009),	  Brawarsky	  et	  al.	  (2004)	  and	  Ahmed	  et	  al.	  (2013).	  	  
Ahmed	  and	  colleagues	  found	  a	  strong	  and	  statistically	  significant	  relationship	  between	  a	  
usual	  source	  of	  health	  care	  and	  odds	  of	  reporting	  a	  physician	  recommendation	  for	  
screening.	  	  Individuals	  with	  a	  usual	  source	  of	  health	  care	  in	  that	  study	  were	  2.83	  times	  
more	  likely	  than	  those	  without	  to	  report	  receiving	  a	  recommendation	  (p	  <	  .001).	  	  All	  of	  
these	  examples,	  however,	  use	  models	  that	  predict	  any	  recommendation	  and	  conflate	  
diagnostic	  referrals	  with	  true	  screening	  recommendations.	  In	  contrast,	  when	  we	  
adjusted	  for	  the	  impetus	  for	  the	  recommendation	  in	  multivariate	  models,	  we	  found	  that	  
neither	  educational	  attainment	  nor	  the	  presence	  of	  a	  usual	  source	  of	  health	  care	  was	  
predictive.	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This	  study	  is	  subject	  to	  some	  unavoidable	  limitations.	  	  A	  key	  question	  of	  rates	  of	  
adherence	  is	  left	  unanswered	  due	  to	  the	  methodological	  barriers	  present	  in	  the	  data.	  	  
We	  utilized	  data	  on	  the	  impetus	  for	  testing	  to	  determine	  the	  impetus	  for	  the	  physician	  
recommendation.	  	  However,	  we	  have	  no	  data	  on	  individuals	  who	  did	  not	  engage	  in	  CRC	  
testing;	  therefore	  we	  are	  unable	  to	  determine	  rates	  of	  adherence	  to	  true	  screening	  
recommendations	  vs.	  diagnostic	  referrals.	  	  However,	  based	  on	  the	  results	  reported	  
herein,	  we	  predict	  that	  once	  both	  physician	  recommendations	  and	  testing	  behaviors	  are	  
correctly	  specified,	  adherence	  rates	  would	  likely	  go	  down,	  as	  much	  of	  the	  testing	  
counting	  as	  adherence	  to	  recommendations	  are	  actually	  compliance	  with	  referrals	  for	  
diagnostic	  testing.	  
First,	  we	  analyzed	  NHIS	  data	  collected	  in	  2008,	  as	  analyses	  began	  as	  the	  2010	  
survey	  was	  being	  released.	  	  2008	  data	  remained	  the	  best	  option,	  however,	  due	  to	  its	  
specificity	  with	  its	  questions	  pertaining	  to	  physician	  recommendations.	  A	  general	  
limitation	  of	  using	  NHIS	  data	  is	  the	  inability	  to	  conduct	  analyses	  by	  geographic	  region	  
with	  much	  certainty;	  other	  data	  collected	  by	  state-­‐level	  public	  health	  departments	  or	  
representative	  to	  each	  state’s	  population	  (including	  BRFSS	  data)	  would	  be	  more	  
appropriate.	  	  CRC	  screening	  rates	  vary	  considerably	  by	  state,	  and	  within	  state	  by	  county;	  
this	  variation	  should	  be	  considered	  in	  future	  studies	  of	  MCC	  and	  CRC	  screening	  (Rim	  et	  
al.,	  2011;	  Weir	  et	  al.,	  2003).	  
Common	  to	  survey	  data,	  NHIS	  data	  are	  subject	  to	  recall	  bias	  on	  the	  part	  of	  the	  
respondents	  for	  both	  dependent	  and	  independent	  variables.	  	  Prior	  studies	  have	  found	  
that	  self-­‐report	  of	  CRC	  screening	  behaviors	  are	  demonstrated	  to	  be	  moderate	  to	  high	  in	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both	  sensitivity	  and	  specificity	  with	  no	  clear	  patterns	  in	  differences	  in	  the	  accuracy	  of	  
self-­‐report	  by	  age,	  sex,	  race	  or	  family	  history	  (Baier	  et	  al.,	  2000).	  	  Another	  potential	  
source	  of	  bias	  in	  this	  study	  is	  selection	  bias	  due	  to	  differential	  nonresponse	  among	  
specific	  subgroups	  of	  individuals,	  which	  is	  addressed	  via	  nonresponse	  adjustments	  of	  
the	  weights	  provided	  by	  NHIS	  to	  survey	  analysts	  (Centers	  for	  Disease	  Control	  and	  
Prevention,	  2012).	  In	  addition,	  there	  may	  be	  differential	  bias	  in	  comprehension	  of	  
survey	  questions.	  	  Differential	  interpretation	  of	  questions	  by	  race,	  gender,	  and	  
socioeconomic	  status	  may	  explain	  some	  of	  our	  findings.	  	  However,	  the	  pivotal	  questions	  
of	  interest	  were	  follow-­‐up	  questions	  to	  screening	  responses.	  	  These	  questions	  received	  
very	  little	  attention	  in	  cognitive	  testing,	  as	  the	  majority	  of	  the	  cognitive	  testing	  subjects	  
(which	  numbered	  only	  9	  over	  age	  40)	  indicated	  they	  did	  not	  undergo	  CRC	  testing,	  
resulting	  in	  little	  to	  no	  cognitive	  testing	  on	  the	  follow-­‐up	  questions	  (B.	  Taylor,	  personal	  
communication,	  June	  17,	  2014).	  	  NHIS	  does	  not	  collect	  data	  on	  gastrointestinal	  
comorbidities,	  which	  may	  affect	  an	  individual’s	  odds	  of	  receiving	  a	  physician	  referral	  for	  
diagnostic	  testing.	  	  Finally,	  our	  practice	  of	  deriving	  full	  population	  rates	  using	  unadjusted	  
testing	  recommendation	  rates	  and	  estimates	  from	  the	  subpopulation	  resulted	  in	  
estimates	  that	  may	  have	  confidence	  intervals	  narrower	  than	  what	  they	  should	  be.	  	  This	  
is	  due	  to	  the	  fact	  that	  we	  are	  unable	  to	  account	  for	  the	  fact	  that	  we	  are	  treating	  the	  rate	  
used	  in	  estimation	  as	  fixed	  when	  it	  is,	  in	  fact,	  an	  estimate.	  	  The	  confidence	  interval	  for	  
the	  true	  screening	  recommendation	  rate	  of	  the	  full	  population	  excludes	  the	  variance	  
estimates	  true	  screening	  recommendation	  rate	  of	  the	  study’s	  subpopulation.	  Therefore,	  
the	  resulting	  tests	  of	  statistical	  significance	  will	  be	  more	  likely	  to	  show	  statistical	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significance	  than	  they	  would	  have	  had	  the	  results	  not	  been	  derived	  from	  two	  estimates.	  	  
In	  the	  future,	  researchers	  should	  explore	  the	  use	  of	  jackknifing	  as	  a	  tool	  to	  incorporate	  
the	  variance	  of	  both	  estimates	  when	  calculating	  confidence	  intervals	  and	  resulting	  
statistical	  tests	  for	  the	  full	  population.	  
To	  our	  knowledge,	  this	  is	  the	  first	  analysis	  of	  a	  nationally	  representative	  dataset	  
to	  measure	  the	  degree	  to	  which	  the	  methodological	  approach	  of	  BRFSS	  and	  analytic	  
approach	  of	  some	  researchers	  using	  NHIS	  data	  impacts	  our	  understanding	  of	  screening	  
recommendation	  rates.	  	  Researchers	  using	  data	  from	  BRFSS	  consistently	  cite	  the	  lack	  of	  
data	  on	  the	  impetus	  for	  testing	  as	  a	  limitation,	  noting	  that	  rates	  may	  be	  over-­‐	  or	  
underestimated.	  	  Our	  study	  demonstrates	  that	  both	  overall	  and	  across	  all	  
sociodemographic	  groups,	  rates	  are	  grossly	  overestimated	  when	  we	  fail	  to	  account	  for	  
the	  impetus	  for	  the	  referral	  or	  recommendation.	  	  This	  not	  only	  has	  implications	  for	  
understanding	  rates	  and	  trends,	  but	  also	  disparities	  by	  race,	  sex,	  and	  socioeconomic	  
status.	  In	  addition	  to	  large-­‐scale	  surveys,	  the	  challenges	  to	  BRFSS	  methodology	  herein	  
extend	  to	  practices	  of	  evaluating	  interventions.	  	  Simply	  counting	  changes	  in	  the	  number	  
of	  recommendations	  reported	  is	  insufficient,	  as	  we	  need	  to	  differentiate	  between	  
referrals	  for	  diagnostic	  testing	  and	  true	  screening	  recommendations.	  	  	  	  
In	  addition	  to	  implications	  for	  research,	  our	  results	  suggest	  important	  
implications	  for	  health	  care	  services	  and	  policy.	  	  The	  patterns	  of	  lower	  true	  screening	  
recommendations	  in	  women	  and	  respondents	  with	  lower	  socioeconomic	  advantages	  
support	  the	  need	  for	  initiatives	  that	  extend	  the	  responsibility	  of	  cancer	  screening	  
recommendations.	  	  To	  date,	  this	  burden	  has	  been	  with	  the	  primary	  care	  physician.	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However,	  the	  source	  of	  care	  for	  women	  is	  often	  other	  providers	  (e.g.	  gynecologist)	  and	  
populations	  of	  lower	  socioeconomic	  advantage	  often	  use	  the	  emergency	  room	  or	  
urgent	  care	  as	  their	  first	  point	  of	  contact	  with	  the	  health	  care	  system	  (Smedley	  et	  al.,	  
2002).	  Extending	  the	  responsibility	  of	  the	  recommendation	  to	  all	  health	  care	  providers	  
will	  broaden	  the	  reach	  of	  state-­‐	  and	  federal-­‐level	  initiatives.	  
Interventions	  directed	  toward	  meeting	  federal	  goals	  are	  critical	  to	  reducing	  the	  
burden	  of	  CRC.	  	  However,	  considering	  the	  variation	  in	  screening	  recommendation	  rates	  
that	  is	  evident	  in	  this	  nationally	  representative	  sample,	  it	  is	  time	  to	  consider	  the	  
usefulness	  of	  overall	  population	  goals	  and	  instead	  consider	  goals	  that	  are	  group-­‐specific.	  	  
Furthermore,	  quality	  metrics	  developed	  at	  the	  policy	  level	  by	  AHRQ	  use	  BRFSS	  data	  to	  
assess	  success	  or	  failure	  to	  meet	  goals	  (Agency	  for	  Healthcare	  Research	  and	  Quality,	  
2013).	  	  As	  we	  demonstrate	  in	  this	  study,	  the	  risks	  of	  using	  data	  that	  conflates	  the	  two	  
behavioral	  outcomes	  of	  interest	  are	  substantial,	  and	  it	  paints	  a	  much	  different	  picture	  
than	  what	  is	  actually	  occurring	  at	  the	  institutional	  level.	  
Finally,	  our	  study	  makes	  it	  clear	  that	  we	  must	  use	  great	  caution	  when	  reviewing	  
the	  literature	  in	  this	  area.	  Significant	  variation	  in	  overestimation	  of	  rates	  by	  subgroup	  
makes	  it	  difficult	  to	  apply	  a	  “one	  size	  fits	  all”	  adjustment	  of	  overestimation	  of	  BRFSS	  
rates.	  	  A	  wide	  range	  of	  research	  studies	  and	  HP	  2020	  state	  benchmarks	  rely	  on	  BRFSS	  
data,	  while	  other	  studies	  and	  HP	  2020	  national	  benchmarks	  rely	  on	  NHIS	  data.	  	  A	  revised	  
methodological	  approach	  of	  both	  surveys	  –	  both	  at	  the	  data	  collection	  and	  analysis	  
levels	  –	  is	  required	  in	  order	  to	  accurately	  assess	  rates,	  trends,	  adherence,	  and	  
disparities.	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CHAPTER	  FOUR	  
	  




The	  segment	  of	  the	  US	  population	  at	  the	  greatest	  risk	  of	  developing	  colorectal	  
cancer	  (CRC)	  is	  growing	  at	  a	  rapid	  rate.	  	  By	  the	  year	  2015,	  an	  estimated	  one	  in	  five	  
Americans	  will	  be	  ages	  50-­‐64	  (Holden,	  Jonas,	  Porterfield,	  Reuland,	  &	  Harris,	  2010).	  
Despite	  widespread	  CRC	  screening	  initiatives,	  studies	  consistently	  demonstrate	  that	  
individuals	  at	  the	  younger	  end	  of	  the	  at-­‐risk	  age	  group	  (50-­‐64)	  are	  less	  likely	  to	  engage	  
in	  CRC	  screening	  compared	  to	  their	  older	  counterparts	  (Breen,	  Wagener,	  Brown,	  Davis,	  
&	  Ballard-­‐Barbash,	  2001;	  Klabunde,	  Breen,	  &	  Meissner,	  2005;	  Schneider,	  2009;	  
Subramanian,	  Klosterman,	  Amonkar,	  &	  Hunt,	  2004;	  Wee,	  McCarthy,	  &	  Phillips,	  2005).	  	  
The	  difference	  in	  adherence	  between	  those	  50-­‐64	  and	  65	  and	  older	  is	  often	  attributed	  
to	  the	  availability	  of	  insurance	  coverage	  through	  Medicare	  (Gross	  et	  al.,	  2006;	  Ko,	  
Kreuter,	  &	  Baldwin,	  2005;	  O’Malley,	  Forrest,	  Feng,	  &	  Mandelblatt,	  2005).	  	  	  
To	  date,	  empirical	  research	  exploring	  predictors	  of	  CRC	  screening	  has	  focused	  on	  
differences	  in	  screening	  patterns	  across	  sociodemographic	  characteristics	  such	  as	  age,	  
race/ethnicity,	  and	  socioeconomic	  status.	  However,	  it	  is	  possible	  that	  other	  factors	  
including	  the	  experience	  of	  multiple	  chronic	  conditions	  (MCC),	  defined	  as	  two	  or	  more	  
chronic	  conditions,	  are	  associated	  with	  CRC	  screening.	  	  MCC	  creates	  context	  for	  patients	  
and	  their	  health	  care	  providers	  that	  may	  directly	  and	  indirectly	  influence	  the	  two	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behavioral	  outcomes	  of	  interest	  in	  CRC	  screening	  research:	  	  the	  physician	  
recommendation	  to	  screen6	  and	  guideline-­‐adherent	  screening.	  	  
Background	  
As	  adults	  reach	  the	  age	  at	  which	  CRC	  screening	  should	  begin,	  many	  are	  
experiencing	  worsening	  health	  including	  the	  onset	  or	  progression	  of	  one	  or	  more	  
chronic	  diseases;	  more	  than	  25%	  of	  Americans	  live	  with	  MCC	  (Singh-­‐Manoux,	  Ferrie,	  
Chandola,	  &	  Marmot,	  2004;	  US	  Department	  of	  Health	  &	  Human	  Services,	  2010).	  It	  is	  
estimated	  that	  by	  the	  year	  2020,	  the	  prevalence	  of	  MCC	  will	  increase	  to	  81	  million	  
Americans,	  up	  42%	  from	  the	  year	  2000	  (Brody,	  2011).	  	  	  	  Many	  of	  the	  risk	  factors	  for	  MCC	  
also	  predispose	  individuals	  to	  a	  higher	  risk	  of	  CRC	  including	  sedentary	  lifestyle,	  poor	  
diet,	  smoking	  and	  alcohol	  consumption	  and	  environmental	  exposures	  (Amos,	  Bosken,	  
Soliman,	  &	  Frazier,	  2005;	  Potter	  &	  Hunter,	  2002).	  	  MCC	  is	  unequally	  distributed	  across	  
demographic	  groups.	  	  Individuals	  in	  lower	  socioeconomic	  tiers	  report	  poor/fair	  health	  
status	  at	  higher	  rates	  than	  those	  in	  higher	  tiers	  (AARP,	  2010;	  Cummings	  &	  Jackson,	  
2008).	  	  An	  individual’s	  socioeconomic	  position	  is	  also	  related	  to	  both	  the	  timing	  and	  
severity	  of	  chronic	  disease	  burden	  across	  the	  life	  course.	  	  Individuals	  in	  lower	  
socioeconomic	  classes	  experience	  morbidity	  earlier	  and	  to	  a	  greater	  degree	  than	  those	  
in	  higher	  socioeconomic	  classes	  (House,	  Kessler,	  &	  Herzog,	  1990;	  Kington	  &	  Smith,	  
1997).	  	  African	  Americans	  suffer	  a	  disproportionate	  burden	  of	  MCC,	  and	  face	  diagnosis	  
of	  chronic	  disease	  at	  a	  much	  younger	  age	  than	  their	  White	  counterparts,	  regardless	  of	  
socioeconomic	  status	  (Williams	  &	  Jackson,	  2005).	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  With	  few	  exceptions,	  from	  this	  point	  forward,	  a	  physician	  or	  other	  health	  care’s	  recommendation	  will	  be	  
referred	  to	  as	  simply	  a	  ‘recommendation.’	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The	  experience	  of	  MCC	  in	  older	  adulthood	  may	  influence	  an	  individual’s	  
likelihood	  to	  receive	  appropriate	  physician	  recommendations	  to	  screen	  and	  engage	  in	  
CRC	  screening	  in	  a	  number	  of	  ways.	  	  Patients	  with	  MCC	  may	  not	  receive	  a	  
recommendation	  from	  a	  physician	  or	  other	  health	  professional	  to	  screen,	  which	  is	  
consistently	  one	  of	  the	  strongest	  correlates	  of	  future	  screening	  behaviors	  across	  
populations	  (Messina,	  2011).	  	  A	  recommendation	  serves	  two	  functions:	  	  first,	  as	  a	  cue	  to	  
action	  for	  patients,	  reminding	  them	  of	  their	  risk	  of	  CRC	  and	  recommended	  screening	  
practices;	  and	  second,	  as	  a	  mechanism	  through	  which	  referrals	  can	  be	  made	  within	  the	  
health	  care	  system	  to	  ensure	  appropriate	  delivery	  and	  payment	  of	  screening	  services.	  	  
Individuals	  with	  MCC	  and	  their	  health	  care	  providers	  face	  competing	  demands	  during	  
the	  clinical	  encounter,	  as	  the	  focus	  of	  their	  interactions	  shifts	  from	  wellness	  care	  to	  
chronic	  disease	  management	  and	  treatment.	  	  In	  addition,	  physicians’	  perception	  that	  
the	  patient	  will	  not	  comply	  due	  to	  his	  or	  her	  medical	  condition	  may	  preclude	  them	  from	  
recommending	  screening	  (Brawarsky,	  Brooks,	  Mucci,	  &	  Wood,	  2004;	  Shokar,	  Carlson,	  &	  
Weller,	  2008).	  	  	  As	  health	  care	  delivery	  becomes	  more	  segmented	  through	  use	  of	  highly	  
specialized	  care	  and	  the	  primary	  responsibility	  for	  CRC	  recommendation	  remains	  in	  the	  
hands	  of	  a	  primary	  care	  provider,	  a	  recommendation	  may	  not	  be	  made	  to	  individuals	  
with	  MCC.	  	  	  	  To	  date,	  health	  care	  institutions	  have	  focused	  their	  efforts	  to	  increase	  
patient	  screening	  rates	  through	  initiatives	  at	  the	  primary	  care	  level.	  	  While	  placing	  the	  
burden	  for	  recommendations	  on	  the	  primary	  care	  provider	  is	  relevant	  for	  individuals	  
who	  have	  access	  to	  and	  use	  that	  segment	  of	  health	  care,	  it	  misses	  an	  increasingly	  large	  
population	  that	  receives	  care	  from	  other	  sources,	  including	  specialty	  care,	  emergency	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departments	  and	  non-­‐clinical	  care	  providers,	  e.g.	  spiritual	  leaders	  (Smedley,	  Stith,	  &	  
Nelson,	  2002).	  	  	  	  
In	  addition	  to	  potentially	  interfering	  with	  the	  receipt	  of	  a	  recommendation	  to	  
screen,	  individuals	  with	  MCC	  face	  unique	  issues	  that	  may	  interfere	  with	  engaging	  in	  
cancer	  screening.	  Results	  from	  our	  earlier	  qualitative	  research	  in	  racial	  and	  ethnic	  
disparities	  in	  CRC	  treatment	  choices	  revealed	  that	  at	  the	  individual	  level,	  patients	  with	  
MCC	  experienced	  physiological	  symptoms	  of	  their	  chronic	  condition	  that	  made	  them	  
apprehensive	  to	  go	  through	  another	  unrelated	  medical	  test.	  	  In	  addition,	  patients	  with	  
MCC	  feared	  another	  diagnosis,	  and	  avoided	  screening	  altogether	  (Becker,	  E.,	  Elliott,	  H.,	  
Griffith,	  D.,	  Alexander,	  G.,	  &	  Morris,	  A.,	  2010).	  	  Finally,	  even	  at	  the	  age	  of	  CRC	  risk,	  
symptoms	  of	  early	  stage	  CRC	  disease	  (change	  in	  bowel	  habits,	  cramping	  or	  abdominal	  
pain,	  weakness,	  fatigue,	  unintended	  weight	  loss)	  may	  be	  mistakenly	  attributed	  to	  an	  
individual’s	  chronic	  disease	  process	  or	  treatment	  (American	  Cancer	  Society,	  2012;	  
Gonzalez,	  Ferrante,	  Van	  Durme,	  Pal,	  &	  Roetzheim,	  2001).	  	  Together,	  these	  findings	  
reflect	  similar	  patterns	  found	  in	  earlier	  research	  across	  cancer	  types	  that	  shows	  inverse	  
relationships	  between	  an	  individual’s	  level	  of	  chronic	  disease	  burden	  (measured	  in	  
number	  of	  chronic	  conditions)	  and	  the	  likelihood	  of	  screening	  for	  breast	  and	  cervical	  
cancer	  as	  well	  as	  being	  diagnosed	  at	  an	  advanced	  stage	  of	  disease	  (Fleming,	  Pursley,	  
Newman,	  Pavlov,	  &	  Chen,	  2005;	  Kiefe,	  Funkhouser,	  Ph,	  Fouad,	  &	  May,	  1998).	  
In	  response	  to	  the	  growing	  public	  health	  threat	  of	  CRC,	  the	  U.S.	  Department	  of	  
Health’s	  Healthy	  People	  2020	  has	  set	  an	  aggressive	  goal	  of	  a	  30%	  increase	  in	  colorectal	  
screening	  uptake	  from	  2008,	  when	  age-­‐adjusted	  rates	  were	  at	  54.2	  percent	  (on	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average),	  to	  its	  goal	  of	  70.5%	  by	  the	  year	  2020	  (US	  Department	  of	  Health	  &	  Human	  
Services,	  2011).	  	  In	  addition,	  Healthy	  People	  2020	  includes	  a	  developmental	  goal	  to	  
increase	  the	  proportion	  of	  adults	  who	  are	  counseled	  by	  their	  providers	  about	  colorectal	  
cancer	  screening.	  	  Understanding	  the	  association	  between	  MCC	  and	  CRC	  screening	  
behaviors	  of	  health	  care	  providers	  and	  patients	  is	  an	  important	  first	  step	  toward	  the	  
design	  and	  implementation	  of	  interventions	  that	  seek	  to	  meet	  the	  CRC	  screening	  goals	  
of	  Healthy	  People	  2020	  and	  the	  needs	  of	  the	  growing	  segment	  of	  the	  population	  living	  
with	  MCC.	  The	  goal	  of	  this	  study	  is	  to	  examine	  the	  associations	  between	  MCC	  and	  both	  
behavioral	  outcomes	  of	  interest.	  	  We	  predict	  that	  MCC	  will	  be	  associated	  with	  
reductions	  in	  rates	  of	  both	  outcomes,	  with	  the	  greatest	  reduction	  of	  rates	  in	  those	  with	  
the	  least	  socioeconomic	  advantage.	  	  We	  further	  predict	  that	  in	  multivariate	  logistic	  
regression	  models,	  including	  MCC	  in	  the	  regression	  model	  will	  attenuate	  the	  odds	  ratio	  
estimates	  of	  sociodemographic	  predictors,	  including	  race/ethnicity,	  age,	  sex,	  
socioeconomic	  status	  measures	  (including	  education,	  poverty	  ratio,	  and	  insurance)	  and	  
usual	  source	  of	  health	  care.	  
Methods	  
Data	  source.	  	  We	  examined	  cross-­‐sectional	  survey	  data	  from	  the	  2008	  National	  
Health	  Interview	  Survey	  (NHIS)	  and	  Cancer	  Screening	  and	  Sun	  Protection	  Supplement	  
(CSSPS).	  	  Although	  there	  are	  other	  options	  for	  collecting	  preventative	  care	  data	  
(including	  other	  nationally	  representative	  datasets	  and	  electronic	  health	  record	  data),	  
we	  are	  using	  NHIS	  for	  the	  specific	  aims	  and	  broader	  goals	  of	  this	  study	  for	  several	  
reasons.	  	  First,	  it	  allows	  us	  to	  consider	  multiple	  factors	  simultaneously	  as	  we	  consider	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influences	  on	  screening	  recommendation	  and	  screening	  behaviors.	  Second,	  NHIS	  is	  the	  
only	  nationally	  representative	  dataset	  that	  allows	  us	  to	  capture	  data	  on	  the	  impetus	  for	  
testing,	  a	  critical	  component	  of	  our	  analyses.	  	  And	  finally,	  due	  to	  its	  frequent	  use	  in	  
survey	  research,	  we	  can	  compare	  and	  contrast	  results	  from	  this	  study	  with	  a	  large	  body	  
of	  literature	  in	  CRC	  and	  other	  cancer	  screening	  behaviors.	  	  Since	  its	  inception	  in	  1957,	  
the	  NHIS	  has	  been	  the	  principal	  source	  of	  information	  on	  the	  health	  and	  health	  
behaviors	  of	  civilian,	  non-­‐institutionalized	  households	  in	  the	  United	  States	  (Centers	  for	  
Disease	  Control	  and	  Prevention,	  2012).	  The	  survey	  is	  administered	  annually	  by	  the	  
National	  Center	  for	  Health	  Statistics	  (NCHS)	  of	  the	  Centers	  for	  Disease	  Control	  and	  
Prevention	  (CDC)	  and	  uses	  a	  stratified	  multistage	  probability	  sample	  design	  (Inter-­‐
University	  Consortium	  for	  Political	  and	  Social	  Research,	  2012).	  	  The	  2008	  Cancer	  
Screening	  and	  Sun	  Protection	  Supplement	  (CSSPS)	  was	  sponsored	  by	  the	  National	  
Cancer	  Institute	  (NCI)	  and	  includes	  questions	  on	  physician	  recommendation	  for	  
screening,	  screening	  tests,	  and	  reasons	  for	  screening	  tests.	  	  	  The	  2008	  NHIS/CSSPS	  was	  
selected	  over	  the	  more	  recent	  2010	  NHIS	  due	  to	  the	  fact	  that	  questions	  on	  physician	  
recommendations	  for	  screening	  were	  linked	  to	  respondents’	  screening	  behaviors	  rather	  
than	  in	  a	  more	  general	  manner.	  	  This	  allowed	  us	  to	  identify	  the	  impetus	  for	  the	  
physician	  recommendation	  as	  well	  as	  CRC	  testing.	  
The	  NHIS	  sampling	  strategies	  result	  in	  an	  oversample	  of	  self-­‐identified	  Black,	  
Hispanic	  and	  Asian	  Americans.	  	  Weights	  constructed	  for	  the	  NHIS	  respondents	  reflect	  
the	  resulting	  unequal	  probabilities	  of	  selection	  and	  also	  incorporate	  adjustments	  for	  
non-­‐response	  and	  post-­‐stratification	  procedures	  designed	  to	  align	  survey	  estimates	  with	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population	  distributions	  from	  the	  2000	  Census.	  	  The	  application	  of	  these	  weights	  in	  
secondary	  analyses	  of	  the	  NHIS	  data	  results	  in	  estimates	  that	  are	  representative	  of	  the	  
adult	  civilian	  non-­‐institutionalized	  population	  of	  the	  U.S.	  (Inter-­‐University	  Consortium	  
for	  Political	  and	  Social	  Research,	  2012).	  	  The	  annual	  NHIS	  response	  rate	  averages	  close	  
to	  ninety	  percent	  of	  the	  eligible	  households	  in	  the	  sample	  (Centers	  for	  Disease	  Control	  
and	  Prevention,	  2012).	  
Study	  population.	  The	  full	  study	  population	  consisted	  of	  non-­‐Hispanic	  White	  and	  
non-­‐Hispanic	  Black	  respondents	  ages	  50-­‐64	  with	  no	  history	  of	  colorectal	  disease.	  	  We	  
chose	  these	  two	  groups	  because	  Non-­‐Hispanic	  Whites	  and	  Non-­‐Hispanic	  Blacks	  suffer	  
the	  highest	  rates	  of	  cancers	  of	  the	  colon	  and	  rectum	  in	  the	  United	  States	  (American	  
Cancer	  Society,	  2011)	  and	  are	  the	  most	  common	  population	  groups	  studied	  in	  CRC	  
screening	  literature	  (Ananthakrishnan,	  Schellhase,	  Sparapani,	  Laud,	  &	  Neuner,	  2007;	  
Bellizzi,	  Breslau,	  Burness,	  &	  Waldron,	  2011;	  Breen,	  Wagener,	  Brown,	  Davis,	  &	  Ballard-­‐
Barbash,	  2001;	  Centers	  for	  Disease	  Control	  and	  Prevention	  (CDC),	  2001;	  James,	  2006;	  
Klabunde	  et	  al.,	  2005).	  	  	  
Individuals	  with	  a	  history	  of	  colorectal	  cancer	  were	  excluded	  since	  testing	  is	  used	  
as	  disease	  management	  and	  not	  preventative	  care.	  	  We	  are	  focusing	  on	  adults	  ages	  50-­‐
64	  because	  CRC	  screening	  should	  be	  initiated	  at	  age	  50	  for	  those	  at	  average	  risk	  of	  the	  
disease	  and	  research	  consistently	  shows	  underutilization	  of	  CRC	  screening	  modalities	  in	  
this	  age	  group	  (American	  Cancer	  Society,	  2011).	  	  For	  the	  analysis	  examining	  patterns	  of	  
recommendations	  for	  any	  CRC	  testing,	  the	  full	  study	  population	  was	  analyzed.	  	  We	  
created	  one	  subpopulation	  from	  this	  full	  study	  population	  for	  each	  set	  of	  analyses	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differentiating	  a)	  referrals	  for	  diagnostic	  testing	  from	  true	  screening	  recommendations7	  
and	  b)	  true	  screening8	  from	  diagnostic	  testing.	  	  Due	  to	  the	  fact	  that	  only	  those	  who	  
reported	  testing	  were	  asked	  about	  the	  impetus	  for	  testing,	  we	  restricted	  both	  
subpopulations	  for	  the	  secondary	  analyses	  to	  individuals	  who	  reported	  American	  Cancer	  
Society	  (ACS)	  guideline	  adherent	  testing.	  	  	  Subpopulation	  A	  (physician	  screening	  
recommendation	  aim)	  includes	  only	  those	  individuals	  who	  reported	  a	  recommendation	  
for	  testing	  and	  ACS	  guideline	  adherent	  testing.	  	  Subpopulation	  B	  (CRC	  screening	  aim)	  
includes	  only	  those	  respondents	  who	  reported	  ACS	  guideline	  adherent	  testing.	  	  
This	  study	  received	  an	  exempt	  status	  designation	  from	  the	  University	  of	  
Michigan	  Institutional	  Review	  Board	  (Study	  HUM00062074).	  	  
Measures.	  
Dependent	  variables.	  	  The	  authors’	  previous	  work	  demonstrated	  the	  importance	  
of	  accounting	  for	  the	  impetus	  for	  testing	  in	  estimating	  physician	  recommendation	  and	  
screening	  rates	  (see	  Chapters	  2	  and	  3).	  	  We	  established	  that	  conflation	  of	  diagnostic	  and	  
screening	  tests	  and	  referrals	  results	  in	  inaccurate	  screening	  and	  recommendation	  rates.	  	  
For	  the	  current	  research	  aims,	  we	  provide	  information	  on	  two	  outcomes	  –	  first,	  an	  
outcome	  that	  conflates	  diagnostic	  testing	  referrals	  and	  true	  screening	  recommendations	  
(or	  diagnostic	  testing	  and	  true	  screening),	  and	  second	  we	  examine	  true	  screening	  
recommendations	  and	  true	  screening.	  This	  second	  set	  of	  outcomes	  may	  not	  be	  as	  easily	  
compared	  with	  existing	  literature	  in	  physician	  recommendation	  and	  screening	  behaviors	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  “True	  screening	  recommendation”	  refers	  to	  a	  recommendation	  that	  results	  in	  pre-­‐symptomatic	  
screening	  (and	  not	  diagnostic	  testing).	  	  8	  “True	  Screening”	  refers	  to	  CRC	  testing	  that	  is	  done	  as	  part	  of	  a	  routine	  exam	  (pre-­‐symptomatic)	  and	  not	  
due	  to	  a	  problem	  (diagnostic).	  
	  	   94	  
due	  to	  the	  common	  practice	  of	  conflating	  true	  screening	  with	  diagnostic	  testing.	  	  
However,	  defining	  the	  outcomes	  in	  a	  manner	  that	  accounts	  for	  the	  impetus	  for	  testing	  is	  
most	  consistent	  with	  assessing	  accurate	  rates	  and	  significant	  predictors	  of	  the	  
behaviors.	  	  	  
Physician	  recommendation.	  	  Respondents	  who	  reported	  any	  type	  of	  testing	  
(including	  fecal	  occult	  blood	  tests	  (FOBT))	  in	  the	  past	  ten	  years	  were	  asked,	  “Was	  your	  
most	  recent	  [screening]	  test	  recommended	  by	  a	  doctor	  or	  other	  health	  professional?”	  
Respondents	  who	  did	  not	  report	  testing	  in	  the	  past	  ten	  years	  were	  asked,	  “In	  the	  past	  
twelve	  months,	  has	  a	  doctor	  or	  other	  health	  professional	  recommended	  that	  you	  be	  
tested	  to	  look	  for	  problems	  in	  your	  colon	  or	  rectum?”	  	  A	  response	  of	  “yes”	  or	  “no”	  was	  
coded	  as	  such,	  while	  a	  response	  of	  “did	  not	  see	  a	  doctor	  in	  the	  past	  12	  months”	  was	  
coded	  as	  “no.”	  	  A	  response	  of	  “refused”	  or	  “don’t	  know”	  was	  coded	  as	  missing	  data	  and	  
excluded	  from	  analysis.	  	  However,	  in	  the	  case	  of	  respondents	  who	  were	  asked	  the	  
question	  twice	  due	  to	  affirmative	  responses	  to	  both	  non-­‐invasive	  and	  invasive	  testing,	  
an	  answer	  resulting	  in	  a	  code	  of	  ‘yes’	  or	  ‘no’	  for	  any	  question	  resulted	  in	  missing	  data	  
from	  the	  other	  being	  ignored9	  (total	  missing	  n	  =	  197).	  	  	  
In	  order	  to	  accurately	  assess	  whether	  or	  not	  the	  physician	  recommendation	  was	  
for	  true	  screening,	  we	  created	  a	  dichotomous	  variable	  combining	  data	  on	  reports	  of	  
recommendations	  for	  testing	  (as	  described	  above)	  and	  the	  impetus	  for	  the	  reported	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9	  As	  an	  example,	  a	  respondent	  did	  not	  provide	  an	  answer	  to	  the	  question	  concerning	  whether	  or	  not	  a	  
recommendation	  was	  received	  for	  FOBT	  testing	  but	  indicated	  that	  a	  physician	  had	  recommended	  a	  form	  
of	  invasive	  testing.	  	  This	  respondent’s	  recommendation	  status	  was	  coded	  as	  ‘yes’	  despite	  the	  missing	  data	  
for	  the	  FOBT	  question.	  	  This	  same	  coding	  was	  used	  for	  CRC	  testing.	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testing.	  Individuals	  who	  reported	  invasive	  tests	  (sigmoidoscopy,	  proctoscopy,	  or	  
colonoscopy)	  were	  asked,	  “What	  was	  the	  MAIN	  reason	  you	  had	  this	  exam	  -­‐	  was	  it	  part	  
of	  a	  routine	  exam,	  because	  of	  a	  problem,	  or	  some	  other	  reason?”	  The	  dependent	  
variable	  was	  coded	  as	  ‘true	  screening’	  for	  responses	  of	  “part	  of	  a	  routine	  exam”	  and	  as	  
‘diagnostic	  testing’	  for	  responses	  of	  “because	  of	  a	  problem,	  or	  some	  other	  reason.”	  	  
Responses	  of	  “refused”	  or	  “don’t	  know”	  were	  coded	  as	  missing	  data	  and	  excluded	  from	  
this	  step.	  	  If	  the	  respondent’s	  answer	  to	  this	  question	  was	  coded	  as	  missing	  data	  but	  the	  
respondent	  did	  report	  engagement	  in	  ACS	  guideline-­‐adherent	  FOBT	  testing,	  the	  missing	  
data	  were	  ignored4	  (total	  missing	  n	  =	  4).	  	  Since	  non-­‐invasive	  FOBT	  testing	  is	  used	  
exclusively	  for	  screening,	  most	  reports	  of	  FOBT	  testing	  was	  coded	  as	  ‘true	  screening.’	  	  
However,	  if	  respondents	  reported	  both	  FOBT	  and	  invasive	  modes	  of	  ACS	  guideline	  
adherent	  testing,	  the	  impetus	  for	  testing	  was	  categorized	  solely	  on	  the	  impetus	  for	  the	  
invasive	  testing.	  A	  total	  of	  287	  respondents	  fit	  this	  criteria:	  	  67	  were	  coded	  as	  diagnostic	  
and	  220	  were	  coded	  as	  true	  screeners.	  	  The	  resulting	  dependent	  variable	  is	  a	  binary	  
measure	  indicating	  whether	  the	  recommendation	  was	  a	  referral	  for	  diagnostic	  testing	  or	  
a	  true	  screening	  recommendation.	  	  
CRC	  screening.	  To	  assess	  ACS	  guideline	  adherence,	  we	  created	  a	  dichotomous	  
variable	  using	  respondents’	  self-­‐reports	  of	  the	  type	  of	  testing	  they	  underwent	  and	  the	  
time	  frame	  in	  which	  the	  procedure	  occurred.	  	  To	  assess	  engagement	  with	  non-­‐invasive	  
testing,	  respondents	  were	  asked,	  “The	  following	  questions	  are	  about	  the	  blood	  stool	  or	  
occult	  blood	  test,	  a	  test	  to	  determine	  whether	  you	  have	  blood	  in	  your	  stool	  or	  bowel	  
movement.	  The	  blood	  stool	  test	  can	  be	  done	  at	  home	  using	  a	  kit.	  You	  use	  a	  stick	  or	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brush	  to	  obtain	  a	  small	  amount	  of	  stool	  at	  home	  and	  send	  it	  back	  to	  the	  doctor	  or	  lab.	  
Have	  you	  EVER	  HAD	  a	  blood	  stool	  test,	  using	  a	  HOME	  test	  kit?”	  	  Responses	  of	  “yes”	  or	  
“no”	  were	  coded	  as	  such,	  while	  responses	  of	  “refused”	  or	  “don’t	  know”	  were	  coded	  as	  
missing	  data	  and	  excluded	  from	  analysis.	  	  However,	  in	  the	  case	  of	  respondents	  whose	  
response	  was	  coded	  as	  missing	  for	  non-­‐invasive	  testing	  but	  “yes”	  or	  “no”	  for	  invasive	  
testing	  (see	  following	  paragraph),	  missing	  data	  from	  the	  non-­‐invasive	  testing	  question	  
were	  ignored4	  (missing	  n	  =	  52).	  Respondents	  reporting	  testing	  also	  reported	  testing	  
timelines	  in	  one	  of	  the	  following	  formats:	  	  month/year,	  number	  of	  days,	  weeks,	  months	  
or	  years	  since	  testing,	  or	  by	  using	  years	  since	  testing	  (a	  year	  ago	  or	  less/more	  than	  1	  
year	  but	  not	  more	  than	  2	  years/more	  than	  2	  years	  but	  not	  more	  than	  3	  years/more	  than	  
3	  years	  but	  not	  more	  than	  5	  years/more	  than	  5	  years	  but	  not	  more	  than	  10	  years/over	  
10	  years	  ago).	  	  FOBT	  testing	  reported	  to	  occur	  within	  one	  year	  of	  the	  survey	  
administration	  was	  coded	  as	  ACS	  guideline	  adherent	  and	  all	  FOBT	  testing	  was	  coded	  as	  
true	  screening,	  as	  it	  is	  used	  exclusively	  for	  that	  purpose.	  
To	  assess	  engagement	  with	  invasive	  testing,	  respondents	  were	  asked,	  “Have	  you	  
ever	  had	  a	  sigmoidoscopy,	  colonoscopy,	  or	  proctoscopy?	  	  	  These	  are	  exams	  in	  which	  a	  
health	  care	  professional	  inserts	  a	  tube	  into	  the	  rectum	  to	  look	  for	  signs	  of	  cancer	  or	  
other	  problems.”	  	  Responses	  of	  “yes”	  or	  “no”	  were	  coded	  as	  such,	  while	  responses	  of	  
“refused”	  or	  “don’t	  know”	  were	  coded	  as	  missing	  data	  and	  excluded	  from	  analysis.	  	  
However,	  in	  the	  case	  of	  respondents	  whose	  response	  was	  coded	  as	  missing	  for	  invasive	  
testing	  but	  “yes”	  or	  “no”	  for	  non-­‐invasive	  testing	  (see	  preceding	  paragraph),	  missing	  
data	  from	  the	  invasive	  testing	  question	  were	  ignored	  (missing	  n	  =	  23).	  Respondents	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reporting	  testing	  also	  reported	  testing	  timelines	  in	  one	  of	  the	  following	  formats:	  	  
month/year,	  number	  of	  days,	  weeks,	  months	  or	  years	  since	  testing,	  or	  by	  using	  years	  
since	  testing	  (a	  year	  ago	  or	  less/more	  than	  1	  year	  but	  not	  more	  than	  2	  years/more	  than	  
2	  years	  but	  not	  more	  than	  3	  years/more	  than	  3	  years	  but	  not	  more	  than	  5	  years/more	  
than	  5	  years	  but	  not	  more	  than	  10	  years/over	  10	  years	  ago).	  	  	  Invasive	  testing	  
(sigmoidoscopy,	  proctoscopy,	  colonoscopy)	  was	  coded	  as	  ACS	  guideline	  adherent	  if	  the	  
testing	  was	  reported	  to	  be	  within	  five,	  five	  and	  ten	  years,	  respectively.	  	  	  
To	  measure	  reports	  of	  true	  screening	  versus	  diagnostic	  testing	  behaviors,	  we	  
created	  a	  dichotomous	  variable	  combining	  data	  on	  ACS	  guideline-­‐adherent	  screening	  
behaviors	  and	  the	  impetus	  for	  the	  reported	  testing.	  	  In	  order	  to	  determine	  the	  impetus	  
for	  the	  reported	  testing	  for	  individuals	  who	  reported	  invasive	  tests	  (sigmoidoscopy,	  
proctoscopy,	  or	  colonoscopy),	  we	  assessed	  responses	  to	  the	  question	  “What	  was	  the	  
MAIN	  reason	  you	  had	  this	  exam	  -­‐	  was	  it	  part	  of	  a	  routine	  exam,	  because	  of	  a	  problem,	  
or	  some	  other	  reason?”	  The	  dependent	  variable	  was	  coded	  as	  ‘true	  screening’	  for	  
responses	  of	  “part	  of	  a	  routine	  exam”	  and	  as	  ‘diagnostic	  testing’	  for	  responses	  of	  
“because	  of	  a	  problem,	  or	  some	  other	  reason.”	  	  Responses	  of	  “refused”	  or	  “don’t	  know”	  
were	  coded	  as	  missing	  data	  and	  excluded	  from	  analysis	  if	  non-­‐invasive	  testing	  was	  not	  a	  
“yes”4	  (missing	  n	  =	  40).	  
If	  respondents	  reported	  both	  non-­‐invasive	  and	  invasive	  modes	  of	  ACS	  guideline	  
adherent	  testing,	  their	  answer	  to	  the	  question	  above	  with	  respect	  to	  the	  impetus	  for	  the	  
invasive	  tests	  determined	  whether	  or	  not	  it	  was	  true	  screening	  or	  diagnostic	  testing.	  	  A	  
total	  of	  287	  respondents	  fit	  these	  criteria:	  	  67	  were	  coded	  as	  diagnostic	  and	  220	  were	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coded	  as	  true	  screeners.	  	  	  
Independent	  variables.	  	  	  The	  primary	  independent	  variable	  of	  interest	  in	  this	  
study	  is	  multiple	  chronic	  conditions	  (MCC),	  defined	  as	  2	  or	  more	  chronic	  conditions.	  	  
Information	  on	  chronic	  conditions	  is	  available	  from	  the	  NHIS	  in	  two	  different	  ways,	  and	  
we	  utilized	  both	  methods	  in	  creating	  a	  count	  of	  chronic	  conditions	  for	  each	  respondent.	  
First,	  respondents	  can	  report	  the	  diagnosis	  of	  a	  chronic	  condition.	  	  They	  are	  asked,	  
“Have	  you	  EVER	  been	  told	  by	  a	  doctor	  or	  other	  health	  professional	  that	  you	  had	  
[condition]?”	  	  Second,	  respondents	  can	  report	  a	  limitation	  of	  daily	  living	  and	  attribute	  
that	  limitation	  to	  the	  presence	  of	  a	  chronic	  condition.	  	  They	  are	  asked,	  	  “The	  next	  
questions	  ask	  about	  difficulties	  you	  may	  have	  doing	  certain	  activities	  because	  of	  a	  
HEALTH	  PROBLEM.	  By	  "health	  problem"	  we	  mean	  any	  physical,	  mental,	  or	  emotional	  
problem	  or	  illness	  (not	  including	  pregnancy).	  	  By	  yourself,	  and	  without	  using	  any	  special	  
equipment,	  how	  difficult	  is	  it	  for	  you	  to...	  
...Walk	  a	  quarter	  of	  a	  mile	  -­‐	  about	  3	  city	  blocks?	  
...Walk	  up	  10	  steps	  without	  resting?	  
...Stand	  or	  be	  on	  your	  feet	  for	  about	  2	  hours?	  
...Sit	  for	  about	  2	  hours?	  
...Stoop,	  bend,	  or	  kneel?	  
...Reach	  up	  over	  your	  head?	  
...Use	  your	  fingers	  to	  grasp	  or	  handle	  small	  objects?	  
...Lift	  or	  carry	  something	  as	  heavy	  as	  10	  pounds	  such	  as	  a	  full	  bag	  of	  groceries?	  
...Push	  or	  pull	  large	  objects	  like	  a	  living	  room	  chair?	  
...Go	  out	  to	  things	  like	  shopping,	  movies,	  or	  sporting	  events?	  
...Participate	  in	  social	  activities	  such	  as	  visiting	  friends,	  attending	  clubs	  and	  meetings,	  	  
	  	  	  going	  to	  parties?	  
...Do	  things	  to	  relax	  at	  home	  or	  for	  leisure	  (reading,	  watching	  TV,	  sewing,	  listening	  to	  music)?”	  
	  
If	  respondents	  reported	  any	  difficulty	  with	  any	  of	  these	  activities,	  they	  are	  asked	  an	  
open	  ended	  question,	  “What	  condition	  or	  health	  problem	  causes	  you	  to	  have	  difficulty	  
with	  [the	  activity]?”	  	  	  Unlike	  in	  the	  first	  option	  to	  reply	  to	  a	  question	  concerning	  a	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specific	  condition,	  they	  may	  offer	  any	  answer.	  	  In	  addition	  to	  the	  health	  problem,	  they	  
report	  the	  duration	  of	  the	  condition.	  	  	  
Together,	  these	  two	  sets	  of	  questions	  allowed	  us	  to	  capture	  data	  on	  
respondents’	  reports	  of	  the	  following	  conditions	  (listed	  alphabetically):	  
Angina	   Grave’s	  Disease	  
Arthritis	   Hearing/current	  use	  of	  aid	  
Arthritis	  (rheumatoid)	   Heart	  condition	  (any	  not	  mentioned)	  
Asthma	  (current)	   Hypertension	  
Benign	  tumors,	  cysts	   Joint	  condition	  (other)	  
Bronchitis	  (chronic)	   Kidney	  disease	  (weak	  or	  failing)	  
Cancer	  (excluding	  colorectal)	   Liver	  condition	  
Cataracts	   Lupus	  
Cerebral	  palsy	   Macular	  degeneration	  
Chronic	  Fatigue	   Movement	  disorder	  
Coronary	  heart	  disease	   Multiple	  Sclerosis	  
Diabetes	   Osteoporosis,	  tendinitis	  
Diabetes	  (pre-­‐)	   Stroke	  
Diabetic	  retinopathy	   Thyroid	  (low)	  
Emphysema	   Vision/blindness	  
Epilepsy/seizures	   Vision/problem	  seeing	  w/aids	  
Fibromyalgia	   Weight	  problem	  
Glaucoma	   	  
Gout	   	  
	  	  
Chronic	  disease	  is	  characterized	  by	  the	  presence	  of	  a	  disease	  for	  3	  months	  or	  greater.	  	  
Therefore,	  if	  a	  respondent	  reports	  condition	  duration	  of	  less	  than	  three	  months,	  the	  
condition	  was	  not	  counted.	  	  We	  utilized	  coding	  to	  prevent	  duplication	  of	  condition	  
counts	  across	  the	  two	  sections.	  	  For	  example,	  if	  a	  respondent	  answered	  that	  they	  had	  
been	  told	  by	  a	  doctor	  that	  they	  have	  diabetes,	  and	  also	  reported	  that	  the	  diabetes	  
impaired	  their	  ability	  to	  walk	  a	  quarter	  of	  a	  mile,	  those	  responses	  would	  result	  in	  only	  
one	  chronic	  condition	  adding	  to	  their	  count.	  
We	  utilized	  NHIS	  data	  directly	  for	  variables	  of	  race/ethnicity	  (non-­‐Hispanic	  
White/non-­‐Hispanic	  Black),	  sex	  (male/female),	  age	  (continuous	  50-­‐80,	  categorical	  50-­‐
54/55-­‐59/60-­‐64/65-­‐69/70-­‐74/75-­‐80,	  and	  categorical	  50-­‐64/65-­‐80),	  educational	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attainment	  (less	  than	  a	  high	  school	  diploma/high	  school	  graduate	  or	  GED/some	  college	  
no	  degree	  or	  associate	  degree/bachelor’s	  degree/master	  professional	  or	  doctorate),	  
poverty	  ratio	  (tertiles	  (measured	  as	  ratio	  of	  family	  income	  to	  poverty	  threshold):	  	  low	  
(under	  .50	  to	  2.49)/medium	  (2.50	  to	  4.99)/high	  (5.00	  and	  over)),	  insurance	  status	  
(covered/not	  covered),	  and	  usual	  source	  of	  health	  care	  (yes/no).	  The	  poverty	  ratio	  
variable	  came	  from	  NHIS	  with	  no	  missing	  values	  as	  the	  result	  of	  multiple	  imputations	  
done	  by	  the	  survey	  administrator.	  	  Missing	  values	  for	  all	  variables	  except	  poverty	  ratio	  
were	  below	  3%,	  a	  threshold	  determined	  to	  be	  acceptable	  with	  this	  sample	  size.	  	  	  
Statistical	  analysis.	  
Data	  analysis.	  	  All	  data	  analyses	  for	  this	  chapter	  were	  performed	  with	  the	  
SAS/STAT	  statistical	  software,	  version	  9.3_M1	  of	  the	  SAS	  System	  for	  Windows,	  Copyright	  
©	  2002-­‐2010	  SAS	  Institute	  Inc.	  	  SAS	  employs	  procedures	  capable	  of	  computing	  
appropriate	  variance	  estimates	  for	  survey	  estimates	  generated	  from	  analyses	  of	  
complex	  sample	  survey	  data	  sets	  such	  as	  the	  2008	  NHIS	  (Heeringa,	  West,	  &	  Berglund,	  
2010;	  SAS	  Institute	  Inc.,	  2014).	  	  Due	  to	  the	  fact	  that	  SAS	  excludes	  strata	  with	  only	  one	  
PSU	  including	  sample	  from	  the	  subpopulation	  of	  interest	  from	  its	  variance	  estimates,	  we	  
ran	  selected	  models	  in	  a	  different	  software	  package,	  Stata	  13.0,	  which	  enables	  multiple	  
ad-­‐hoc	  variance	  estimation	  methods	  for	  dealing	  with	  “singleton”	  primary	  sampling	  unit	  
(PSU)	  to	  compare	  estimated	  standard	  errors	  (StataCorp,	  2013).	  	  For	  the	  logistic	  
regression	  models	  including	  main	  effect,	  of	  268	  estimates	  only	  ten	  had	  greater	  than	  or	  
equal	  to	  a	  10%	  difference	  in	  standard	  errors,	  with	  the	  greatest	  difference	  at	  17%.	  In	  
most	  cases,	  Stata	  produced	  higher	  standard	  errors;	  none	  of	  these	  differences	  resulted	  in	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changes	  in	  statistical	  inferences.	  	  
We	  began	  our	  analysis	  with	  weighted	  and	  unweighted	  estimates	  of	  true	  
screening	  recommendations	  and	  true	  screening10	  frequencies	  for	  each	  of	  the	  
independent	  variables	  of	  interest	  in	  the	  full	  subpopulation	  as	  defined	  above.	  	  We	  then	  
obtained	  estimates	  of	  weighted	  and	  unweighted	  frequencies	  of	  both	  outcomes	  for	  each	  
of	  the	  independent	  variables	  of	  interest	  in	  the	  smaller	  subpopulation	  of	  ACS	  guideline-­‐
adherent	  screeners.	  	  
We	  calculated	  estimates	  of	  true	  screening	  recommendation	  and	  true	  screening	  for	  the	  
full	  study	  population	  by	  applying	  the	  true	  screening	  recommendation	  and	  true	  
screening	  rates	  from	  the	  smaller	  subpopulation	  to	  the	  unadjusted11	  testing	  rates	  of	  the	  
full	  study	  population.	  	  For	  example,	  the	  unadjusted	  recommendation	  rates	  for	  the	  full	  
study	  population	  was	  61.04%.	  	  In	  the	  smaller	  subpopulation,	  the	  estimated	  true	  
screening	  recommendation	  rate	  was	  71.81%.	  	  We	  applied	  this	  rate	  to	  the	  unadjusted	  
testing	  rate	  (61.04%	  *	  71.81%)	  to	  calculate	  an	  adjusted	  true	  screening	  rate	  of	  43.83%.	  	  
This	  same	  process	  was	  repeated	  for	  each	  subgroup	  of	  the	  full	  study	  population.	  	  Since	  
this	  calculation	  reflects	  the	  rates	  of	  referrals	  for	  diagnostic	  testing	  of	  only	  respondents	  
reporting	  ACS	  guideline	  adherent	  testing,	  it	  is	  likely	  a	  conservative	  estimate	  of	  the	  true	  
estimate	  for	  the	  full	  study	  population.	  We	  calculated	  estimates	  of	  the	  confidence	  
intervals	  and	  resulting	  tests	  of	  significance	  for	  the	  adjusted	  true	  screening	  and	  true	  
screening	  recommendation	  rates	  of	  the	  full	  population.	  	  In	  this	  process,	  we	  were	  unable	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  10	  “True	  screening”	  refers	  to	  pre-­‐symptomatic	  screening	  (and	  not	  diagnostic	  testing).	  11	  “Unadjusted”	  rates	  refers	  to	  rates	  prior	  to	  accounting	  for	  the	  impetus	  for	  testing	  (comparable	  to	  BRFSS	  
methodology),	  while	  “adjusted”	  rates	  refers	  to	  rates	  after	  such	  accounting	  (utilizing	  NHIS	  methodology).	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to	  account	  for	  the	  fact	  that	  we	  derived	  the	  true	  screening	  and	  true	  screening	  
recommendation	  rates	  for	  the	  full	  population	  from	  two	  estimates.	  	  This	  resulted	  in	  the	  
possibility	  of	  narrower	  confidence	  intervals	  and	  inferences	  that	  were	  more	  likely	  to	  
result	  in	  statistically	  significant	  values.	  	  However,	  given	  the	  precise	  nature	  of	  the	  
subpopulation	  rate	  estimates,	  this	  issue	  is	  likely	  negligible.	  	  	  
In	  preparation	  for	  fitting	  multivariate	  logistic	  regression	  models,	  we	  examined	  
weighted	  bivariate	  associations	  between	  independent	  and	  dependent	  variables	  for	  each	  
outcome	  using	  the	  Rao-­‐Scott	  chi-­‐square	  test	  to	  account	  for	  the	  features	  of	  the	  complex	  
sampling	  design.	  	  Our	  goal	  with	  the	  multivariate	  logistic	  regression	  modeling	  was	  not	  to	  
establish	  a	  fitted	  regression	  model.	  	  Instead,	  we	  sought	  to	  assess	  the	  level	  of	  
attenuation	  in	  the	  adjusted	  odds	  ratios	  of	  covariates	  when	  MCC	  was	  added	  to	  the	  
model.	  	  Since	  significant	  interactions	  varied	  across	  models,	  making	  interpretation	  of	  
odds	  ratios	  invalid,	  we	  report	  main	  effect	  logistic	  regression	  models	  only.	  	  
In	  the	  second	  stage	  of	  analysis,	  we	  performed	  a	  four	  step	  fitting	  of	  weighted	  
multivariate	  logistic	  regression	  models	  of	  main	  effects	  to	  the	  odds	  of	  reporting	  a	  true	  
screening	  recommendation	  (Subpopulation	  A)	  and	  true	  screening	  (Subpopulation	  B),	  
including	  variables	  for	  sociodemographic	  factors	  including	  sex,	  race,	  age,	  education,	  
poverty	  ratio,	  health	  insurance	  status,	  and	  usual	  source	  of	  health	  care	  (Breen	  et	  al.,	  
2001;	  O’Malley	  et	  al.,	  2005;	  Rosen	  &	  Schneider,	  2004).	  	  We	  estimated	  the	  regression	  
parameters	  using	  pseudo-­‐maximum	  likelihood	  estimation,	  due	  to	  the	  complex	  sampling	  
nature	  of	  the	  NHIS	  (Heeringa	  et	  al.,	  2010),	  and	  we	  used	  Taylor	  Series	  Linearization	  to	  
compute	  design-­‐based	  estimates	  of	  standard	  errors	  for	  the	  estimated	  regression	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parameters.	  	  Hypothesis	  tests	  were	  performed	  using	  design-­‐adjusted	  Wald	  X2	  tests.	  	  	  We	  
report	  odds	  ratios	  and	  their	  95%	  confidence	  intervals.	  
Results	  
	  Please	  refer	  to	  Table	  4.1	  for	  weighted	  estimates	  of	  demographic	  characteristics	  
and	  MCC	  distribution	  for	  the	  full	  population	  and	  each	  subpopulation.	  Comparing	  the	  full	  
study	  population	  to	  subpopulations	  A	  and	  B,	  the	  most	  significant	  changes	  in	  estimates	  
of	  the	  distribution	  of	  sociodemographic	  characteristics	  were	  in	  NHB	  males	  (+17%	  (A)	  
and	  +14%	  (B)),	  the	  youngest	  age	  group	  (+23%	  (A)	  and	  +21%	  (B)),	  those	  with	  no	  college	  
education	  (+27%	  and	  +12%	  (A)	  and	  +29%	  and	  +13%	  (B)),	  those	  in	  the	  low	  and	  high	  
poverty	  ratio	  tertile	  (+24%	  (A	  and	  B)	  and	  -­‐14%	  (A)	  and	  -­‐13%	  (B)),	  those	  without	  
insurance	  coverage	  (+138%	  (A)	  and	  +115%	  (B))	  and	  those	  with	  no	  usual	  source	  of	  health	  
care	  (+222%	  (A)	  and	  170%	  (B)).	  	  	  
Compared	  to	  the	  full	  study	  population,	  both	  subpopulations	  had	  higher	  rates	  of	  
MCC	  across	  sociodemographic	  categories.	  	  Across	  all	  populations,	  compared	  to	  non-­‐
Hispanic	  Whites	  (NHW),	  non-­‐Hispanic	  Blacks	  (NHB)	  reported	  higher	  rates	  of	  MCC	  and	  
across	  all	  populations.	  	  Female	  respondents	  reported	  higher	  rates	  of	  MCC	  than	  males.	  	  
Rates	  of	  MCC	  were	  greatest	  in	  older	  respondents,	  those	  with	  the	  least	  education,	  and	  
those	  in	  the	  lowest	  poverty	  ratio	  tertile.	  	  	  
Physician	  recommendation.	  
	  
Table	  4.2	  shows	  weighted	  estimates	  of	  true	  screening	  recommendation	  rates	  
and	  rates	  of	  referrals	  for	  diagnostic	  testing	  by	  MCC	  status	  for	  Subpopulation	  A.	  	  Table	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4.3	  shows	  weighted	  estimates	  of	  the	  unadjusted	  recommendation	  rate	  and	  the	  adjusted	  
true	  screening	  recommendation	  rates	  by	  MCC	  status	  for	  the	  full	  study	  population.	  	  	  
Respondents	  with	  MCC	  reported	  higher	  rates	  of	  referrals	  for	  diagnostic	  testing	  
than	  their	  counterparts	  (31.34%	  versus	  23.55%)	  but	  reported	  much	  higher	  rates	  of	  
recommendations	  overall	  (57.39%	  versus	  44.74%).	  In	  the	  full	  study	  population,	  the	  
estimated	  rate	  of	  true	  screening	  recommendations	  was	  43.83%	  once	  we	  accounted	  for	  
the	  impetus	  for	  the	  testing.	  	  Compared	  to	  the	  full	  population,	  the	  rate	  for	  individuals	  
without	  MCC	  was	  slightly	  lower	  at	  41.20%,	  while	  the	  true	  screening	  recommendation	  
rate	  for	  those	  with	  MCC	  was	  higher	  at	  46.28%.	  The	  difference	  in	  adjusted	  true	  screening	  
recommendation	  rates	  between	  those	  with	  and	  without	  MCC	  was	  statistically	  significant	  












! n % CI!of!% %!(SE!of!%) n % CI!of!% %!(SE!of!%) n % CI!of!% %!(SE!of!%)
001!Chronic!Conditions!(MCC!=!no) 2073 47.36 (45.62,!49.09) 812 40.42 (38.19,!42.64) 900 41.37 (39.20,!43.54)
2+!Chronic!Conditions!(MCC!=!yes) 2282 52.64 (50.91,!54.38) 1196 59.58 (57.36,!61.81) 1268 58.63 (56.46,!60.80)
! ! ! !
Non0Hispanic!White 3528 87.14 (86.11,!88.17) 52.03!(0.95) 1675 88.68 (87.46,!89.89) 58.75!(1.19) 1807 88.58 (87.31,!89.84) 58.02!(1.15)
Non0Hispanic!Black 827 12.86 (11.83,!13.89) 56.77!(1.90) 333 11.32 (7.52,!9.67) 66.12!(2.89) 361 11.42 (10.16,!12.69) 63.75!(2.75)
!
Male 1963 45.78 (44.21,!47.36) 47.06!(1.24) 899 45.48 (43.29,!47.67) 54.32!(1.76) 977 45.85 (43.65,!48.06) 53.90!(1.73)
Female 2392 54.22 (52.64,!55.79) 57.36!(1.23) 1109 54.52 (52.33,!56.71) 63.97!(1.60) 1191 54.15 (51.94,!56.35) 62.71!(1.56)
Non0Hispanic!White!Male 1619 40.44 (38.87,!42.02) 46.39!(1.36) 767 40.90 (38.72,!43.09) 53.14!(1.90) 832 41.20 (39.01,!43.40) 52.98!(1.86)
Non0Hispanic!Black!Male 344 5.34 (4.76,!5.92) 52.11!(2.83) 132 4.58 (3.77,!5.38) 64.86!(4.59) 145 4.65 (3.83,!5.47) 62.13!(4.50)
Non0Hispanic!White!Female 1909 46.70 (45.02,!48.38) 56.92!(1.34) 908 47.77 (45.49,!50.05) 63.55!(1.73) 975 47.37 (45.05,!49.70) 62.40!(1.69)
Non0Hispanic!Black!Female 483 7.52 (6.68,!8.35) 60.09!(2.64) 201 6.75 (5.70,!7.79) 66.98!(3.61) 216 6.77 (5.72,!7.82) 64.85!(3.51)
! !
Ages!50054 1565 36.03 (34.61,!37.45) 43.06!(1.51) 575 29.39 (27.18,!31.50) 50.32!(2.28) 629 29.66 (27.54,!31.78) 49.00!(2.22)
Ages!55059 1511 34.06 (32.47,!35.65) 52.95!(1.48) 739 35.89 (33.60,!38.19) 56.24!(1.87) 796 35.79 (33.54,!38.04) 55.91!(1.81)
Ages!60064 1279 29.91 (28.39,!31.42) 63.84!(1.41) 694 34.77 (23.67,!28.03) 70.85!(1.86) 743 34.55 (32.24,!36.86) 69.81!(1.79)
!
Less!than!High!School!Diploma 455 10.18 (9.04,!11.32) 67.92!(2.38) 161 8.04 (6.66,!9.41) 80.84!(3.34) 172 7.88 (6.59,!9.17) 80.34!(3.21)
High!School!Degree!or!GED 1279 28.55 (27.01,!30.09) 54.87!(1.41) 522 25.57 (23.56,!27.57) 65.71!(2.05) 563 25.21 (23.25,!27.18) 63.88!(1.96)
Some!College!No!Degree!or!Associate!Degree 1341 30.87 (29.33,!32.41) 54.80!(1.48) 629 31.54 (29.25,!33.83) 61.10!(2.20) 674 31.41 (29.18,!33.63) 60.68!(2.13)
Bachelor's!Degree 739 17.23 (16.00,!18.48) 45.13!(1.94) 369 18.36 (16.59,!20.12) 51.31!(2.65) 410 18.97 (17.23,!20.72) 50.82!(2.47)
Master's,!Professional!or!Doctorate!Degree 519 12.66 (11.57,!13.75) 41.66!(2.43) 321 16.50 (14.83,!18.17) 46.59!(2.80) 343 16.26 (14.59,!17.94) 45.85!(2.76)
! !
Poverty!Ratio!0!Low!Tertile 1292 29.67 (27.91,!31.49) 65.70!(1.36) 480 23.88 (21.51,!26.43) 76.70!(2.18) 518 23.87 (21.62,!26.27) 74.49!(2.07)
Poverty!Ratio!0!Medium!Tertile 1330 30.55 (29.12,!32.02) 51.96!(1.41) 605 30.12 (27.85,!32.49) 61.29!(2.16) 655 30.23 (28.12,!32.43) 59.98!(2.02)
Poverty!Ratio!0!High!Tertile 1732 39.78 (38.00,!41.58) 43.43!(1.35) 924 46.00 (43.46,!48.56) 49.58!(1.15) 995 45.90 (43.51,!48.31) 49.60!(1.65)
! !
Insurance!0!Not!Covered 514 11.22 (10.17,!12.27) 47.48!(2.24) 101 4.72 (3.55,!5.89) 64.17!(4.52) 120 5.21 (4.03,!6.38) 62.12!(4.06)
Insurance!0!Covered 3836 88.78 (87.73,!89.83) 53.30!(0.92) 1905 95.28 (94.11,!96.45) 59.33!(1.15) 2046 94.79 (93.62,!95.97) 58.46!(1.10)
Living!with!Marital!Spouse!or!Unmarried!Partner 2368 55.50 (53.57,!57.44) 49.12!(1.14) 1173 59.24 (56.65,!61.84) 55.15!(1.51) 1267 59.25 (56.68,!61.82) 54.37!(1.46)
Never!Married!/!Unknown!Status 479 10.32 (9.34,!11.30) 48.95!(2.51) 182 8.77 (7.49,!10.05) 53.03!(3.81) 201 8.96 (7.67,!10.25) 52.87!(3.59)
Marital!Spouse!not!in!HH!or!Separated 202 4.43 (3.74,!5.12) 58.62!(4.23) 83 3.90 (2.97,!4.84) 62.62!(6.37) 90 3.87 (2.97,!4.78) 61.16!(6.15)
Widowed!or!Divorced 1306 29.74 (28,02,!31.47) 59.6!(1.47) 570 28.08 (25.87,!30.29) 70.57!(1.99) 610 27.92 (25.70,!30.13) 69.34!(1.87)
! !
Usual!Source!of!Health!Care!0!No 373 8.59 (7.66,!9.53) 31.51!(2.58) 54 2.67 (1.94,!3.40) 48.57!(6.42) 69 3.18 (2.37,!4.00) 46.91!(6.12)
Usual!Source!of!Health!Care!0!Yes 3920 91.41 (90.48,!92.34) 54.66!(0.93) 1954 97.33 (96.59,!98.06) 59.89!(1.17) 2099 96.82 (96.00,!97.63) 59.06!(1.13)
!
Physician!Recommendation!0!No 1668 38.96 (37.18,!40.73) 44.31!(1.30) 162 7.21 (5.97,!8.46) 46.96!(3.97)


















Recommendation&% CI&of&% Diagnostic&Referral&% CI&of&%
RaoAScott&
ChiASquare Pr&>&ChiSq
Subpopulation+A 2008 71.81 (69.61,+74.01) 28.19 (25.99,+30.39)
0;1+Multiple+Chronic+Conditions+(MCC+=+no) 812 76.45 (73.48,+79.42) 23.55 (20.58,+26.51) 16.29 <.0001
2++Chronic+Conditions+(MCC+=+yes) 1196 68.66 (65.90,+71.42) 31.34 (28.58,+34.10)








Full!Study!Population!(n!missing!=!197) 4158 61.04 (59.27,!62.82) 43.83
!
0A1!Multiple!Chronic!Conditions!(MCC!=!no) 1965 53.89 (51.32,!56.45) 79.88 <.0001 41.20 (39.22,!43.17) 4.50 <.0001
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Table	  4.4	  shows	  estimates	  of	  unadjusted	  and	  adjusted	  CRC	  testing	  and	  screening	  
rates	  by	  MCC	  status	  for	  Subpopulation	  B.	  	  Table	  4.5	  shows	  estimates	  of	  unadjusted	  and	  
adjusted	  CRC	  testing	  and	  screening	  rates	  by	  MCC	  status	  for	  the	  full	  study	  population.	  	  	  
	  
	   	  
	  
In	  the	  subpopulation	  of	  respondents	  ages	  50-­‐64	  reporting	  ACS	  guideline	  
adherent	  screening,	  true	  screening	  rates	  were	  higher	  in	  the	  general	  population	  than	  in	  
those	  with	  MCC	  (79.94%	  versus	  77.03%).	  	  The	  highest	  rates	  of	  true	  screening	  were	  in	  
those	  with	  no	  MCC	  at	  84.08%.	  	  The	  difference	  in	  rates	  between	  those	  with	  and	  without	  
MCC	  was	  statistically	  significant	  (p	  <	  .0001).	  
Applying	  the	  subpopulation	  true	  screening	  rates	  to	  the	  full	  study	  population,	  
true	  screening	  rates	  in	  the	  full	  study	  population	  were	  estimated	  to	  be	  41.08%	  after	  
accounting	  for	  the	  impetus	  for	  testing.	  	  Similar	  to	  recommendation	  results,	  the	  adjusted	  
population	  rate	  of	  true	  screening	  was	  lower	  in	  those	  without	  MCC	  (37.62%)	  and	  higher	  
Table&4.4.&&Weighted&Estimates&of&True&Screening&Rates&and&Diagnostic&Testing&Rates&for&Subpopulation&B&
n True&Screening&&% CI&of&% Diagnostic&Testing&% CI&of&%
Rao@Scott&
Chi@Square Pr&>&ChiSq
Subpopulation+B 2168 79.94 (77.96,+81.92) 20.06 (18.08,+22.04)
091+Multiple+Chronic+Conditions+(MCC+=+no)900 84.08 (81.47,+86.68) 15.92 (13.32,+18.53) 16.37 <.0001







Full$Study$Population$(n$missing$=$40) 4315 51.39 (49.63,$53.15) 41.08 $
$
0?1$Multiple$Chronic$Conditions$(MCC$=$no) 2058 44.74 (42.36,$47.12) 68.41 <.0001 37.62 (35.62,$39.62) 5.31 <.0001
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in	  those	  with	  MCC	  (44.21%).	  After	  adjustment,	  only	  those	  with	  zero	  chronic	  conditions	  
had	  true	  screening	  rates	  lower	  than	  the	  full	  study	  population,	  due	  in	  large	  part	  by	  the	  
higher	  rate	  of	  any	  ACS	  guideline	  adherent	  testing	  in	  respondents	  with	  MCC.	  	  Again,	  the	  
difference	  between	  those	  with	  and	  without	  MCC	  was	  statistically	  significant	  (p	  <	  .0001).	  
Multivariate	  Logistic	  Regression	  Modeling	  
	   Table	  4.6	  provides	  estimated	  odds	  ratios	  from	  multivariate	  logistic	  regression	  
models	  predicting	  true	  screening	  recommendations	  in	  Subpopulation	  A.	  	  Table	  4.7	  
provides	  estimated	  odds	  ratios	  from	  multivariate	  logistic	  regression	  models	  predicting	  
true	  screening	  in	  Subpopulation	  B.	  	  	  
Our	  primary	  interest	  in	  these	  analyses	  was	  to	  determine	  whether	  MCC	  accounts	  
for	  any	  of	  the	  effects	  demonstrated	  in	  the	  CRC	  screening	  recommendation	  and	  CRC	  
screening	  literature	  to	  date,	  namely	  effects	  of	  race/ethnicity,	  age,	  sex,	  education,	  
poverty	  ratio,	  insurance	  coverage,	  and	  a	  usual	  source	  of	  health	  care.	  For	  these	  analyses,	  
we	  used	  multivariate	  logistic	  regression	  to	  compare	  estimates	  of	  these	  effects	  in	  
modeling	  both	  outcomes	  without	  MCC	  and	  with	  MCC.	  	  In	  contrast	  to	  other	  regression	  
approaches,	  we	  were	  not	  seeking	  to	  identify	  a	  ‘best	  fit’	  model,	  therefore	  tests	  of	  
interactions	  were	  not	  performed	  and	  all	  main	  effects	  remained	  in	  both	  models	  
irrespective	  of	  statistical	  significance.	  Despite	  this	  not	  being	  a	  ‘best	  fit’	  model,	  it	  is	  of	  
interest	  to	  note	  that	  controlling	  for	  other	  covariates,	  MCC	  was	  statistically	  significant	  at	  
the	  p	  <	  .02	  level	  and	  negatively	  associated	  with	  the	  odds	  of	  reporting	  a	  true	  screening	  
recommendation,	  with	  an	  adjusted	  odds	  ratio	  of	  0.754	  (CI	  [0.605,	  0.941],	  p	  =	  0.0123)	  
and	  statistically	  significant	  at	  the	  p	  <	  .01	  level	  and	  negatively	  associated	  with	  the	  odds	  of	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reporting	  true	  screening,	  with	  an	  adjusted	  odds	  ratio	  of	  0.642	  (CI	  [0.504,	  0.818],	  p	  =	  
0.0003).	  	  All	  odds	  ratio	  estimates	  reported	  reflect	  statistical	  adjustment	  for	  other	  
covariates	  in	  the	  multivariate	  model.	  
	   True	  Screening	  Recommendations.	  
In	  the	  models	  predicting	  true	  screening	  recommendations,	  comparing	  models	  
without	  and	  with	  MCC	  we	  find	  that	  MCC	  has	  little	  effect	  on	  the	  adjusted	  odds	  ratios	  of	  
other	  covariates.	  	  Race/ethnicity	  and	  age	  effects	  increased	  slightly	  with	  MCC	  in	  the	  
model	  but	  both	  remained	  statistically	  significant	  across	  models.	  	  NHB	  were	  more	  likely	  
to	  report	  a	  true	  screening	  recommendation	  than	  their	  NHW	  counterparts.	  	  Older	  age	  
was	  only	  slightly	  associated	  with	  the	  outcome.	  	  The	  effect	  of	  sex	  increased	  slightly	  in	  
models	  with	  MCC	  and	  remained	  statistically	  significant.	  	  Males	  were	  more	  likely	  than	  
females	  to	  report	  a	  true	  screening	  recommendation.	  	  	  
The	  effects	  of	  characteristics	  of	  socioeconomic	  status	  varied	  across	  models.	  	  
Global	  tests	  for	  education	  showed	  that	  the	  effect	  was	  not	  statistically	  significant	  in	  
either	  model,	  while	  global	  tests	  for	  poverty	  ratio	  showed	  stable	  statistical	  significance	  
across	  models,	  with	  a	  stronger	  effect	  on	  the	  outcome	  in	  the	  model	  with	  MCC.	  	  As	  the	  
ratio	  of	  family	  income	  to	  poverty	  threshold	  increased,	  so,	  too,	  did	  odds	  of	  reporting	  a	  
true	  physician	  recommendation.	  	  Neither	  insurance	  coverage	  nor	  source	  of	  usual	  care	  
was	  statistically	  significant	  in	  any	  model	  and	  both	  varied	  only	  slightly	  across	  models	  
without	  and	  with	  MCC.	  
	   True	  Screening.	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Comparing	  models	  without	  and	  with	  MCC,	  we	  found	  again	  that	  MCC	  had	  little	  
effect	  on	  the	  adjusted	  odds	  ratios	  of	  other	  covariates	  in	  the	  model.	  	  Race/ethnicity	  was	  
significant	  at	  the	  p	  	  <	  .001	  level	  across	  all	  models,	  and	  the	  effect	  was	  slightly	  higher	  in	  
models	  with	  MCC	  versus	  without	  MCC.	  	  NHB	  were	  more	  likely	  than	  NHW	  to	  report	  true	  
screening	  across	  both	  models.	  	  Age	  remained	  statistically	  significant	  across	  models,	  with	  
mild	  positive	  effects	  on	  the	  likelihood	  of	  true	  screening	  as	  age	  increases.	  Sex	  effects	  
were	  slightly	  attenuated	  with	  MCC	  in	  the	  model	  but	  remained	  statistically	  significant	  
across	  all	  models.	  	  Males	  were	  more	  likely	  to	  report	  true	  screening	  than	  females.	  
Characteristics	  of	  socioeconomic	  status	  had	  varying	  levels	  of	  association	  with	  
true	  screening.	  	  Global	  tests	  for	  education	  show	  that	  the	  effect	  was	  highly	  significant	  in	  
the	  model	  without	  MCC,	  but	  no	  longer	  statistically	  significant	  in	  the	  model	  with	  MCC.	  	  
Global	  tests	  for	  poverty	  ratio	  show	  stable	  statistical	  significance	  across	  models,	  with	  an	  
attenuated	  effect	  on	  the	  outcome	  in	  models	  with	  MCC.	  	  Finally,	  insurance	  coverage	  was	  
not	  statistically	  significant	  in	  any	  model.	  
Features	  of	  the	  health	  care	  system	  had	  positive	  associations	  with	  the	  odds	  of	  
true	  screening.	  	  Although	  the	  presence	  of	  a	  usual	  source	  of	  health	  care	  was	  statistically	  
significant	  at	  the	  p	  <	  .02	  level	  in	  each	  of	  the	  models,	  however,	  a	  physician	  
recommendation	  was	  not	  statistically	  significant	  in	  predicting	  true	  screening	  in	  any	  of	  
the	  regression	  models.	  
	  




Predictor* Category OR t&for&H0 Pr&>&|t| OR t&for&H0 Pr&>&|t| %&Change&(OR)
intercept 0.469 0.232 0.949 /2.1 0.0354 0.568 0.277 1.168 /1.54 0.124 21%
MCCCat Yes 0.754 0.605 0.941 /2.5 0.0123
Race/Ethnicity Non/Hispanic?Black 1.749 1.279 2.392 3.5 0.0005 1.766 1.291 2.414 3.56 0.0004 1%
Age Centered?Age?(57) 1.048 1.022 1.074 3.66 0.0003 1.053 1.026 1.080 3.93 <.0001 1%
Sex Male 1.605 1.302 1.979 4.43 <.0001 1.573 1.278 1.937 4.28 <.0001 /2%
Education High?School?Graduate?or?GED 1.756 1.121 2.749 2.46 0.0139 1.726 1.102 2.703 2.38 0.0172 /2%
Some?College?(no?degree)?or?Associates?Degree 1.608 1.065 2.426 2.26 0.0238 1.573 1.042 2.374 2.16 0.0309 /2%
Bachelor's?Degree 1.534 0.920 2.558 1.64 0.1008 1.480 0.888 2.468 1.51 0.1323 /3%
Master's,?Professional?or?Doctorate 1.517 0.917 2.509 1.62 0.1044 1.438 0.868 2.383 1.41 0.1586 /5%
Poverty?Ratio Medium?Tertile 1.539 1.108 2.137 2.57 0.0101 1.485 1.064 2.073 2.33 0.02 /3%
High?Tertile 2.449 1.782 3.366 5.53 <.0001 2.317 1.672 3.210 5.05 <.0001 /5%
Insurance Covered 1.546 0.941 2.541 1.72 0.0858 1.578 0.953 2.612 1.77 0.076 2%







Predictor* Category OR t&for&H0 Pr&>&|t| OR t&for&H0 Pr&>&|t| %&Change&(OR)
intercept 0.446 0.208 0.956 02.08 0.0380 0.576 0.268 1.236 01.42 0.1568 29%
MCCCat Yes 0.642 0.504 0.818 03.59 0.0003
Race/Ethnicity Non0Hispanic?Black 1.956 1.348 2.838 3.53 0.0004 1.974 1.355 2.874 3.55 0.0004 1%
Age Centered?Age?(57) 1.052 1.023 1.082 3.59 0.0003 1.061 1.031 1.091 4.09 <.0001 1%
Sex Male 1.581 1.240 2.016 3.7 0.0002 1.539 1.207 1.960 3.48 0.0005 03%
Education High?School?Graduate?or?GED 1.570 1.005 2.454 1.98 0.0476 1.508 0.963 2.362 1.79 0.0727 04%
Some?College?(no?degree)?or?Associates?Degree 1.556 1.024 2.367 2.07 0.0386 1.494 0.985 2.266 1.89 0.0588 04%
Bachelor's?Degree 1.663 1.011 2.736 2 0.0453 1.559 0.946 2.571 1.74 0.0816 06%
Master's,?Professional?or?Doctorate 1.356 0.810 2.271 1.16 0.2469 1.233 0.743 2.046 0.81 0.418 09%
Poverty?Ratio Medium?Tertile 1.374 0.991 1.905 1.91 0.0563 1.309 0.941 1.820 1.6 0.1098 05%
High?Tertile 1.919 1.377 2.675 3.86 0.0001 1.785 1.273 2.503 3.37 0.0008 07%
Insurance Covered 1.302 0.797 2.129 1.05 0.2919 1.327 0.799 2.202 1.09 0.274 2%
Usual?Source?of?Health?Care Yes 1.965 1.115 3.463 2.34 0.0194 2.089 1.167 3.738 2.48 0.0132 6%
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Discussion	  
	   Our	  primary	  goal	  in	  this	  study	  was	  to	  examine	  the	  role	  that	  MCC	  has	  on	  two	  
behavioral	  outcomes	  in	  CRC	  screening:	  	  a	  physician	  recommendation	  to	  screen	  and	  
engagement	  with	  screening	  itself.	  	  Although	  we	  found	  that	  rates	  of	  referrals	  for	  
diagnostic	  testing	  and	  diagnostic	  testing	  itself	  were	  higher	  in	  those	  with	  MCC,	  overall	  
rates	  of	  both	  outcomes	  are	  unexpectedly	  higher	  in	  those	  with	  MCC	  when	  compared	  to	  
those	  without.	  	  Our	  secondary	  goal	  was	  to	  explore	  how	  the	  presence	  of	  MCC	  in	  
multivariate	  models	  changes	  the	  association	  of	  key	  predictors	  with	  the	  odds	  of	  both	  
outcomes.	  	  Multivariate	  logistic	  regression	  models	  revealed	  that	  although	  MCC	  does	  not	  
account	  for	  much	  of	  the	  effect	  of	  sociodemographic	  variables,	  it	  is	  negatively	  associated	  
with	  both	  outcomes,	  adjusting	  for	  other	  covariates	  in	  the	  model.	  
	   Comparing	  our	  results	  to	  those	  described	  earlier,	  we	  hypothesize	  that	  the	  
contradictory	  outcomes	  in	  rates	  are	  due	  to	  the	  difference	  in	  outcome	  variable	  
specification.	  	  We	  have	  estimated	  rates	  of	  true	  screening	  recommendations	  and	  true	  
screening	  for	  the	  full	  population,	  while	  other	  studies	  typically	  conflate	  diagnostic	  testing	  
(and	  referrals)	  with	  true	  screening	  (and	  recommendations).	  	  And	  while	  our	  multivariate	  
models	  were	  not	  fitted	  to	  a	  ‘best	  fit’	  model,	  the	  adjusted	  odds	  ratios	  associated	  with	  
MCC	  in	  models	  of	  both	  outcomes	  merit	  the	  attention	  of	  future	  research.	  	  	  
This	  study	  is	  subject	  to	  some	  unavoidable	  limitations.	  	  First,	  we	  analyzed	  data	  
collected	  in	  2008,	  as	  analyses	  began	  as	  the	  2010	  survey	  was	  being	  released.	  	  2008	  data	  
remained	  the	  best	  option,	  however,	  due	  to	  its	  specificity	  with	  its	  questions	  pertaining	  to	  
physician	  recommendations.	  	  A	  general	  limitation	  of	  using	  NHIS	  data	  is	  the	  inability	  to	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conduct	  analyses	  by	  geographic	  region	  with	  much	  certainty;	  other	  data	  collected	  by	  
state-­‐level	  entities	  such	  as	  the	  Department	  of	  Public	  Health	  or	  data	  that	  are	  
representative	  to	  each	  state’s	  population	  (including	  BRFSS	  data)	  would	  be	  more	  
appropriate.	  	  CRC	  screening	  rates	  vary	  considerably	  by	  state,	  and	  within	  state	  by	  county;	  
this	  variation	  should	  be	  considered	  in	  future	  studies	  of	  CRC	  screening	  (Rim	  et	  al.,	  2011;	  
Weir	  et	  al.,	  2003).	  
Common	  to	  survey	  data,	  NHIS	  data	  are	  subject	  to	  recall	  bias	  on	  the	  part	  of	  the	  
respondents	  for	  both	  dependent	  and	  independent	  variables.	  	  Prior	  studies	  have	  found	  
that	  self-­‐report	  of	  CRC	  screening	  behaviors	  and	  MCC	  are	  demonstrated	  to	  be	  moderate	  
to	  high	  in	  both	  sensitivity	  and	  specificity	  with	  no	  clear	  patterns	  in	  differences	  in	  the	  
accuracy	  of	  self-­‐report	  by	  age,	  sex,	  race	  or	  family	  history	  (Baier	  et	  al.,	  2000;	  Martin,	  Leff,	  
Calonge,	  Garrett,	  &	  Nelson,	  2000).	  	  Another	  potential	  source	  of	  bias	  in	  this	  study	  is	  
selection	  bias	  due	  to	  differential	  nonresponse	  among	  specific	  subgroups	  of	  individuals,	  
which	  is	  addressed	  via	  nonresponse	  adjustments	  of	  the	  weights	  provided	  by	  NHIS	  to	  
survey	  analysts	  (Centers	  for	  Disease	  Control	  and	  Prevention,	  2012).	  	  In	  addition,	  there	  
may	  be	  differential	  bias	  in	  comprehension	  of	  survey	  questions.	  	  Differential	  
interpretation	  of	  questions	  by	  race,	  gender,	  and	  socioeconomic	  status	  may	  explain	  some	  
of	  our	  findings.	  	  However,	  the	  pivotal	  questions	  of	  interest	  were	  follow-­‐up	  questions	  to	  
screening	  responses.	  	  These	  questions	  received	  very	  little	  attention	  in	  cognitive	  testing,	  
as	  the	  majority	  of	  the	  cognitive	  testing	  subjects	  (which	  numbered	  only	  9	  over	  age	  40)	  
indicated	  they	  did	  not	  undergo	  CRC	  testing,	  resulting	  in	  little	  to	  no	  cognitive	  testing	  on	  
the	  follow-­‐up	  questions	  (B.	  Taylor,	  personal	  communication,	  June	  17,	  2014).	  	  Our	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practice	  of	  deriving	  full	  population	  rates	  using	  estimates	  from	  unadjusted	  testing	  rates	  
and	  adjusted	  true	  screening	  and	  true	  screening	  recommendation	  rates	  of	  the	  
subpopulation	  resulted	  in	  estimates	  that	  may	  have	  confidence	  intervals	  narrower	  than	  
what	  they	  should	  be.	  	  This	  is	  due	  to	  the	  fact	  that	  we	  are	  unable	  to	  account	  for	  the	  fact	  
that	  we	  are	  treating	  the	  rates	  used	  in	  estimation	  as	  fixed	  when	  it	  is,	  in	  fact,	  an	  estimate.	  	  
The	  confidence	  intervals	  for	  the	  true	  screening	  and	  true	  screening	  recommendation	  
rates	  of	  the	  full	  population	  exclude	  the	  variance	  estimates	  of	  the	  true	  screening	  and	  
true	  screening	  recommendation	  rates	  of	  the	  study’s	  subpopulation.	  Therefore,	  the	  
resulting	  tests	  of	  statistical	  significance	  will	  be	  more	  likely	  to	  show	  statistical	  significance	  
than	  they	  would	  have	  had	  the	  results	  not	  been	  derived	  from	  two	  estimates.	  	  In	  the	  
future,	  researchers	  should	  explore	  the	  use	  of	  jackknifing	  as	  a	  tool	  to	  incorporate	  the	  
variance	  of	  both	  estimates	  when	  calculating	  confidence	  intervals	  and	  resulting	  statistical	  
tests	  for	  the	  full	  population.	  
The	  artificiality	  of	  the	  measurement	  and	  cutpoints	  of	  MCC	  may	  be	  seen	  as	  a	  
limitation	  to	  this	  study,	  as	  a	  chronic	  disease	  count	  does	  not	  reveal	  information	  to	  
support	  or	  refute	  the	  hypothesized	  mechanisms	  of	  influence,	  including	  competing	  
demands	  in	  the	  clinical	  encounter	  and	  diminished	  individual	  resources	  to	  complete	  
screening.	  	  However,	  in	  an	  effort	  to	  be	  consistent	  with	  existing	  literature	  in	  other	  cancer	  
screening	  modalities	  as	  well	  as	  federal	  initiatives,	  it	  will	  be	  important	  to	  maintain	  the	  
measurement	  and	  cutpoints	  as	  proposed,	  and	  allow	  future	  qualitative	  and	  quantitative	  
research	  to	  determine	  alternative	  ways	  of	  measuring	  and	  operationalizing	  chronic	  
disease	  burden	  in	  this	  population.	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Finally,	  no	  measure	  of	  availability	  of	  services	  is	  being	  incorporated	  into	  these	  
analyses,	  as	  variables	  of	  interest	  are	  limited	  to	  those	  at	  the	  individual	  level.	  	  Clearly,	  
structural	  factors	  such	  as	  health	  care	  policy	  (including	  mandated	  insurance	  coverage	  of	  
CRC	  screening),	  physician	  supply	  and	  market	  conditions	  (e.g.	  availability	  of	  technology)	  
are	  relevant	  to	  both	  screening	  recommendations	  and	  services;	  however,	  these	  
structural	  factors	  are	  beyond	  the	  scope	  of	  the	  present	  study.	  	  	  
To	  our	  knowledge,	  this	  is	  the	  first	  study	  to	  explore	  the	  impact	  of	  MCC	  on	  CRC	  
screening	  outcomes	  using	  a	  nationally	  representative	  survey	  sample.	  	  The	  results	  of	  this	  
study	  are	  highly	  relevant	  to	  both	  researchers	  and	  practitioners.	  As	  we	  face	  a	  growing	  
population	  with	  MCC	  in	  the	  future,	  understanding	  how	  MCC	  creates	  individual	  and	  
institutional	  context	  in	  cancer	  screening	  behaviors	  will	  become	  critical.	  For	  researchers,	  
it	  will	  be	  important	  to	  develop	  and	  test	  measures	  that	  can	  accurately	  assess	  chronic	  
disease	  burden.	  	  Studies	  on	  MCC	  burden	  show	  linear	  associations	  between	  MCC	  and	  
individual	  economic	  burdens,	  frequency	  of	  health	  care	  interaction	  and	  other	  related	  
outcomes	  (Anderson,	  2010;	  US	  Department	  of	  Health	  &	  Human	  Services,	  2011).	  	  
However,	  there	  is	  little	  consistency	  across	  studies	  with	  respect	  to	  the	  approach	  to	  
measuring	  chronic	  disease	  burden.	  A	  measure	  that	  can	  capture	  the	  burden	  of	  chronic	  
disease	  on	  individuals’	  social,	  financial,	  and	  physical	  resources	  and	  on	  the	  ways	  in	  which	  
they	  engage	  with	  the	  health	  care	  system	  will	  be	  useful	  in	  future	  studies	  in	  cancer	  
screening	  and	  other	  preventative	  health	  behaviors.	  	  	  
At	  the	  institutional	  level,	  our	  evidence	  supports	  consideration	  for	  shifting	  the	  
responsibility	  of	  physician	  recommendation	  delivery	  to	  all	  health	  care	  providers.	  	  In	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most	  cases,	  this	  responsibility	  of	  cancer	  screening	  recommendations	  falls	  solely	  on	  
primary	  care	  physicians,	  which	  is	  useful	  for	  patients	  using	  primary	  care	  for	  preventative	  
health	  care.	  However,	  we	  know	  that	  patients	  with	  MCC	  use	  the	  health	  care	  system	  
differently	  and	  more	  frequently	  than	  their	  healthier	  counterparts	  including	  a	  shift	  in	  use	  
from	  primary	  care	  to	  more	  frequent	  specialty	  or	  emergency	  care	  (Kane,	  Priester,	  &	  
Totten,	  2005;	  Vogeli	  et	  al.,	  2007).	  Furthermore,	  when	  patients	  with	  MCC	  visit	  their	  
primary	  care	  provider,	  the	  short	  time	  afforded	  to	  their	  visit	  may	  be	  spent	  in	  discussions	  
of	  issues	  related	  to	  their	  multiple	  chronic	  conditions	  such	  as	  visits	  with	  specialists,	  new	  
medications,	  mental	  health	  concerns	  and	  other	  disease-­‐related	  care,	  rather	  than	  
preventative	  care	  (Anderson,	  2010;	  Gonzalez	  et	  al.,	  2001;	  Messina,	  2011).	  	  The	  potential	  
for	  improvement	  in	  recommendation	  and	  screening	  rates	  in	  this	  growing	  population	  
starts	  with	  increasing	  the	  opportunities	  for	  cancer	  screening	  counseling	  by	  promoting	  
recommendations	  outside	  of	  primary	  care	  including	  emergency	  care,	  specialty	  care,	  and	  
non-­‐traditional	  sources	  of	  health	  care.	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Colorectal	  cancer	  is	  largely	  preventable	  through	  the	  early	  detection	  of	  pre-­‐
cancerous	  polyps,	  yet	  estimates	  of	  population	  screening	  rates	  are	  far	  below	  a	  level	  that	  
will	  prevent	  an	  increasing	  burden	  of	  morbidity	  and	  mortality	  from	  the	  disease.	  Accurate	  
assessment	  of	  screening	  is	  critical	  as	  we	  design	  interventions	  to	  promote	  screening	  and	  
improve	  population	  health.	  
An	  often-­‐cited	  limitation	  of	  CRC	  screening	  research	  is	  the	  conflation	  of	  diagnostic	  
testing	  and	  true	  screening.	  	  To	  my	  knowledge,	  this	  is	  the	  first	  study	  to	  measure	  the	  
impact	  of	  this	  limitation	  on	  population	  screening	  rates,	  rates	  of	  physician	  
recommendations	  and	  across	  sociodemographic	  groups.	  	  I	  hypothesized	  that	  conflation	  
of	  diagnostic	  testing	  and	  true	  screening	  would	  result	  in	  overestimated	  screening	  rates	  
and	  that	  the	  overestimation	  would	  be	  higher	  in	  those	  with	  less	  socioeconomic	  and	  
social	  privilege.	  	  The	  results	  support	  these	  hypotheses	  and	  demonstrate	  not	  only	  
significant	  overestimation	  of	  rates,	  but	  also	  substantial	  variation	  in	  rates	  of	  
overestimation	  across	  levels	  of	  privilege.	  	  For	  both	  screening	  and	  recommendations,	  it	  is	  
clear	  from	  these	  studies	  that	  the	  omission	  of	  two	  questions,	  ‘why	  did	  you	  engage	  in	  
screening?’	  	  and	  ‘why	  did	  your	  physician	  recommend	  the	  screening	  test?’,	  results	  in	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gross	  overestimation	  of	  screening	  and	  recommendation	  rates	  and	  false	  impressions	  
about	  predictors	  of	  screening	  and	  screening	  recommendations.	  	  	  
To	  improve	  public	  health,	  we	  must	  increase	  rates	  of	  true	  screening.	  	  Conflating	  
diagnostic	  testing	  and	  true	  screening	  when	  researchers	  specify	  behavioral	  outcomes	  is	  
misguided,	  as	  these	  are	  distinct	  behaviors.	  	  Diagnostic	  testing	  is	  important	  to	  determine	  
the	  causes	  of	  symptoms;	  however,	  true	  screening	  at	  the	  pre-­‐symptomatic	  stage	  is	  what	  
will	  improve	  population	  health.	  	  Measuring	  both	  and	  calling	  them	  both	  screening	  is	  
wrong,	  and	  leads	  to	  highly	  problematic	  overestimation	  of	  true	  screening	  rates.	  	  By	  
failing	  to	  distinguish	  the	  two	  behaviors,	  accepting	  the	  BRFSS	  limitation,	  and	  
disseminating	  rates,	  trends	  and	  disparities	  data	  based	  on	  it,	  the	  research	  community	  is	  
misinforming	  researchers,	  practitioners,	  policymakers	  and	  the	  American	  public	  about	  
the	  nature	  of	  the	  underutilization	  of	  screening.	  
When	  researchers	  conflated	  diagnostic	  testing	  and	  true	  screening	  in	  existing	  
research,	  their	  results	  masked	  several	  unexpected	  findings	  discovered	  in	  these	  studies.	  	  
Contrary	  to	  the	  results	  noted	  in	  published	  literature	  that	  shows	  advantages	  for	  NHW	  
and	  women,	  my	  study	  shows	  that	  NHW	  women	  engaged	  in	  the	  highest	  rate	  of	  
diagnostic	  testing.	  	  Using	  BRFSS	  methodology	  and	  ignoring	  the	  distinction	  between	  
diagnostic	  testing	  and	  true	  screening,	  the	  advantage	  over	  NHB	  women	  significantly	  less	  
than	  when	  the	  outcome	  is	  correctly	  specified	  (9.98%	  versus	  16.78%).	  This	  type	  of	  error	  
is	  easily	  corrected	  at	  the	  survey	  level	  for	  future	  research,	  but	  the	  mistake	  is	  not	  easily	  
adjusted	  as	  we	  look	  back	  at	  past	  research,	  since	  the	  rate	  of	  overestimation	  due	  to	  
conflation	  varies	  greatly	  across	  subgroups.	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I	  also	  found	  that	  the	  misspecification	  of	  the	  outcome	  significantly	  changed	  the	  
degree	  to	  which	  established	  predictors	  of	  screening	  were	  predictive	  of	  true	  screening.	  	  I	  
hypothesized	  that	  predictors	  of	  the	  outcome	  would	  change	  in	  magnitude	  when	  the	  
model	  is	  correctly	  specified,	  but	  I	  did	  not	  expect	  that	  the	  model	  would	  change	  so	  
drastically.	  	  Specifically,	  both	  aspects	  of	  health	  care	  delivery	  –	  the	  physician	  
recommendation	  and	  a	  usual	  source	  of	  health	  care	  –	  were	  predictive	  of	  any	  ACS	  
guideline	  adherent	  testing	  but	  were	  insignificant	  in	  the	  model	  of	  true	  screening	  
behaviors.	  	  Overall,	  the	  results	  challenge	  the	  status	  quo	  of	  accepting	  limitations	  that	  are	  
preventable	  by	  more	  effective	  survey	  design.	  	  Some	  limitations	  are	  unavoidable	  –	  but	  
the	  conflation	  of	  diagnostic	  testing	  with	  true	  screening	  is	  solved	  by	  the	  addition	  of	  two	  
question	  –	  ‘why	  did	  you	  engage	  in	  screening?’	  	  and	  ‘why	  did	  your	  physician	  recommend	  
the	  screening	  test?’.	  
The	  results	  of	  both	  studies	  reveal	  that	  NHW	  females	  are	  the	  most	  likely	  to	  
engage	  in,	  and	  receive	  referrals	  for,	  diagnostic	  testing.	  	  These	  results	  are	  perplexing,	  as	  
they	  are	  inconsistent	  with	  research	  on	  health	  care	  utilization	  and	  patterning	  of	  CRC	  
disease.	  	  With	  respect	  to	  health	  care	  utilization	  and	  gender,	  research	  has	  shown	  that	  
women	  are	  more	  likely	  to	  use	  preventative	  and	  curative	  health	  care	  services	  than	  their	  
male	  counterparts	  (Green	  &	  Pope,	  1999;	  Bertakis	  et	  al.,	  2000).	  	  I	  expected	  that	  females’	  
engagement	  with	  true	  CRC	  screening,	  not	  diagnostic	  testing,	  might	  be	  higher.	  	  Instead,	  I	  
found	  that	  females	  reported	  higher	  rates	  of	  diagnostic	  testing	  than	  their	  male	  
counterparts.	  	  Higher	  diagnostic	  testing	  rates	  in	  women	  across	  both	  race/ethnicity	  
groups	  may	  suggest	  differences	  in	  diagnostic	  testing	  patterns	  due	  to	  physiological	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differences	  (including	  higher	  risk	  of	  abdominal	  pain	  and	  chronic	  GI	  disease).	  In	  health	  
care	  utilization	  patterning,	  we	  typically	  find	  a	  higher	  level	  of	  engagement	  with	  the	  
health	  care	  system	  in	  NHW	  when	  compared	  to	  NHB,	  particularly	  in	  older	  adults.	  	  I	  
expected	  that	  this	  would	  result	  in	  higher	  rate	  estimates	  of	  true	  screening;	  instead,	  I	  
found	  higher	  rates	  of	  diagnostic	  testing	  and	  referrals	  in	  NHW	  despite	  these	  high	  
diagnostic	  testing	  rates,	  they	  had	  higher	  true	  screening	  rates	  than	  NHB	  females.	  	  
Although	  these	  results	  may	  reflect	  gender-­‐specific	  differences	  in	  study	  measure	  
conceptualizations,	  specifically	  differences	  between	  true	  screening	  and	  diagnostic	  
testing,	  these	  differences	  would	  not	  likely	  account	  for	  the	  combination	  of	  gender	  and	  
race/ethnicity	  contributions	  to	  the	  pre-­‐	  and	  post-­‐adjustment	  rate	  differences.	  	  Instead,	  
we	  hypothesize	  that	  differential	  perceptions	  of	  risk	  across	  gender	  and	  race/ethnicity	  
groups	  may	  be	  a	  significant	  contributor	  to	  these	  findings.	  	  Prior	  research	  has	  often	  
focused	  on	  the	  higher	  burden	  of	  CRC	  in	  males	  and	  in	  NHB	  populations.	  	  This	  may	  be	  
contributing	  to	  a	  much	  lower	  perception	  of	  risk,	  both	  on	  the	  part	  of	  the	  patient	  and	  her	  
health	  care	  provider,	  for	  NHW	  females.	  Therefore,	  rather	  than	  engaging	  in	  true	  
screening,	  NHW	  females	  are	  more	  likely	  than	  their	  male	  and	  NHB	  counterparts	  to	  
engage	  in	  diagnostic	  testing	  after	  symptoms	  are	  present.	  	  It	  will	  be	  important	  to	  explore	  
perceptions	  of	  risk	  in	  these	  populations,	  and	  in	  their	  health	  care	  providers,	  as	  we	  seek	  to	  
determine	  best	  practices	  for	  multilevel	  interventions	  to	  increase	  true	  screening	  rates.	  
Although	  this	  study	  sample	  is	  comprised	  of	  individuals	  without	  a	  history	  of	  CRC,	  I	  
would	  expect	  the	  patterning	  of	  diagnostic	  testing	  versus	  true	  screening	  behaviors	  to	  
correspond	  with	  patterns	  by	  gender	  and	  race/ethnicity	  in	  CRC	  incidence	  and	  stage	  at	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diagnosis.	  For	  example,	  CRC	  incidence	  and	  mortality	  are	  significantly	  higher	  for	  men	  
than	  women	  across	  race/ethnicity	  groups	  (American	  Cancer	  Society,	  2011).	  	  	  Based	  on	  
morbidity	  and	  mortality	  data,	  	  I	  would	  therefore	  expect	  that	  males	  engage	  in	  more	  
diagnostic	  testing	  than	  their	  female	  counterparts.	  	  Instead,	  the	  estimates	  show	  that	  
females	  are	  more	  likely	  to	  engage	  in,	  and	  receive	  referrals	  for,	  diagnostic	  testing.	  	  With	  
respect	  to	  gender	  and	  stage	  at	  diagnosis,	  there	  is	  little	  evidence	  of	  differences	  between	  
race/ethnicity	  groups;	  I	  only	  find	  differences	  between	  groups	  by	  race/ethnicity	  
(American	  Cancer	  Society,	  2011).	  	  This	  suggests	  that	  the	  higher	  rate	  of	  diagnostic	  testing	  
in	  NHW	  females	  may	  be	  the	  result	  of	  other	  factors	  and	  merits	  further	  study.	  
NHB	  suffer	  a	  significantly	  higher	  burden	  of	  CRC	  incidence	  and	  mortality	  when	  
compared	  to	  their	  NHW	  counterparts;	  compared	  to	  Whites,	  NHB	  are	  less	  likely	  to	  be	  
diagnosed	  at	  the	  earliest,	  most	  treatable,	  stage	  of	  CRC	  disease	  (American	  Cancer	  
Society,	  2011).	  	  I	  would	  therefore	  expect	  to	  see	  higher	  diagnostic	  testing	  estimates	  in	  
NHB,	  as	  screening	  is	  most	  often	  associated	  with	  earlier	  stage	  at	  diagnosis.	  	  Instead,	  the	  
estimates	  reveal	  higher	  rates	  of	  diagnostic	  testing	  in	  NHW.	  	  Despite	  the	  higher	  rates	  of	  
diagnostic	  testing,	  true	  screening	  rates	  of	  NHW	  remained	  higher	  than	  NHB,	  but	  the	  
disparity	  was	  much	  less	  after	  adjustment	  for	  the	  impetus	  for	  testing.	  	  These	  results	  
suggest	  that	  the	  diagnostic	  testing	  in	  NHW	  may	  not	  contribute	  to	  increased	  disease	  risk	  
and	  instead	  may	  represent	  a	  benign	  difference	  in	  diagnostic	  test	  utilization.	  	  However,	  
this	  cannot	  be	  fully	  explored	  until	  we	  collect	  and	  analyze	  screening/diagnostic	  testing	  
data	  on	  individuals	  who	  have	  been	  diagnosed	  with	  CRC.	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A	  full	  explanation	  for	  both	  of	  these	  unexpected	  results	  can	  not	  be	  ascertained	  
through	  this	  type	  inquiry.	  	  Instead,	  the	  results	  provide	  strong	  motivation	  for	  future	  work	  
utilizing	  both	  qualitative	  and	  quantitative	  analytic	  approaches.	  	  Qualitatively,	  
understanding	  psychosocial	  and	  instrumental	  barriers	  and	  facilitators	  across	  
demographic	  groups	  is	  critical	  to	  the	  design	  and	  implementation	  of	  effective	  
interventions.	  	  Interventions	  based	  on	  prior	  ‘screening’	  data	  need	  to	  be	  reconsidered,	  as	  
these	  data	  provided	  false	  estimates	  across	  sociodemographic	  groups	  and	  under-­‐	  and	  
overestimated	  differences	  between	  and	  within	  groups.	  	  Engaging	  a	  wide	  range	  of	  
subjects	  in	  qualitative	  research	  spanning	  sociodemographic	  groups	  and	  intersections	  
(e.g.	  race/ethnicity	  and	  poverty	  ratio)	  will	  help	  as	  we	  attempt	  to	  fully	  elucidate	  the	  
mechanisms	  contributing	  to	  our	  findings,	  particular	  those	  findings	  that	  are	  contradictory	  
to	  the	  help-­‐seeking	  and	  CRC	  risk	  literature.	  	  In	  addition	  to	  suggestions	  already	  
articulated	  herein,	  quantitative	  approaches	  also	  require	  a	  more	  critical	  approach	  to	  
subject	  selection,	  ensuring	  adequate	  representation	  from	  respondents	  across	  
sociodemographic	  groups	  and	  intersections	  of	  race/ethnicity	  and	  socioeconomic	  status.	  	  
Furthermore,	  surveys	  of	  health	  care	  providers	  (including	  providers	  outside	  of	  primary	  
care)	  will	  be	  useful	  as	  we	  determine	  if	  perceived	  risk	  and	  perceived	  adherence	  to	  
screening	  recommendations	  contribute	  to	  the	  patterns	  in	  our	  results.	  
My	  third	  study	  is	  in	  response	  to	  the	  narrow	  lens	  through	  which	  we	  view	  
predictors	  of	  screening	  and	  recommendations.	  	  A	  focus	  on	  sociodemographic	  
characteristics	  of	  both	  patient	  and	  physician	  has	  ignored	  the	  growing	  reality	  of	  older	  
adults	  who	  face	  multiple	  chronic	  conditions	  that	  can	  interfere	  with	  preventative	  care	  at	  
	  	   128	  
the	  individual	  and	  institutional	  level.	  	  I	  hypothesized	  that	  MCC	  would	  be	  negatively	  
associated	  with	  the	  odds	  of	  screening	  recommendations	  and	  screening	  itself.	  	  My	  results	  
show,	  however,	  that	  although	  population	  rates	  were	  higher	  in	  those	  with	  MCC	  than	  the	  
population	  rate	  and	  their	  healthier	  counterparts,	  MCC	  was	  negatively	  associated	  with	  
both	  outcomes	  in	  multivariate	  models.	  	  Considering	  the	  results	  of	  earlier	  chapters	  
showing	  that	  the	  physician’s	  role	  is	  not	  as	  important	  as	  once	  thought,	  the	  impact	  of	  
MCC	  on	  reduced	  odds	  of	  screening	  in	  multivariate	  models	  may	  show	  that	  individual	  
level,	  not	  institutional,	  factors	  are	  likely	  to	  influence	  screening	  rates	  in	  individuals	  with	  
MCC.	  	  	  
The	  measures	  utilized	  in	  these	  studies	  designating	  testing	  as	  true	  screening	  or	  
diagnostic	  in	  nature	  are	  subject	  to	  limitations	  that	  merit	  further	  exploration.	  	  Patterning	  
of	  testing	  type	  across	  demographic	  categories	  may	  reflect	  differing	  interpretations	  of	  
the	  survey	  questions.	  	  However,	  the	  patterning	  of	  diagnostic	  testing	  across	  the	  age	  
continuum	  is	  still	  highly	  problematic	  and	  less	  likely	  to	  be	  the	  result	  of	  such	  a	  limitation.	  	  
Recall	  issues	  related	  to	  the	  timing	  of	  the	  testing	  may	  also	  affect	  these	  estimates.	  	  For	  
example,	  a	  respondent’s	  odds	  of	  remembering	  the	  impetus	  for	  testing	  nine	  years	  earlier	  
may	  be	  less	  reliable	  than	  another’s	  recall	  of	  a	  more	  recent	  test.	  	  Unfortunately,	  
cognitive	  testing	  on	  screening	  questions	  (and	  particularly	  their	  follow-­‐up	  questions)	  is	  
limited.	  	  Data	  provided	  in	  personal	  correspondence	  from	  the	  National	  Center	  for	  Health	  
Statistics	  (NCHS)	  shows	  that	  questions	  related	  to	  testing	  were	  tested	  on	  few	  
respondents,	  ranging	  from	  one	  to	  nine	  depending	  on	  modality.	  	  The	  follow-­‐up	  question	  
inquiring	  about	  the	  impetus	  for	  testing	  was	  only	  tested	  on	  two	  individuals,	  neither	  of	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who	  struggled	  to	  answer	  the	  question	  (B.	  Taylor,	  personal	  communication,	  June	  17,	  
2014).	  	  Future	  research	  on	  variation	  in	  interpreting	  this	  question	  is	  needed	  to	  
understand	  if	  any	  of	  the	  findings	  reported	  herein	  are	  due	  to	  measurement	  issues.	  
Despite	  these	  limitations,	  the	  results	  of	  these	  three	  studies	  challenge	  the	  
research	  community	  in	  several	  ways.	  	  The	  results	  speak	  loudly	  to	  the	  need	  for	  changes	  
in	  survey	  methodology	  in	  cancer	  screening.	  	  We	  must	  avoid	  the	  limitation	  of	  conflating	  
diagnostic	  testing	  and	  true	  screening	  by	  asking	  ‘why?’	  in	  cancer	  screening	  research.	  
Immediate	  changes	  in	  BRFSS	  methodologies	  are	  required	  so	  that	  we	  may	  begin	  to	  
accurately	  assess	  national-­‐	  and	  state-­‐level	  estimates	  of	  screening	  patterns.	  	  We	  must	  
critically	  examine	  assumptions	  that	  have	  been	  made	  based	  on	  BRFSS	  data	  including	  data	  
on	  trends,	  disparities,	  and	  health	  care	  quality	  benchmarks.	  	  We	  must	  also	  reassess	  the	  
importance	  and	  relevance	  of	  the	  physician	  recommendation,	  as	  it	  is	  not	  predictive	  of	  
screening	  when	  the	  outcome	  is	  correctly	  specified.	  	  Further	  research	  is	  necessary	  to	  
examine	  the	  nature	  of	  the	  relationship	  between	  MCC	  and	  CRC	  screening	  to	  determine	  
what	  aspects	  of	  MCC	  promote	  true	  screening	  and	  what	  aspects	  of	  MCC	  interfere	  with	  
appropriate	  and	  timely	  screening.	  	  Finally,	  cancer	  registries	  should	  consider	  the	  addition	  
of	  information	  on	  the	  method	  by	  which	  patients	  have	  been	  diagnosed	  with	  CRC.	  	  The	  
results	  of	  my	  studies	  are	  helpful	  to	  assess	  relationships	  among	  variables	  in	  individuals	  
without	  cancer,	  but	  understanding	  rates	  of	  diagnostic	  testing	  versus	  true	  screening	  and	  
comorbidities	  and	  their	  associations	  with	  stage	  at	  diagnosis	  will	  prove	  to	  be	  valuable	  as	  
we	  seek	  to	  improve	  public	  health.	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My	  results	  should	  also	  help	  inform	  the	  activities	  and	  focus	  of	  practitioners.	  	  The	  
health	  care	  system	  is	  faced	  with	  an	  enormous	  challenge	  of	  the	  generation	  entering	  
older	  adulthood.	  	  Unlike	  the	  generation	  that	  preceded	  them,	  this	  generation	  faces	  a	  
burden	  of	  chronic	  disease	  that	  is	  unprecedented.	  	  The	  resulting	  changes	  in	  health	  care	  
utilization	  including	  higher	  rates	  of	  specialty	  should	  not	  impact	  preventative	  care	  such	  
as	  CRC	  screening.	  	  Although	  the	  results	  of	  my	  second	  study	  show	  that	  a	  physician	  
recommendation	  is	  not	  predictive	  of	  true	  screening,	  the	  fact	  remains	  that	  CRC	  screening	  
remains	  an	  event	  that	  requires	  coordination	  and	  action	  of	  both	  practitioner	  and	  patient.	  	  
Extending	  responsibility	  of	  this	  coordinated	  effort	  outside	  of	  primary	  care	  will	  be	  critical	  
as	  these	  older	  adults	  enter	  the	  at-­‐risk	  age	  group	  for	  CRC.	  	  
Finally,	  the	  results	  of	  all	  of	  these	  studies	  are	  informative	  for	  policymakers.	  	  The	  
need	  for	  accountability	  for	  adequate	  data	  collection	  and	  accurate	  data	  analysis	  by	  
federally	  funded	  agencies	  is	  critical	  to	  the	  proper	  design	  and	  success	  of	  screening	  
interventions.	  	  The	  results	  support	  the	  need	  for	  continued	  funding	  to	  improve	  nationally	  
representative	  surveys	  to	  capture	  all	  data	  necessary	  to	  correctly	  specify	  behavioral	  
outcomes.	  	  In	  addition,	  the	  use	  of	  past	  BRFSS	  data	  should	  be	  avoided	  in	  future	  studies,	  
especially	  when	  assessing	  quality	  benchmarks	  (e.g.	  the	  Agency	  for	  Healthcare	  Research	  
and	  Quality	  Report).	  	  Finally,	  we	  need	  to	  critically	  examine	  the	  utility	  of	  Healthy	  People-­‐
style	  goals	  and	  benchmarks	  for	  screening.	  	  Federal	  goals	  and	  progress	  reports	  that	  are	  
not	  specific	  to	  subgroups	  miss	  the	  problematic	  variation	  in	  rates	  and	  the	  unique	  
multilevel	  contexts	  that	  drive	  that	  variation.	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Overall,	  I	  found	  that	  there	  are	  many	  answers	  to	  the	  question	  of	  “What	  are	  we	  
missing?”	  	  Challenging	  the	  status	  quo	  of	  methodological	  approaches	  to	  survey	  design	  
and	  analysis	  as	  well	  as	  valid	  suspects	  for	  predictors	  of	  screening	  led	  to	  significant	  
findings	  in	  the	  estimation	  of	  screening	  rates,	  rates	  of	  screening	  recommendations,	  and	  
the	  role	  that	  MCC	  plays	  in	  the	  odds	  of	  both.	  	  The	  results	  have	  implications	  for	  these	  
areas	  as	  well	  as	  trends	  in	  screening	  rates	  over	  time	  (which	  may	  reflect	  increasing	  
diagnostic	  testing,	  not	  screening),	  intervention	  effectiveness	  (counting	  colonoscopies	  
pre-­‐	  and	  post-­‐intervention	  is	  inadequate)	  and	  disparities	  (changes	  in	  rates	  resulted	  in	  
reductions	  in	  some	  disparities	  and	  increases	  in	  others).	  I	  hope	  to	  extend	  this	  research	  to	  
other	  outcomes	  including	  mammography,	  where	  the	  same	  methodological	  limitations	  
are	  present	  in	  the	  literature.	  	  In	  the	  end,	  I	  hope	  that	  these	  studies	  lead	  to	  improvements	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